Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRP,Agouti-related protein,42754,0.269633093105319,0.00483992171207347,0.260146846549655,0.279119339660983,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN1,CCN family member 1,42569,0.351813031725482,0.00699834915637206,0.338096267378992,0.365529796071971,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLR,Low-density lipoprotein receptor,42644,0.404608416684834,0.00399281014745139,0.396782508795829,0.412434324573839,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPL,Lipoprotein lipase,42636,-0.186043519962195,0.0045586705739793,-0.194978514287195,-0.177108525637196,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFGE8,Lactadherin,42611,0.216827949582303,0.00412070586304139,0.208751366090742,0.224904533073864,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPY,Pro-neuropeptide Y,42721,0.3393771962948,0.00601193317736731,0.32759380726716,0.35116058532244,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.14338376059917,0.00321153330288028,0.137089155325525,0.149678365872816,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0853047528895875,0.00215870108385512,0.0810736987652315,0.0895358070139436,1.11253692925583e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.285647308908865,0.00734861037571662,0.27124403257246,0.30005058524527,1.12557338337421e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHR,Growth hormone receptor,40283,0.106780841989211,0.00276766326407162,0.10135622199163,0.112205461986791,1.09710006695041e-305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES1,Liver carboxylesterase 1,42661,0.303625826985538,0.00798057475585483,0.287983900464063,0.319267753507014,6.32214433729577e-301
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.119660717182605,0.00324208013434699,0.113306240119285,0.126015194245925,3.2505023288364e-284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FURIN,Furin,42679,0.118741666843434,0.00322431540611416,0.11242200864745,0.125061325039418,5.5184340800129e-283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADIPOQ,Adiponectin,40539,-0.251192184168196,0.00679066873591841,-0.264501894890596,-0.237882473445796,6.73034160039626e-283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCG,Pro-glucagon,42346,0.449455105393237,0.0125178431786488,0.424920132763086,0.473990078023389,2.03963892726512e-269
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.148924351626083,0.00418886089112645,0.140714184279475,0.15713451897269,1.0102230917495e-264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF9,Protein turtle homolog A,40511,0.289246530158259,0.00817949484681624,0.273214720258499,0.305278340058018,6.52801374720181e-260
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F7,Coagulation factor VII,42671,0.106494410779171,0.00308204777379985,0.100453597142524,0.112535224415819,9.39330327666497e-251
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBC,Inhibin beta C chain,42611,0.138432793042978,0.00408437433349737,0.130427419349323,0.146438166736633,1.11303294715593e-241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,42705,0.158468471927138,0.00468145268030437,0.149292824673742,0.167644119180535,3.65774570343867e-241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL23,C-C motif chemokine 23,42676,0.140534367498828,0.00418031825332924,0.132340943722303,0.148727791275353,5.28540551528902e-238
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH,Parathyroid hormone,40182,0.271044590314687,0.0081253907714348,0.255118824402675,0.2869703562267,1.72974922036924e-232
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL27,C-C motif chemokine 27,42636,0.193733476596346,0.00587836010539,0.182211890789782,0.20525506240291,3.86493502479706e-229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.283730463502234,0.00862204471626449,0.266831255858355,0.300629671146112,1.87999931979002e-228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLTP,Phospholipid transfer protein,42752,-0.11766134938071,0.00357867749521322,-0.124675557271328,-0.110647141490092,3.59073444907747e-228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.266575600521631,0.00810485146689746,0.250690091646512,0.28246110939675,4.4862317798158e-228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP1,Neuropilin-1,42705,-0.0904114756168675,0.00277455110599191,-0.0958495957846117,-0.0849733554491234,2.75548867795233e-224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,40527,0.133523241695345,0.00412915845281381,0.12543009112783,0.14161639226286,1.66371675924186e-219
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,42594,0.171930227447939,0.00538665302255592,0.161372387523729,0.182488067372149,1.58883456364413e-215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.253157119030145,0.00793375880992854,0.237606951762685,0.268707286297605,2.09284158622239e-215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.10842162125109,0.00345155174047748,0.101656579839754,0.115186662662426,4.03895812929904e-209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.469325995299593,0.0150253806743259,0.439876249177915,0.498775741421272,9.55210370857208e-207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROC,Vitamin K-dependent protein C,42663,0.0785077406390994,0.00251605989454636,0.0735762632457885,0.0834392180324103,1.98811978610354e-206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.325783244930926,0.0104559669032208,0.305289549800614,0.346276940061239,8.07000939309499e-206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG2,Desmoglein-2,42611,-0.0849171649558677,0.0027296375921765,-0.0902672546365337,-0.0795670752752018,3.19417869309111e-205
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,40387,0.0978378663098717,0.00314487191168708,0.091673917362965,0.104001815256778,7.16253475630387e-204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,42570,0.0961875083630066,0.00310956720459282,0.0900927566420047,0.102282260084009,5.58236194333249e-203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN3,Contactin-3,42611,0.0965657506689615,0.00312909968150435,0.090432715293213,0.10269878604471,4.28133510223388e-202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APCS,Serum amyloid P-component,40419,0.105148378657142,0.00341203037484742,0.0984607991224413,0.111835958191843,2.94961100449961e-200
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTR,Transthyretin,40424,0.0763828093696653,0.00252602822050937,0.071431794057467,0.0813338246818637,3.61129612409718e-193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR37,Prosaposin receptor GPR37,42357,0.206237413485469,0.00685307357642227,0.192805389275681,0.219669437695257,1.76463689251042e-192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCHE,Cholinesterase,40346,0.0826656263210869,0.00279054270929474,0.0771961626108692,0.0881350900313046,1.03372531357579e-185
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9,Complement component C9,40532,-0.155340912241687,0.00531694181782099,-0.165762118204616,-0.144919706278758,5.53555358773828e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.172851881706577,0.00593862550712969,-0.184491587700551,-0.161212175712603,1.28496589238732e-180
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.331452892994965,0.0114285486267494,0.309052937686536,0.353852848303394,1.99383257635396e-179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,42754,0.221598438033357,0.007703054233136,0.206500451736411,0.236696424330304,1.04733881461792e-176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.234199324093189,0.00817745549414256,0.21817151132467,0.250227136861708,4.74500163655617e-175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA4,Kallistatin,40342,0.0692010583463516,0.00241964422643878,0.0644585556625316,0.0739435610301716,1.1489745154566e-173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.199905561092045,0.00701690178027661,0.186152433602702,0.213658688581387,2.23776692128585e-173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPM,Carboxypeptidase M,42655,0.0967534502313604,0.00339829878572383,0.0900927846113417,0.103414115851379,3.42867551500685e-173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIP2,Cysteine-rich protein 2,42495,0.10478208530688,0.00369429994097995,0.0975412574225594,0.112022913191201,7.11111797480781e-172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUSB,Beta-glucuronidase,42711,0.173166984006497,0.00611411129000602,0.161183325878085,0.185150642134909,1.7649201140088e-171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,42618,0.088236901454918,0.00311819519844683,0.0821252388659622,0.0943485640438738,3.72684688607087e-171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.176424952936196,0.00625285662970145,-0.188680551930411,-0.164169353941981,2.96822573631094e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.341067538754487,0.0121202902573156,-0.364823307658826,-0.317311769850149,2.18618943797834e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFP,Properdin,40539,0.0630888740173291,0.00224233300334147,0.0586939013307798,0.0674838467038784,2.01845913969526e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCA,Alpha-synuclein,40283,0.323152359792297,0.0115585507416354,0.300497600338691,0.345807119245902,2.83946764195216e-166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS15,Enteropeptidase,42587,0.255727371654147,0.0092069225598524,0.237681803436837,0.273772939871458,3.91001854384007e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0871917269046494,0.00313435618221384,-0.0933350650217885,-0.0810483887875103,1.09004121730734e-164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,42611,0.0748014687492518,0.00270059815322299,0.0695082963689347,0.0800946411295689,2.93472474219388e-164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.164878525338772,0.00596034221962164,0.153196254588314,0.176560796089231,9.1374970990476e-164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.143545660363901,0.00523075105819308,0.133293388289843,0.15379793243796,2.16039878432044e-161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,40511,0.154259520913339,0.00562990307742164,0.143224910881592,0.165294130945085,4.27927964633589e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFM,Afamin,40539,0.0543106064437634,0.00200868603583928,0.0503735818135184,0.0582476310740083,4.39638530828997e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFH,Complement factor H,39956,0.0622465719220196,0.00230176059779988,0.0577351211503318,0.0667580226937074,6.94110347847934e-156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.198352233234486,0.00736237693227821,0.183921974447221,0.212782492021751,1.04586730829214e-155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0534097795012777,0.00199915364204618,0.0494914383628672,0.0573281206396883,3.87268610042612e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LG,CMRF35-like molecule 9,42611,-0.103783989937599,0.00389237215140954,-0.111413039354361,-0.0961549405208361,1.14659102709409e-152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0510936809033195,0.0019169832740271,0.0473363936862263,0.0548509681204126,1.51184401793172e-152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0680881074903714,0.00257998312443081,0.063031340566487,0.0731448744142558,1.14364850980652e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAT,Tissue-type plasminogen activator,42760,0.133922851683153,0.00510767192184291,0.123911814716341,0.143933888649965,7.36932512707933e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUMB,Protein numb homolog,40199,0.215605109528849,0.00828704454326104,0.199362502224057,0.23184771683364,7.19642157242492e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA3,Glutathione S-transferase A3,42346,0.200492946550478,0.00772646309023014,0.185349078893626,0.215636814207329,8.00118660997464e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR3,Anterior gradient protein 3,42326,0.15633498774651,0.00606268353517948,0.144452128017558,0.168217847475462,4.44012408125029e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,42495,0.0796353120666605,0.00309384377803431,0.0735713782617133,0.0856992458716078,1.2593148831732e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF21,Fibroblast growth factor 21,42689,0.305409410242209,0.0118688125676188,0.282146537609676,0.328672282874742,1.36539991843329e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,42346,0.286039564827116,0.0111145265949762,0.264255092700963,0.307824036953269,1.52707531999513e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFI,Complement factor I,40539,0.0509614224311704,0.00197653415215286,0.0470874154929508,0.05483542936939,1.65712310499256e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,42640,0.104400289708737,0.00406299319911298,0.0964368230384756,0.112363756378998,3.45443251769918e-142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,P4HB,Protein disulfide-isomerase,42563,0.0985796955958071,0.00387773873714475,0.0909793276710034,0.106180063520611,2.85660756203418e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,42587,0.316186976136728,0.0124797578264258,0.291726650796934,0.340647301476523,2.26764645642967e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO3,Beta-enolase,40223,0.151050436961802,0.00595991296145719,0.139369007557346,0.162731866366258,8.67421789197284e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,40351,0.0681926878322491,0.00269864167018078,0.0629033501586948,0.0734820255058034,4.75428776664756e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.176573961737628,0.00699193692326744,0.162869765368024,0.190278158107232,6.36187844911893e-137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,40199,0.215116380370683,0.00852283071835838,0.198411632162701,0.231821128578666,1.0759405377462e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHBG,Sex hormone-binding globulin,40532,-0.128790612874753,0.00510545517470191,-0.138797305017168,-0.118783920732337,1.16702520243133e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.141103973074703,0.00561482846647304,0.130098909280416,0.15210903686899,3.63820967078658e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.186944121897112,0.00747567537494238,0.172291798162225,0.201596445631999,6.6080482679338e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,42658,0.0833650003252437,0.00334766454989515,0.0768035778074492,0.0899264228430382,7.31198418074622e-134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,40482,0.144664885549457,0.00581953796051602,0.133258591146846,0.156071179952069,7.52588203064435e-133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,42676,-0.0713848991898357,0.00288759000889773,-0.0770445756072753,-0.0657252227723962,5.37089251314796e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,42573,-0.156628740359806,0.00634111050083712,-0.169057316941447,-0.144200163778165,9.2311107779322e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0853826596583794,0.00346469285222159,-0.0921734576487337,-0.078591861668025,3.18503115206647e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.344888865250543,0.0139826344441918,0.317482901739927,0.372294828761159,7.2076161944612e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL16,C-C motif chemokine 16,42794,0.130044933741582,0.00530081807543859,0.119655330313723,0.140434537169442,4.32799010371427e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTYMK,Thymidylate kinase,40511,0.168272336096086,0.00687443231069,0.154798448767134,0.181746223425038,5.52507591407236e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLA,Alpha-galactosidase A,40267,0.0921791169714486,0.00377099924151111,0.0847879584580868,0.0995702754848103,1.4269686140478e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR5,Cadherin-related family member 5,42636,0.0955011551354562,0.00393320110372823,0.0877920809721489,0.103210229298764,1.70920058838598e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",42311,0.134655986016346,0.00556195916209585,0.123754546058638,0.145557425974054,1.02651319158459e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOMO1,Nodal modulator 1,42611,0.0565800235216627,0.0023501476949931,0.0519737340394763,0.0611863130038492,2.04550240793711e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPIND1,Heparin cofactor 2,40516,0.0686599024523621,0.00284759052802966,0.0630786250174239,0.0742411798873002,2.64037746486375e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS1,Protein MTSS 1,40449,0.272237706884984,0.0113060881328399,0.250077774144618,0.29439763962535,5.83338441335159e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYAP1,Synapse-associated protein 1,40283,0.139389858647168,0.00579752740661742,0.128026704930198,0.150753012364138,1.47348095366029e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.165323856506776,0.00689423137050619,0.151811163020583,0.178836549992968,2.06374544431456e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKB,Creatine kinase B-type,40527,-0.146912450428036,0.00612210296105024,-0.158911772231695,-0.134913128624378,3.621855327956e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F9,Coagulation factor IX,42663,0.0439009571425016,0.00183377792390573,0.0403067524116464,0.0474951618733568,4.48945858615535e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.138650396386501,0.00579419288849198,0.127293778325056,0.150007014447945,2.05832382752748e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0904792572930586,0.00381383649133941,-0.0979543768160839,-0.0830041377700334,6.29032211772044e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,42679,0.218976332452917,0.00925785083648394,0.200830944813408,0.237121720092425,3.1771264313641e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0992061355143024,0.00420296995924009,-0.107443956634413,-0.0909683143941918,9.99966582365569e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPB1,Beta-ureidopropionase,40511,0.21539637411569,0.00911752041744215,0.197526034097504,0.233266714133877,1.73332199262784e-120
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EEF1D,Elongation factor 1-delta,40511,0.218114859838279,0.00926320914048523,0.199958969922928,0.23627074975363,1.00602855703184e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRP,Gastrin-releasing peptide,40223,0.133788714948591,0.00569349298250793,0.122629468702875,0.144947961194306,3.47675125016955e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,42679,0.058864588085899,0.002512114141639,0.0539408443682866,0.0637883318035114,4.71937140096068e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY1,Aminoacylase-1,42636,0.143885284577197,0.00614333594444079,0.131844346126093,0.155926223028301,6.14198455953349e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA1,Glutathione S-transferase A1,42611,0.195981996884252,0.00836769902777787,0.179581306789808,0.212382686978697,6.21823345027262e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.161453435214608,0.0068796153108276,0.147969389205386,0.17493748122383,7.27849159025719e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,42679,0.0532371067346508,0.0022762404786495,0.0487756753964978,0.0576985380728038,1.27551825017166e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLKB1,Plasma kallikrein,40293,0.0586275701388327,0.00250227153145225,0.0537231179371863,0.0635320223404791,1.55756711910242e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRN,"Attractin, Isoform 2",40539,0.0398093035911709,0.00170156105332286,0.0364742439266581,0.0431443632556837,2.90064487215928e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL16,Pro-interleukin-16,42754,0.0979982169375823,0.00420066223044558,0.0897649189659089,0.106231514909256,4.66521543616032e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,42587,0.267387430788732,0.0115064362737794,0.244834815692124,0.289940045885339,3.84195957172581e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,40182,0.284252901026343,0.0122285706668145,0.260284902519387,0.308220899533299,1.01827063207135e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FYB1,FYN-binding protein 1,42590,0.21613381398464,0.00933399511478559,0.19783918355966,0.23442844440962,2.42536708050728e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,42711,0.147236823292096,0.00637739869226793,0.134737121855251,0.159736524728942,1.06061701005855e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,42587,0.156484796463253,0.0067889970579805,0.143178362229611,0.169791230696895,2.55794946891872e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0738036311803734,0.00320434830659951,0.0675231084994384,0.0800841538613084,3.56869396510981e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORT1,Sortilin,42613,0.0864379468798616,0.00375625297692151,0.0790756910450955,0.0938002027146278,5.89060058926101e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH9,Myosin-9,40527,0.266705789377111,0.0116258959797719,0.243919033256758,0.289492545497464,7.00492559787747e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJAP1,Tight junction-associated protein 1,42679,0.191219001162288,0.00836680197644764,0.174820069288451,0.207617933036125,1.86153602145716e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP5,Retinol-binding protein 5,42587,0.129748720175189,0.00567852285284766,0.118618815383608,0.140878624966771,2.17051333506757e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYNU,Kynureninase,42754,0.103279718403725,0.00452448949846245,0.094411718986739,0.112147717820712,3.33483430003311e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.112503692469692,0.00493300926531928,0.102834994309666,0.122172390629718,5.85864032228885e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0447114854684203,0.00196534305861638,0.0408594130735322,0.0485635578633084,1.80371165629799e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.100858004561721,0.00443626241904893,0.0921629302203848,0.109553078903057,2.66743386537418e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,42476,0.054300901220862,0.00239093331542387,0.0496146719226312,0.0589871305190927,4.66907214290814e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.222553864607607,0.00980868538205955,0.203328841258771,0.241778887956444,7.20116400725459e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,40456,0.250483944890024,0.011025342244013,0.228874274091759,0.27209361568829,9.25716182382382e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPY30,Protein dpy-30 homolog,42651,0.139017152995916,0.00613365795370421,0.126995183406656,0.151039122585177,1.2153438055294e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLUL1,Clusterin-like protein 1,42621,-0.103565903184395,0.00457147185414338,-0.112525988018516,-0.0946058183502735,1.52209531504899e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.205108633669046,0.00905521939891265,0.187360403647177,0.222856863690915,1.74706584726528e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.091407651369658,0.00405393496732508,0.0834619388337008,0.0993533639056151,1.58756781357573e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HJV,Hemojuvelin,40482,0.10126340248893,0.00448365892104234,0.0924754310036867,0.110051373974173,1.6735469096801e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.180700848805486,0.00802405953368803,0.164973692119457,0.196428005491514,6.94277306268875e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0764031515003132,0.00341799486953245,0.0697038815560296,0.0831024214445968,1.08046428901804e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLN,Promotilin,42594,0.201001464579287,0.00904952335042363,0.183264398812456,0.218738530346117,2.28910927050287e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F10,Coagulation factor X,40532,0.0641579867688421,0.00288544758872835,0.0585025094949345,0.0698134640427497,3.0289627833111e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.218712980871729,0.00986245342083907,0.199382572166884,0.238043389576573,4.85551731214091e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4R,Reticulon-4 receptor,42721,0.0776057999902081,0.00351135075164772,0.0707235525169786,0.0844880474634377,2.31301529464206e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH1,Somatotropin,42613,-0.386534494350529,0.0174884194794077,-0.420811796530168,-0.35225719217089,2.3472763776352e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROS1,Vitamin K-dependent protein S,40539,0.0588985308599429,0.00266090316565088,0.0536831606552672,0.0641139010646187,2.55476914331392e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES3,Carboxylesterase 3,42587,0.158147596983197,0.00717961827591735,0.144075545162399,0.172219648803995,1.17266970311053e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.18128951916455,0.00825202289353844,0.165115554293215,0.197463484035886,3.88131364757163e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAB2,Stabilin-2,40527,0.0627445449253054,0.00285616858828297,0.0571464544922708,0.0683426353583401,8.78289790976983e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BECN1,Beclin-1,40223,0.133675317002283,0.00609233123225606,0.121734347787061,0.145616286217504,1.75671389679035e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11R,Junctional adhesion molecule A,42611,0.12373121590796,0.00565490730992811,0.112647597580501,0.134814834235419,2.63880839277945e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0612369233829959,0.00280582815400726,0.0557375002011417,0.0667363465648502,8.5629969351978e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.186787844585563,0.0085523779881596,0.17002518372877,0.203550505442356,1.47193218902217e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXLNA,Alpha-taxilin,42495,0.194749176787749,0.00893716797660369,0.177232327553606,0.212266026021892,1.80739992079637e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN2,Ficolin-2,42597,0.091165969347235,0.00418764201805928,0.0829581909918388,0.0993737477026312,2.71035245680577e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2AP,CD2-associated protein,42636,0.140996106649085,0.00647776526104098,0.128299686737445,0.153692526560726,2.9191108937311e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0703922641659126,0.00323621564052477,0.064049281510484,0.0767352468213412,3.92083556814315e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,42594,0.0934418098671694,0.00429843058378185,0.085016885922957,0.101866733811382,5.28279207713485e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.120388377614286,0.00554649490566649,0.10951724759918,0.131259507629393,1.06644564374733e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0521269860924927,0.00240573088998529,0.0474117535481215,0.0568422186368638,2.27845983752439e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.246697075740489,0.0113737203825477,0.224404583790696,0.268989567690283,3.30216533691072e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.117395605751717,0.00544791147003515,0.106717699270448,0.128073512232986,2.9058880085912e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.231658898598032,0.0107717069038584,0.21054635306647,0.252771444129595,6.8495851289984e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,42636,0.0672275418440843,0.00312636413584944,0.0610998681378194,0.0733552155503493,7.17643115773562e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0665081825633328,0.00309152577812147,0.0604487920382147,0.0725675730884509,1.23044346989133e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREG1,Protein CREG1,42445,0.0843539859630078,0.00393392220700511,0.0766434984372778,0.0920644734887378,2.67969674433181e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0873295453605461,0.00406685419198165,0.079358511144262,0.0953005795768301,2.75277203342268e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXIN1,Axin-1,42594,0.206535523649861,0.00964176358690762,0.187637667019522,0.2254333802802,4.03755731759233e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A4,Protein S100-A4,42679,0.123841351184382,0.00580501170221869,0.112463528248034,0.135219174120731,2.41196682369218e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN1,Dynactin subunit 1,42721,0.140440934116631,0.00658878618419195,0.127526913195614,0.153354955037647,3.48673550049795e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.174962848673318,0.00819671694143028,0.158897283468114,0.191028413878521,3.88224752428547e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEG1,Protein HEG homolog 1,40283,0.058648488098267,0.00274771345179215,0.0532629697327544,0.0640340064637796,4.25930707052797e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0470042133716596,0.00220360244364954,0.0426851525821065,0.0513232741612127,5.66064223893262e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,42370,0.183935019888698,0.00864657328338888,0.166987736253255,0.20088230352414,9.24884527983248e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.180187032152522,0.00847314358328331,0.163579670729286,0.196794393575757,2.1446794905041e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC1,Stanniocalcin-1,42711,0.0978594112564078,0.00461405159769125,0.0888158701249329,0.106902952387883,3.11980596153302e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,40317,0.0292269850576358,0.00137999726453391,0.0265221904191494,0.0319317796961223,1.24384350898552e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.183712885876261,0.0087172820334595,0.16662701309068,0.200798758661841,9.87706728167666e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,40116,0.136193819604005,0.00646903822786908,0.123514504677381,0.148873134530628,1.73942600626911e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS2,Protein MTSS 2,40451,0.211167233279522,0.0100351437033922,0.191498351620873,0.230836114938171,1.8912131261142e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPC,C-type natriuretic peptide,42594,0.107449280109479,0.00512558180984948,0.0974031397621737,0.117495420456784,4.89883129481352e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM20A,Pseudokinase FAM20A,40511,0.0604421927856865,0.0028818570850257,0.0547937528990361,0.0660906326723369,7.55380560771353e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAXX,Protein PAXX,40283,0.0970496698631148,0.00462985915695023,0.0879751459154924,0.106124193810737,1.03977093749288e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.207550400997532,0.00990371662056277,0.188139116421229,0.226961685573835,1.06635837896305e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,42754,0.0867488602821478,0.004146474309188,0.0786217706361393,0.0948759499281563,1.10949990391789e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.140591978107145,0.00673166221675883,0.127397920162298,0.153786036051992,2.55479511239289e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFC,Platelet-derived growth factor C,42346,0.0608336612362599,0.00291594904872576,0.0551184011007575,0.0665489213717624,4.05325722875116e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0848815628703372,0.00407929462662371,-0.0928769803385197,-0.0768861454021547,1.1324813081797e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,40483,0.100842174191556,0.00484973294405603,0.0913366976212061,0.110347650761906,2.87053833029498e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.151644617345021,0.00735018958126507,0.137238245765741,0.1660509889243,4.24492553270844e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,42754,0.0695271983945833,0.00337108731628833,0.0629198672546581,0.0761345295345084,4.40499496251822e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHBP1,EH domain-binding protein 1,40511,0.15604520269975,0.00756277093777731,0.141222171661706,0.170868233737794,6.97816372766111e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZN,Kazrin,40449,0.21895278165303,0.0106151886897108,0.198147011821197,0.239758551484863,8.1886466363414e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL22,C-C motif chemokine 22,42509,0.111496181598088,0.00541571608570595,0.100881378070104,0.122110985126072,9.80860059568266e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARF6,ADP-ribosylation factor 6,40449,0.224771920517242,0.0109157064032062,0.203377135966958,0.246166705067526,1.63580522734245e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,42346,0.134080379497473,0.00652990596723921,0.121281763801684,0.146878995193262,3.01635648003167e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.151691496711739,0.00737682369977471,0.13723292226018,0.166150071163297,3.10656382615919e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD63,CD63 antigen,42475,0.106635172697245,0.00521871797579093,0.0964064854646948,0.116863859929795,2.14141944824457e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.116233105154334,0.00569438554083019,0.105072109494307,0.127394100814361,3.35351895281476e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.215543170373978,0.0105690318964944,0.194827867856849,0.236258472891107,4.54792386592138e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,42311,0.16239119217527,0.00796442065783013,0.146780927685923,0.178001456664618,5.29232440906664e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.222854139645184,0.0109319774948977,0.201427463755185,0.244280815535184,9.56911467836171e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXT,Oxytocin-neurophysin 1,42711,0.287452695965397,0.0141390479766708,0.259740161931122,0.315165229999672,1.5546405285631e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R9B,Neurabin-2,42754,0.194103489731578,0.00955165908166306,0.175382237931518,0.212824741531638,1.83851594824737e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0425637822995976,0.00209444965775443,0.038458660970399,0.0466689036287963,1.88482556996897e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCS1,Neuronal calcium sensor 1,42721,0.0600881416558246,0.00295719229174896,0.0542920447639967,0.0658842385476526,1.93146727936561e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR2,Cadherin-related family member 2,42587,0.146444629524234,0.00721328207876913,0.132306596649847,0.160582662398622,2.79896909117e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,40116,0.140714186367888,0.00694160137664102,0.127108647669672,0.154319725066104,1.02248491389478e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,42594,0.187733608457434,0.00928260555301601,0.169539701573523,0.205927515341346,1.29594260141024e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBIN,Erbin,42587,0.208698882104396,0.0103991132531077,0.188316620128305,0.229081144080488,2.72615747275304e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTD,Biotinidase,40539,0.0422557491699099,0.00210366621852687,0.0381325633815973,0.0463789349582226,3.26414545696137e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORD,Sorbitol dehydrogenase,42658,0.136578985347612,0.00683083995210779,0.12319053904148,0.149967431653743,1.14638491923591e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,40283,0.151826896314386,0.00759274749324622,0.136945111227624,0.166708681401149,2.03969363828595e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,42676,0.251573734475749,0.012606837667943,0.226864332646581,0.276283136304918,2.4441867959743e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0598719646897075,0.00299757045880855,0.0539967265904428,0.0657472027889723,3.01353466703002e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0751315771000937,0.00377504541433729,0.0677324880879926,0.0825306661121948,6.85552296715914e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.136326339810481,0.00684255253907484,0.122914936833895,0.149737742787068,7.79877681461442e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3F,Semaphorin-3F,42636,0.0550655730053762,0.00277459521441638,0.0496273663851201,0.0605037796256324,2.03786267226989e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.220514954733741,0.0111055597551781,0.198748057613592,0.242281851853891,2.92550406962902e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.149189874728153,0.00752007197207037,0.134450533662895,0.163929215793411,4.46411953136504e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOST,Sclerostin,42613,0.0788550146102784,0.0039834717529848,0.0710474099744282,0.0866626192461286,5.45929948835124e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,40449,0.170522036372487,0.00861204992999628,0.153642418509694,0.187401654235279,8.45198601514819e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.100156683196833,0.00506654388822688,0.0902262571759082,0.110087109217758,9.77022020644728e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,40483,0.17905732382488,0.00905138161145214,0.161316615866434,0.196798031783326,1.18372091102789e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.116137404342913,0.00587983986763369,0.104612918202351,0.127661890483475,1.2993558421078e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM1,Isthmin-1,42594,0.0777025295397581,0.00393777729580825,0.0699844860399739,0.0854205730395422,1.8421151881361e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHK,Ketohexokinase,40223,0.126483118238196,0.00640760919737297,0.113924204211345,0.139042032265047,2.89900166315831e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FN1,Fibronectin,40539,0.0536894334733789,0.00272421836335383,0.0483499654812054,0.0590289014655525,4.81207285655871e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCR,Breakpoint cluster region protein,42594,0.183033356793303,0.00930436378054171,0.164796803783441,0.201269909803164,5.91958946370522e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.111023723642829,0.00564560858674481,0.0999583308128094,0.122089116472849,7.16803837484918e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP20,Centrosomal protein 20,42346,0.150181773616618,0.00764511846736562,0.135197341420581,0.165166205812654,1.05735281221967e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0593025558771869,0.00301757704451535,0.0533881048699368,0.065217006884437,1.4069464315421e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAB2,Disabled homolog 2,42721,0.218411947689181,0.0111441048459065,0.196569502191204,0.240254393187158,2.32935838705191e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0512145702010247,0.00261418999166764,0.0460907578173561,0.0563383825846933,2.69084880594419e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNA4,Plexin-A4,42594,0.163834979060949,0.00837367281683868,0.147422580339945,0.180247377781953,4.5174737218989e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRN,Agrin,42676,0.0726354190091716,0.00372140467698884,0.0653414658422734,0.0799293721760697,1.0927375278681e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.147796276216689,0.00758414551409451,0.132931351009063,0.162661201424314,3.21336250476349e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,42676,0.134637889676634,0.00691868572080018,0.121077265663866,0.148198513689402,3.30540027354564e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGF,Hepatocyte growth factor,42754,0.0691380852074541,0.00356355675807013,0.0621535139616367,0.0761226564532716,9.89146705531212e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN2,Prorelaxin H2,40257,0.0991822660651427,0.00510528244517609,0.0891759124725976,0.109188619657688,1.07217956434736e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.225030611273093,0.0115930361430748,0.202308260432666,0.247752962113519,1.38803859969169e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.127587035701928,0.00659558591257891,0.114659687313274,0.140514384090583,3.14659580695047e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLA2,Src-like-adapter 2,40482,0.204783911766348,0.0105943961471552,0.184018895317923,0.225548928214772,6.35590051558549e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0980047690836229,0.00507645745703143,0.0880549124678413,0.107954625699405,1.04558945307901e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.134014912137333,0.00696073299579917,0.120371875465566,0.147657948809099,1.7462792602816e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCLY,Selenocysteine lyase,42674,0.0918607009769618,0.00478370856053765,0.082484632198308,0.101236769755616,4.22865252730938e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.192273959067349,0.0100161012266552,0.172642400663104,0.211905517471593,4.69344378707347e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,42587,0.268175950520711,0.0139857081566235,0.240763962533729,0.295587938507693,7.23372840146239e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.1189802278364,0.00620971528771533,0.106809185872478,0.131151269800322,1.00180791614894e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK1,Dickkopf-related protein 1,42711,0.114962173425059,0.00600274359967578,0.103196795969694,0.126727550880423,1.09566712830412e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPY,Pancreatic prohormone,42600,0.203226913820414,0.0106116297474654,0.182428119515382,0.224025708125446,1.12336195817047e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTBS,Di-N-acetylchitobiase,40383,0.0525058434394279,0.00274018404078869,0.0471350827194821,0.0578766041593737,1.50541357109487e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.208715538607602,0.0108974767059414,0.187356484263957,0.230074592951247,1.71537348912051e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.135164662160655,0.00706402485230925,0.121319173450129,0.149010150871182,2.43318649570572e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,42711,0.185946699165776,0.00973702608021264,0.16686212804856,0.205031270282993,3.0445785159431e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.141880741338459,0.00743781282081729,0.127302628209657,0.156458854467261,4.55504493663271e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD6,T-cell differentiation antigen CD6,42746,0.102998054564764,0.00540319466267098,0.092407793025929,0.113588316103599,5.74711403340837e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEFTY2,Left-right determination factor 2,42689,0.0975678584135932,0.00511898897135733,0.0875346400297328,0.107601076797454,6.07565583368305e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0527163753794871,0.00277212690383049,0.0472830066479793,0.0581497441109948,1.38742801863175e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BACH1,Transcription regulator protein BACH1,42594,0.141704904432731,0.00746728489947156,0.127069026029766,0.156340782835695,2.89767197184184e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUCB2,Nucleobindin-2,42683,0.0717322621060609,0.00378191092017389,0.0643197167025201,0.0791448075096017,3.40630489251293e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.144465036837786,0.00760821871639453,0.129552928153653,0.15937714552192,3.89361184424056e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.198521508168643,0.0104643169466116,0.178011446953285,0.219031569384002,5.30095103163031e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.215105696442911,0.0113583849481948,0.192843261944449,0.237368130941373,5.9332964325156e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,42676,0.201890637084417,0.0106836029666306,0.180950775269821,0.222830498899013,1.24357086243496e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EZR,Ezrin,42711,0.0461536911360868,0.00244445702456362,0.0413625553679421,0.0509448269042315,1.66956098284907e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0423005305599998,0.00224274935483738,0.0379047418245185,0.0466963192954811,2.52278240280672e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,40199,0.153628848324472,0.00813470925602465,0.137684818182664,0.16957287846628,2.57682402557844e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.161313403969373,0.00854604075753272,0.144563164084609,0.178063643854137,2.87606719606526e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB2,Carboxypeptidase B2,40516,0.0428273323827743,0.00227284466588919,0.0383725568376315,0.0472821079279171,5.20091266940485e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FETUB,Fetuin-B,42663,0.0619538720613364,0.00329249317214944,0.0555005854439235,0.0684071586787493,5.49576149587239e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.222461818833988,0.0118300446779859,-0.24564870640284,-0.199274931265135,6.86902844944217e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.133401851815562,0.00709516734994449,0.11949532380967,0.147308379821453,7.60024011645237e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPD52L2,Tumor protein D54,40283,0.206041810994655,0.0109466187159622,0.184586438311369,0.22749718367794,8.02786294990851e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,42636,0.16629988816476,0.00885255086112018,0.148948888476965,0.183650887852556,9.78810425898335e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINK1,Misshapen-like kinase 1,40483,0.178162915520758,0.00947332118350393,0.15959520600109,0.196730625040425,1.01768713168983e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,40482,0.118962889835737,0.00632833658644266,0.106559350126309,0.131366429545165,1.18605033949627e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.201544528624262,0.0107486364730029,0.180477201137177,0.222611856111348,1.87449943560992e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.183120592590992,0.00977287968890332,0.163965748400742,0.202275436781243,2.33912931523865e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSD,Cathepsin D,41747,0.0809582297759538,0.00432030902776731,0.0724904240815299,0.0894260354703777,2.69008797152429e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPK2,SRSF protein kinase 2,42594,0.159291162862915,0.00852565034111075,0.142580888194338,0.176001437531492,6.3534995971274e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO1,Forkhead box protein O1,42594,0.161555604610937,0.00867781479282344,0.144547087617003,0.178564121604871,2.14228366712949e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.076082698019611,0.00408615219944201,0.0680738397087047,0.0840915563305174,3.09378262188227e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,40451,0.104538275354758,0.00562892853778833,0.0935055754206926,0.115570975288823,7.37423519832066e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.195083370671507,0.0105315288892215,0.174441574048633,0.215725167294382,1.15486652906153e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS6,Growth arrest-specific protein 6,42718,-0.048107692125009,0.00259865125825025,-0.0532010485911795,-0.0430143356588385,1.40070270335971e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.170172844359095,0.00919372997851163,0.152153133601212,0.188192555116978,2.23898287509147e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELN,Elastin,40511,0.0695274121315782,0.00375778268531993,0.0621621580683511,0.0768926661948052,2.54328485267045e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBP,Protein AMBP,42706,0.0396636636063996,0.00214759348557004,0.0354543803746823,0.0438729468381168,3.09185203652328e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK2,Docking protein 2,42636,0.226846478514796,0.0122931833192225,0.20275183920912,0.250941117820472,4.16213438663374e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.204815365562307,0.0111196721424482,0.183020808163108,0.226609922961505,1.14700261101712e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,42594,0.0749028169003792,0.00407480459430966,0.0669161998955323,0.0828894339052262,1.50789825878652e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0662758065448682,0.00361080382101521,-0.073352982034058,-0.0591986310556784,2.45302269671818e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMIP,C-Maf-inducing protein,40451,0.155520324991059,0.00846764200591566,0.138923746659464,0.172116903322654,2.94955482017873e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0972584023328922,0.00530597989982584,0.0868586817292336,0.107658122936551,3.80025395624721e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,40482,0.134680838811121,0.00736483664752912,0.120245758981964,0.149115918640278,1.20917235413285e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,42689,-0.0629001532008022,0.00344687165419212,-0.0696560216430188,-0.0561442847585857,1.62541160409311e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH2,Neutral ceramidase,42495,0.100116336403921,0.0054962099598622,0.0893437648825907,0.11088890792525,3.01270300435837e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD5,Programmed cell death protein 5,42711,0.107204858839055,0.0058945462392273,0.0956515482101694,0.11875816946794,4.83862396125599e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AAMDC,Mth938 domain-containing protein,40223,0.0990853049461649,0.00544244601259535,0.088418110761478,0.109752499130852,5.39174475192333e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN1,Perilipin-1,42311,0.0650420799769542,0.00357930675451716,0.0580266387381006,0.0720575212158078,6.76074642567098e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.142456063358227,0.00784412312364907,0.127081582035874,0.157830544680579,7.86219920108863e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.102177630841698,0.00563321052618099,0.0911365382103835,0.113218723473013,1.14309737427149e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,40283,0.145084393252747,0.00798945342147638,0.129425064546653,0.16074372195884,1.21332241085242e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYY,Peptide YY,40116,0.190980993161743,0.0105179846622178,0.170365743223796,0.21159624309969,1.30165275417776e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,40457,0.107670248555177,0.00593339758670485,0.0960407892852357,0.119299707825119,1.47246393832486e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.156516132473959,0.00864890214585138,0.13956428426809,0.173467980679828,2.45769545733956e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MVK,Mevalonate kinase,42370,0.148154997527135,0.00819072853191531,0.132101169604581,0.164208825449689,2.95081656030562e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.126977850618554,0.00702257744291506,0.11321359883044,0.140742102406667,4.87919742181303e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINH1,Serpin H1,40302,0.238621076521854,0.01320011436812,0.212748852360339,0.264493300683369,5.16485739641517e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.122878528249956,0.00681914482781138,0.109513004387446,0.136244052112466,9.98694328326755e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.174813823027555,0.00971080895332111,0.155780637479046,0.193847008576064,1.32708448653975e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.131688364414115,0.00730846209891154,0.117363778700248,0.146012950127981,1.40380820990418e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP43,Centrosomal protein 43,42255,0.127248126955225,0.00706907044945884,0.113392748874286,0.141103505036165,1.40657250913292e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0701617530598672,0.00390056905938596,0.0625166377034707,0.0778068684162637,1.65114663316634e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.188828536484241,0.0105079512168971,0.168232952099123,0.20942412086936,3.29182266846772e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELP,P-selectin,42689,0.102866025134816,0.00573122937222032,0.0916328155652642,0.114099234704368,3.32016741000897e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,42480,0.0683737414298624,0.00381028649091658,0.0609055799076659,0.0758419029520589,3.65700421801141e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USO1,General vesicular transport factor p115,42587,0.165112832085415,0.00920446170665899,0.147072087140363,0.183153577030466,4.01418536078461e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0854772745266306,0.00476083947759468,0.076146029150545,0.0948085199027161,4.49605471261285e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,40482,0.138426216605876,0.00771484848739737,0.123305113570578,0.153547319641175,5.2685430364096e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,40482,0.207505602158016,0.0115981664052401,0.184773196003746,0.230238008312287,1.2978367486616e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,42594,0.117800417179392,0.00659467572368572,0.104874852760968,0.130725981597816,1.50433437954617e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,40199,0.177019692063822,0.00991192128980732,0.1575923263358,0.196447057791844,2.39726763266973e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNMBP,Dynamin-binding protein,42495,0.109692394768987,0.00615034562818758,0.0976377173377392,0.121747072200235,2.47991515845314e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,40449,0.139617858249688,0.0078251084159708,0.124280645754386,0.154955070744991,3.06570579851651e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0948767923652072,0.00531798571683369,0.0844535403602132,0.105300044370201,3.14843254947141e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.152540826285878,0.00856032052743056,0.135762598052114,0.169319054519642,4.80124179497456e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,42357,0.0638686766645319,0.00358978598082187,0.0568326961421211,0.0709046571869428,5.39030214137908e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0442329788963562,0.00248963837051044,0.0393532876901558,0.0491126701025567,7.95127290590042e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEXIM1,Protein HEXIM1,42594,0.146622624725285,0.00825803473747616,0.130436876639832,0.162808372810738,9.87336201788337e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.141593129159345,0.00796805625049648,0.125975738908371,0.157210519410318,1.06196392678651e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.201850150396916,0.0113943451056952,0.179517233989754,0.224183066804079,2.01797398549149e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,42754,0.136532162977672,0.00771268974270351,0.121415291081973,0.151649034873371,2.42276923835803e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP2,Methionine aminopeptidase 2,42689,0.103346987610171,0.00583825837105384,0.0919040012029056,0.114789974017437,2.46884331289725e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX15,Sorting nexin-15,40283,0.098310457264151,0.0055559056184999,0.0874208822518912,0.109200032276411,4.08401994702119e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPL,N-acetylneuraminate lyase,40511,0.0824906573320081,0.00467043712976533,0.0733366005576681,0.0916447141063482,6.8498610801541e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,42605,0.204693331991377,0.0116023699089485,0.181952686969838,0.227433977012916,6.9753189230811e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,40013,0.0583910576619812,0.00330581574123115,0.0519116588091682,0.0648704565147943,7.43248155296705e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.167085091961114,0.00947576409154993,0.148512594341676,0.185657589580552,8.49532643626956e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,42711,0.120136518958249,0.00681795785462131,0.106773321563191,0.133499716353307,1.00239377907654e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.170234812339384,0.00965991662567464,0.151301375753062,0.189168248925707,1.01122657750801e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,42679,0.100142840388054,0.00569178902265599,0.0889869339036485,0.11129874687246,1.58611090976693e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEP,Leptin,42636,0.119702321360155,0.00680345423412239,0.106367551061275,0.133037091659035,1.59271597386454e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,42357,0.130322296709893,0.00741372010013583,0.115791405313627,0.144853188106159,2.17046511572454e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.114347360514178,0.00651394914567664,0.101580020188652,0.127114700839704,4.4140710162732e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGFR,Opioid growth factor receptor,42587,0.0584802772376161,0.00333528223472557,0.0519431240575539,0.0650174304176782,4.5452569218123e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,42594,0.153015580305323,0.00873839258363139,0.135888330841405,0.17014282976924,6.75508229399784e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAMBP,STAM-binding protein,42476,0.113450540527098,0.00648322474616609,0.100743420024613,0.126157661029584,8.37455262323442e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.112649534638918,0.00644167478313556,0.100023852063972,0.125275217213864,1.03712841091958e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2B3,SH2B adapter protein 3,42346,0.173813014484244,0.00997684180976456,0.154258404537106,0.193367624431383,3.20759699918091e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPHN1,Oligophrenin-1,40483,0.190819250817543,0.0109448146038173,0.169367414194061,0.212271087441025,3.40489721948219e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,40283,0.067607564661759,0.00387842650307603,0.06000584871573,0.075209280607788,3.7123332217198e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.161034494747683,0.00924994203396632,0.142904608361109,0.179164381134257,5.28042510898568e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,42711,0.115403130860244,0.00664671373584953,0.102375571937979,0.128430689782509,8.41424165804807e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT2,Omega-amidase NIT2,40462,0.130031493086727,0.00748426755646214,0.115362328676061,0.144700657497393,9.59257997001226e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,40511,0.131113833639632,0.00755711889329057,0.116301880608783,0.145925786670482,1.43564369151468e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.125777470478309,0.00726819453794351,0.11153180918394,0.140023131772679,3.17477531740153e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH2,Cadherin-2,42636,0.0629777911887785,0.00364484908155861,0.0558338869889236,0.0701216953886334,3.53255095873925e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,40482,0.0975533722543452,0.00564106144095453,0.0864968918300744,0.108609852678616,3.74037918340908e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR,GMP reductase 1,42754,0.0874600125839827,0.00506411248755123,0.0775343521083822,0.0973856730595831,3.99068088748479e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCTN3,Tectonic-3,40511,0.0531978751284551,0.00307731104950489,0.0471663454714255,0.0592294047854847,4.14104675730967e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.090618840610224,0.0052505394585452,0.0803277832714754,0.100909897948973,5.12669125152957e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDUA,Alpha-L-iduronidase,42721,0.0820348900418258,0.00475686814882724,0.0727114284701244,0.0913583516135272,6.11754366041296e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS8,Prostasin,42568,0.0741810664268516,0.00430825795049731,0.0657368808438769,0.0826252520098264,9.87403225706333e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THOP1,Thimet oligopeptidase,42571,0.0543623063432103,0.00316632896223753,0.0481563015772248,0.0605683111091959,2.27485075414613e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP5,Fatty acid-binding protein 5,42678,0.119015566137833,0.00693847397042504,0.1054161571558,0.132614975119866,2.93588030688783e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSO,Cathepsin O,42754,0.0539218221258097,0.00315611760241446,0.0477358316250773,0.060107812626542,9.14970961238153e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BID,BH3-interacting domain death agonist,42594,0.117718997278003,0.00688991080023503,0.104214772109542,0.131223222446463,9.18742831089013e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCXR,L-xylulose reductase,42679,0.0920823796237462,0.00539187705612491,0.0815143005937414,0.102650458653751,1.03566823306808e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.110752472388545,0.00647906073933339,0.0980535133394515,0.123451431437638,1.06577030735835e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTDH,Protein LYRIC,40199,0.16427960047024,0.00961961428545344,0.145425156470751,0.183134044469728,1.47498147722749e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1S,Complement C1s subcomponent,40539,0.036478476023527,0.00213671363346699,0.0322905173019317,0.0406664347451223,1.52405203576503e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0350617110318729,0.00205931651014939,0.0310254506719801,0.0390979713917657,2.50400662324079e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0973524726340517,0.00571297835911283,0.0861550350501906,0.108549910217913,2.7284277791084e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.181525492947425,0.010670804139528,0.16061071683395,0.2024402690609,3.15770111571291e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGF,Placenta growth factor,42754,0.0464141001320083,0.00273360031091892,0.0410562435226073,0.0517719567414094,5.36853439594945e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLK1,Protein delta homolog 1,42794,0.0959130648531473,0.00565266426221976,0.0848338428991965,0.106992286807098,6.45852531553485e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",42587,0.140292359233516,0.00827897676393298,0.124065564776207,0.156519153690825,9.55791284783942e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST13,Hsc70-interacting protein,40283,0.098061736777768,0.0057817678180648,0.086729471854361,0.109394001701175,1.02013866531722e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRAP,BRCA1-associated protein,40342,0.189337085440216,0.0111678183411603,0.167448161491542,0.21122600938889,1.12914703891085e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOT,Angiomotin,40283,0.0673544333087264,0.00397729979701013,0.0595589257065865,0.0751499409108662,1.564516367731e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.134312373135473,0.00793504833608931,0.118759678396738,0.149865067874208,1.7372534582698e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.108649662122656,0.00642790228317216,0.0960509736476383,0.121248350597673,2.00115618575744e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.137764430983411,0.00815218061269421,0.121786156982531,0.153742704984292,2.73337995554959e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.18233402915752,0.0107894772040016,0.161186653837676,0.203481404477363,2.80514655058882e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0871897653833288,0.00516576248661653,0.0770648709095604,0.0973146598570972,2.91955199609064e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM13A,Protein FAM13A,40449,0.11656127603118,0.00689979794870765,0.103037672051713,0.130084880010647,3.01689781233358e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,40283,0.14245965257614,0.00843748252402542,0.12592218682905,0.15899711832323,3.61147233712675e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,42587,0.144901363377785,0.00860047724776716,0.128044427972161,0.161758298783408,4.82766484018583e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.153594234024567,0.00910801889433455,0.135742516991672,0.171445951057463,4.93623992287924e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMN,Protein amnionless,42370,0.0814672516568037,0.00483773091458718,0.0719852990642128,0.0909492042493946,5.6545600698803e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,40116,0.0749948900336479,0.00444917284809247,0.0662745112513867,0.0837152688159091,5.91242812442385e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,42346,0.103798557013651,0.00617946577569726,0.0916868040932848,0.115910309934018,1.14689669276036e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0673145953261705,0.00400959230121202,0.0594557944157949,0.075173396236546,1.29341448202633e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,42794,0.113648647905611,0.00677319705050366,0.100373181686624,0.126924114124598,1.47402948393991e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNST,Consortin,42636,0.186498143728754,0.0111150813212484,0.164712584339107,0.208283703118401,1.50730083703583e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,42587,0.101888202508124,0.00607970251536307,0.0899719855780127,0.113804419438236,2.11006393557755e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,42594,0.119355628314195,0.00712388836126819,0.105392807126109,0.133318449502281,2.26944973909196e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0471292372444314,0.00281330643688426,0.0416151566281382,0.0526433178607245,2.34027432912143e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0574610138327079,0.0034269224953891,0.0507442457417452,0.0641777819236705,2.56525233545708e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MITD1,MIT domain-containing protein 1,42495,0.164523694197107,0.00982602703961262,0.145264681199466,0.183782707194747,2.73198038110421e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.102095987241397,0.00610023226233875,0.0901395320072127,0.114052442475581,4.0001025970429e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT1,Deaminated glutathione amidase,40223,0.0815526090601106,0.00487267577115442,0.072002164548648,0.0911030535715733,4.12076606033578e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEC31A,Protein transport protein Sec31A,40223,0.131537208288626,0.00786502083645537,0.116121767449174,0.146952649128079,5.04755638137328e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IST1,IST1 homolog,40375,0.169108175535211,0.010120381763875,0.149272227278016,0.188944123792406,6.26809767779838e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.152490920969783,0.00912598784424066,0.134603984795071,0.170377857144494,6.45532101363312e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,40283,0.0691333208169953,0.00413815530760922,0.0610225364140812,0.0772441052199093,6.71508239105394e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,40511,0.154595082820623,0.00927736619669172,0.136411445075107,0.172778720566139,1.30211475960021e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,40532,0.0464303560056828,0.00278741002919497,0.0409670323484607,0.0518936796629049,1.44373860583614e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.056323013684072,0.00338739651238283,0.0496837165198016,0.0629623108483423,1.82746426792408e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRKL,Crk-like protein,42636,0.178126937247188,0.0107202037336671,0.1571153379292,0.199138536565175,2.18341159880735e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0765303320529491,0.00460740186887714,-0.0855608397159483,-0.0674998243899499,3.12118772570249e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,40482,0.133332121937905,0.00803477330325167,0.117583966263532,0.149080277612279,4.0434033526432e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXN,Paxillin,42311,0.0869877142346396,0.00525227992346409,0.07669324558465,0.0972821828846292,5.46091339061205e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCC,Tubulin-specific chaperone C,42495,0.136205898437704,0.00823179654021895,0.120071577218875,0.152340219656533,6.90201786187101e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,42594,0.0981036508348426,0.00593016364540647,0.0864805300898459,0.109726771579839,7.19175163708251e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,40483,0.107164371125095,0.00648508235899362,0.0944536097014672,0.119875132548722,1.25131597896651e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0395412716115232,0.00239543483317708,0.0348462193384961,0.0442363238845503,1.29374804691843e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGLN1,Egl nine homolog 1,42594,0.0938081951633241,0.00569446376087521,0.0826470461920086,0.104969344134639,2.2260891583486e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.16959997094381,0.0103005630361018,0.14941086739305,0.189789074494569,2.55318657204699e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.181822642272118,0.0110329448848235,0.160198070297864,0.203447214246372,2.5818114770016e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYDGF,Myeloid-derived growth factor,40511,0.165694937013511,0.0100707159690874,0.1459563337141,0.185433540312922,3.96476434878731e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBNL,Drebrin-like protein,42676,0.154345191691674,0.00939104829038138,0.135938737042526,0.172751646340821,4.0996794234232e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.113174642899257,0.00688306496587828,0.0996838355661355,0.126665450232378,4.7277968631328e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.062521792032309,0.0038024883475911,0.0550689148710305,0.0699746691935876,4.7379309632861e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL17,C-C motif chemokine 17,42604,0.154395756889335,0.00940331186939896,0.135965265625313,0.172826248153357,5.3524823297456e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,42600,0.0335428568734763,0.00204475018488579,0.0295351465111001,0.0375505672358524,6.81297522386977e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,42611,0.0849472284014564,0.00518643433678973,0.0747818171013485,0.0951126397015642,1.02920613974503e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0794418074150106,0.00485127191119188,-0.0889503003609467,-0.0699333144690745,1.07447094904045e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.128585112737215,0.00785291872169648,0.11319339204269,0.14397683343174,1.11213955598338e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBPL,FK506-binding protein-like,40449,0.0983904057168666,0.00600864542031445,0.0866134606930503,0.110167350740683,1.41051846824058e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1A,Meprin A subunit alpha,40449,0.12179867236409,0.00744678877540849,0.107202966364289,0.136394378363891,1.91143916395332e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRL,Appetite-regulating hormone,42636,0.142350280319976,0.00873016626802916,0.125239154434639,0.159461406205313,3.33064695515341e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GLB2,Endophilin-B2,40483,0.111709921275315,0.00684564364073696,0.0982924597394703,0.125127382811159,3.46741656630606e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,42370,0.064713030268058,0.00396973838035681,0.0569323430425586,0.0724937174935573,3.64377101717797e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD1,COMM domain-containing protein 1,40223,0.101164407503978,0.00620010211266259,0.0890122073631592,0.113316607644797,3.70147032703478e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL32,Interleukin-32,42594,-0.0742573130033595,0.00455605325461378,-0.0831871773824026,-0.0653274486243165,3.73914124736552e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EREG,Proepiregulin,42476,0.134850252406808,0.00827351882753401,0.118634155504841,0.151066349308774,3.75720049761178e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA2,Apolipoprotein A-II,40532,-0.0824780879317523,0.00505600546409499,-0.0923878586413785,-0.0725683172221261,3.76139587744708e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.074273263035166,0.00455762767485024,0.0653403127924595,0.0832062132778725,3.87175568607068e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.110268266023092,0.00676206707206646,0.097014614561842,0.123521917484343,4.16883446236834e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.103705086430874,0.00636082729450546,0.091237864933643,0.116172307928104,4.61645259029721e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSB,Arylsulfatase B,42587,0.0919039821194952,0.00564339868412687,0.0808429206986065,0.102965043540384,4.6375330670787e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.131661542380343,0.00808506206583891,0.115814820731299,0.147508264029388,4.68486848066475e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAG1,Dystroglycan,42676,0.0765901380564385,0.00470484140238288,0.0673686489077681,0.085811627205109,5.07975765716692e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN2,CCN family member 2,42624,0.0921038528014638,0.00565822997101558,0.0810137220582732,0.103193983544654,5.19984318246127e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F13B,Coagulation factor XIII B chain,40479,0.0433848111677546,0.00266363249226135,0.0381640914829224,0.0486055308525869,5.65484099706413e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0881892735353832,0.00541720993709734,0.0775715420586724,0.0988070050120939,6.62224772826987e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QDPR,Dihydropteridine reductase,42581,0.0709003749441674,0.00436011007323851,0.06235455920062,0.0794461906877149,6.82357534500278e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.048002797733742,0.00295949876648671,0.0422021801514281,0.053803415316056,1.35408907187172e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,40482,0.101359532554359,0.00625971175341092,0.0890904975176735,0.113628567591044,2.58650277316606e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0724666336699194,0.00448240138679776,0.0636811269517958,0.081252140388043,3.13967298354059e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,42586,0.107105843779321,0.00663617731239615,0.0940989362470249,0.120112751311618,4.73221712599209e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.191095715635429,0.0118403864397881,0.167888558213444,0.214302873057413,4.76012042055503e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,40482,0.124573544325664,0.00771895402738035,0.109444394431999,0.13970269421933,6.06238482150394e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,40449,0.157109712856042,0.00974463169205541,0.138010234739613,0.17620919097247,7.83838840904455e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,40199,0.0810556627124146,0.00503019757814005,0.0711964754592602,0.0909148499655691,9.32525898148637e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLB1,Beta-galactosidase,42495,0.0685249124364108,0.00425696636065947,0.0601812583695183,0.0768685665033034,9.37864602431637e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0457045722751736,0.00284187418674502,0.0401344988691534,0.0512746456811939,1.16630960796022e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR2,GMP reductase 2,40283,0.111072250946944,0.0069086999981313,0.0975311989506063,0.124613302943281,1.6446850941742e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL5,C-C motif chemokine 5,42689,0.164093715388848,0.0102211933224469,0.144060176476852,0.184127254300843,1.8161228245384e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0774492051171848,0.00482502435899217,0.0679921573735601,0.0869062528608095,2.40905059691503e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0724810647380409,0.00452075927524883,0.0636203765585532,0.0813417529175286,2.56723386446527e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,42611,0.0882724218345118,0.00550908098419614,0.0774746231054873,0.0990702205635362,2.9933801393953e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELE,E-selectin,42794,0.0835714168524458,0.0052165968264276,0.0733468870726477,0.0937959466322439,3.07734165726179e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,40511,0.135518624963794,0.00845360801079443,0.118949553262637,0.152087696664951,3.31130535513226e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL13,C-C motif chemokine 13,42734,0.113498933948313,0.00709829217449069,0.099586281286311,0.127411586610315,5.01868327248788e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDHD2,Phospholipase DDHD2,40482,0.107668677969189,0.00672893966753949,0.094479956220812,0.120857399717567,5.32810218728455e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,40482,0.191648400486338,0.0119790272704591,0.168169507036239,0.215127293936438,5.51345343722116e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,40199,0.124812931812334,0.00780433031416067,0.10951644439658,0.140109419228089,6.27128657642668e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES2,Cocaine esterase,42587,0.089921768486865,0.00564054764933768,0.0788662950941631,0.100977241879567,1.07468125647407e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D23,TBC1 domain family member 23,42587,0.145843536984508,0.00918081340430612,0.127849142712068,0.163837931256948,2.59976040549595e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.126110763743886,0.00794062130903074,0.110547145978186,0.141674381509586,2.82592413176577e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLM2,Protein GOLM2,42711,0.0376537197469937,0.00237263099768811,0.033003362991525,0.0423040765024624,3.28627703726501e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.138311871223958,0.00870905913804042,0.121242115313398,0.155381627134517,3.54959669741564e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,42587,0.0589330278511703,0.00372268540968305,0.0516365644481916,0.0662294912541491,6.13141888927227e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE4,Ribonuclease 4,40169,0.047597964688572,0.00300808224930144,0.0417021234799412,0.0534938058972029,8.86489870243652e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0778865019032689,0.00492511264995048,0.068233281109366,0.0875397226971719,9.87557175035382e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS9,Galectin-9,42620,0.0523153384599941,0.00331428847791821,0.0458193330432744,0.0588113438767138,1.25189580245641e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,40223,0.143504251908366,0.00909093154610256,0.125686026078004,0.161322477738727,1.58595864324055e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2L,Ataxin-2-like protein,40482,0.0782275124277814,0.00495756102252004,0.0685106928236421,0.0879443320319207,1.68623950599778e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TWF2,Twinfilin-2,40527,0.134403027925399,0.00851918194488524,0.117705431313424,0.151100624537374,1.7548393379626e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0933819724297334,0.00592975332714045,0.0817596559085381,0.105004288950929,2.80853494533445e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASHC3,WASH complex subunit 3,40483,0.120866499604165,0.00768622090398182,0.105801506632361,0.135931492575969,3.90949787950731e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.0533898878494862,0.00339883818689402,0.0467281650031739,0.0600516106957985,4.08553413235216e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,40199,0.088335621554781,0.00561780981833429,0.0773247143108458,0.0993465287987162,4.10077807037136e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0533058265463849,0.00339443987898201,0.0466527243835801,0.0599589287091896,4.37433518285527e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MME,Neprilysin,42587,0.130997330611882,0.00834930420773366,0.114632694364724,0.14736196685904,5.49573410055403e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.114792444345293,0.00731899431532335,0.100447215487259,0.129137673203327,5.97351993536156e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,42676,0.20964405241733,0.0133691498235184,0.183440518763234,0.235847586071426,6.21524010940848e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBXN1,UBX domain-containing protein 1,40283,0.110048228715642,0.00702049126603139,0.0962880658342205,0.123808391597064,8.6300700147534e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0938021042369318,0.00599671157367742,0.082048549552524,0.10555565892134,1.13608208207488e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.131805932111164,0.00842727718467554,0.1152884688292,0.148323395393128,1.44726466191637e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGA,Protein O-GlcNAcase,40449,0.112380071020752,0.00719187786068218,0.0982839904138152,0.126476151627689,1.80667772262257e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPART,Spartin,40283,0.122826690525296,0.00786306541631942,0.10741508230931,0.138238298741282,1.99690944676092e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.083035459716381,0.00532626663435668,0.0725959771130419,0.09347494231972,3.1463483971021e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASC3,Protein CASC3,40182,0.0671768522164061,0.0043120439412656,0.0587252460915255,0.0756284583412866,3.83666765755978e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADD1,Alpha-adducin,40283,0.113795653647384,0.0073063813371096,0.099475146226649,0.128116161068119,4.03398443233877e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.140273758876048,0.00901520129565354,0.122603964336567,0.157943553415529,4.06767341451403e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.232783261528609,0.0149563508873046,0.203468813789492,0.262097709267726,4.65833534689694e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS8,Galectin-8,42711,0.0955464046627685,0.00614641679148815,0.0834994277514517,0.107593381574085,5.04151176022524e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0785847755252052,0.00505857349139409,0.0686699714820728,0.0884995795683376,7.51898454061414e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,42794,0.0656550668169795,0.00423357314235384,0.0573572634579659,0.073952870175993,8.81059557928822e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL3,C-C motif chemokine 3,42594,0.0916717833589396,0.00591734150774973,0.0800737940037502,0.103269772714129,1.14537412904153e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH9,Protocadherin-9,40449,0.0549513922614275,0.00354923583414816,0.0479948900264971,0.0619078944963579,1.61765525142904e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB3,Plexin-B3,42597,0.0742817930794266,0.00480867647912176,0.0648567871803479,0.0837067989785052,2.26194369271441e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMA,Granzyme A,42754,0.0564888333909735,0.00365745952586349,0.049320212720281,0.0636574540616659,2.32585276925598e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,42594,0.0578787718718119,0.0037475922789356,0.0505334910050981,0.0652240527385257,2.37537066496487e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUOM,Fucose mutarotase,40283,0.10056940536932,0.00650604949650377,0.0878175483561723,0.113321262382467,2.40208844481561e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,42620,0.147636124092392,0.00956612077638545,0.128886527370677,0.166385720814108,2.80415087056968e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.138821974616009,0.00899971779240999,0.121182527742886,0.156461421489133,3.87194046617915e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,40199,0.139508353368599,0.009043367827172,0.121783352427342,0.157233354309856,3.89645350783524e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53,Cellular tumor antigen p53,42346,0.0681184870992268,0.00442881606234495,0.0594380076170307,0.0767989665814229,6.36220482310972e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,42676,0.13478280681231,0.0087741994347382,0.117585375920223,0.151980237704397,8.33290102379653e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0946344269602907,0.00617567279690702,0.0825301082783529,0.106738745642228,1.5056224276365e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RWDD1,RWD domain-containing protein 1,42711,0.0989342308598527,0.00645937217996286,0.0862738613871255,0.11159460033258,1.63964573275309e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTPBP2,GTP-binding protein 2,40182,0.127084478755783,0.00829843768249479,0.110819540898093,0.143349416613472,2.13123879179016e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIAE,Sialate O-acetylesterase,42646,0.0719904317022552,0.00471440671834293,0.062750194534303,0.0812306688702073,3.30331665289774e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,42357,0.077229953633854,0.00506643819568471,0.067299734770312,0.087160172497396,5.0594121454145e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,42794,0.0362513977775342,0.00237921141836341,0.0315881433975419,0.0409146521575264,5.41834664993409e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.17140821257019,0.0112525793587353,0.149353157027069,0.193463268113311,5.79809716537455e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK1,Docking protein 1,40483,0.212695935604127,0.013954924913243,0.185344282774171,0.240047588434084,6.14532002940886e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP10,Stromelysin-2,42608,-0.0920965379801339,0.00605045366744556,-0.103955427168327,-0.0802376487919406,6.91283836759593e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0804821980499414,0.00529166011841863,0.0701105442178409,0.0908538518820419,8.48672004577491e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0721735962167603,0.00475209003859579,0.0628594997411126,0.081487692692408,1.16631721918314e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOA,Elongin-A,42587,0.0836502983509602,0.00550866247013053,0.0728533199095044,0.094447276792416,1.19203377965318e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.108900281397907,0.00718782803394616,0.094812138451373,0.122988424344442,1.9904577358518e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COCH,Cochlin,40511,0.0731746082977384,0.00482618336013182,0.0637152889118801,0.0826339276835968,2.01714152664534e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0947481514907093,0.00625765092502866,0.0824831556776532,0.107013147303766,2.30151216261375e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0795825567269105,0.00525741118532108,0.0692780308036812,0.0898870826501398,2.4896292205651e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,42357,0.11717216762933,0.00774083687797434,0.1020001273485,0.13234420791016,2.49978369640498e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY4,Protein canopy homolog 4,42587,0.114998635304551,0.00759909467669597,0.100104409738227,0.129892860870875,2.59706363599286e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD36,Platelet glycoprotein 4,40199,0.0697046571339497,0.00460878754879478,0.060671433538312,0.0787378807295875,3.6545576630772e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.187232010157271,0.0124047641162559,0.16291867248941,0.211545347825133,4.83193738385385e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.111335313363631,0.00737958134689988,0.0968713339237069,0.125799292803554,5.14558210783364e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,40283,0.172009348894026,0.0113973901343491,0.149670464230702,0.19434823355735,5.85534466320472e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA5,Integrin alpha-5,42611,0.0388454967759086,0.00257743593677805,0.0337937223398236,0.0438972712119935,6.51955781299646e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLG4,Disks large homolog 4,40483,0.108554037580152,0.00720001115218481,0.0944420157218693,0.122666059438434,7.17627671630801e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0646056988268885,0.00429203603149824,0.056193308205152,0.0730180894486251,8.73178221143316e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.070065969910147,0.00465511035640294,0.0609419536115972,0.0791899862086968,8.7738494452427e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN3,Ataxin-3,40483,0.0964030101255744,0.00640162943860921,0.0838558164259004,0.108950203825248,9.34371250831288e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM17,Splicing factor 45,40482,0.117764858193529,0.00784928119457046,0.102380267052171,0.133149449334887,2.13643613064479e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,40287,0.100006035177577,0.00667163497420666,0.0869296306281323,0.113082439727022,2.65993459783718e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTBDN,Retbindin,42587,0.0460951023701548,0.00307813496176997,0.0400619578450857,0.0521282468952239,2.72876542802968e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.159525423073753,0.0106681375856247,0.138615873405928,0.180434972741577,3.75148687494718e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TALDO1,Transaldolase,40499,0.0677797744203406,0.0045332587058409,0.0588945873568924,0.0766649614837888,4.56593551519559e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP2B1,AP-2 complex subunit beta,40182,0.0743404444186255,0.00497342130324829,0.0645925386642588,0.0840883501729921,5.00579640175931e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC5,Glypican-5,42495,0.0866781239053226,0.00580464236070925,0.0753010248783325,0.0980552229323127,5.14197013134829e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,42346,0.139142031598483,0.00932651457993998,0.120862063021801,0.157422000175166,6.34743848112274e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.122304415411936,0.00820567809634535,0.106221286343099,0.138387544480772,9.34902090192561e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,42311,0.129406656542507,0.00869382053502213,0.112366768293864,0.14644654479115,1.05072624533132e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.12910994812658,0.00868337119102231,0.112090540592176,0.146129355660984,1.33102334418358e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCG,Gamma-synuclein,42495,0.105451201035708,0.00710014053019049,0.0915349255965343,0.119367476474881,1.68241498102145e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPP,Lipoma-preferred partner,40116,0.100685650314305,0.00677480998689382,0.0874070227399927,0.113964277888616,1.77421619162918e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPACT,Protein IMPACT,40483,0.0856501557067133,0.00576410865473957,0.0743525027434238,0.0969478086700029,1.77709589321465e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUS,RNA-binding protein FUS,42336,0.0607809336353964,0.00409604187785801,0.0527526915547947,0.0688091757159981,2.05950386344307e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXJ3,Forkhead box protein J3,40199,0.0667901479070807,0.00449887702118156,0.0579723489455649,0.0756079468685966,2.21733245924954e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0487402419113021,0.00328716139192171,0.0422974055831355,0.0551830782394686,2.89885817722676e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.116277838732997,0.00785348451409428,0.100885009085372,0.131670668380621,3.280494614818e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICA1,Islet cell autoantigen 1,42370,0.119714390271345,0.00808634640699618,0.103865151313632,0.135563629229057,3.40206987838075e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0576934710376203,0.00390225535502129,0.0500450505417785,0.065341891533462,4.48271489141644e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDC,Nuclear migration protein nudC,42754,0.0941405550405482,0.00637203167047392,0.0816513729664193,0.106629737114677,5.17888473340549e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC13,Mucin-13,42311,0.079430061932262,0.00537846725128539,0.0688882661197426,0.0899718577447814,5.80950662854845e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILPL2,RILP-like protein 2,40511,0.147066154248864,0.00995807928482946,0.127548318850599,0.16658398964713,6.66098656620408e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK10,Kallikrein-10,42636,0.0617129653384172,0.00418704985351669,0.0535063476255245,0.0699195830513099,8.69716856360351e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD207,C-type lectin domain family 4 member K,42365,0.0604068941022284,0.00409975325625409,0.0523713777199704,0.0684424104844864,9.48555827264623e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,42706,0.0547509617765825,0.00371698108943156,0.0474656788412966,0.0620362447118683,9.87898663970524e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.128626712558223,0.00873473274270464,0.111506636382522,0.145746788733924,1.05161834830199e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,42636,0.118799503897685,0.00808203746208333,0.102958710472001,0.134640297323368,1.55220089519709e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",42357,0.139424383880058,0.00949215224492939,0.120819765479997,0.15802900228012,1.84957814046692e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YWHAQ,14-3-3 protein theta,40283,0.110787704742874,0.007552888841474,0.0959840426135848,0.125591366872163,2.9127453846743e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGL1,Fibrinogen-like protein 1,40532,-0.099303574889812,0.00677209951804423,-0.112576889945179,-0.0860302598344453,3.0446823131516e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0621909444096473,0.0042447682768434,0.0538711985870342,0.0705106902322603,3.10461116926051e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMNL1,Formin-like protein 1,42311,0.0932740935110184,0.0063701077523494,0.0807886823164136,0.105759504705623,3.60964209794007e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,42357,0.0807788804392324,0.00552675225093454,0.0699464460274007,0.0916113148510641,5.27874625544047e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YJU2,Splicing factor YJU2,40451,0.0488178367333499,0.00333907098405722,0.0422732576045978,0.0553624158621021,5.74169083914044e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,42602,0.052428269371472,0.00358974938167566,0.0453923605833877,0.0594641781595563,6.09037945889839e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0843290410262019,0.00577726888036014,0.073005594020696,0.0956524880317078,6.87202826549135e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THPO,Thrombopoietin,42357,0.0585439436379459,0.00401310063655323,0.0506782663903016,0.0664096208855903,7.88188573658146e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0988119134531983,0.00677020094442085,0.0855423196021335,0.112081507304263,8.34801381091017e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0873061287231645,0.005990728077619,0.0755643016910313,0.0990479557552978,9.59269209937354e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.104273416529759,0.00715101429742587,0.0902574285068042,0.118289404552714,1.02476708208383e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,40539,0.0255346180337154,0.00175170929298795,0.022101267819459,0.0289679682479718,1.06132089187474e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,40283,0.186364043859729,0.0127868633568834,0.161301791680238,0.211426296039221,1.12244889061055e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEXN,Nexilin,40532,0.103241711197942,0.00708965392174666,0.0893459895113182,0.117137432884565,1.3110815975763e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.146909617437593,0.0100976657911729,0.127118192486894,0.166701042388292,1.39002686173678e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5E,5'-nucleotidase,42679,0.0847876221033691,0.00583095459907989,0.0733589510891725,0.0962162931175657,1.52571308923631e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD244,Natural killer cell receptor 2B4,42754,0.040980009994157,0.00282278962861225,0.035447342322077,0.046512677666237,2.12585874288867e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAX,Protein max,42311,0.156223654288719,0.0107753774097704,0.135103914565569,0.177343394011869,2.88381495454221e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN1,Pantetheinase,40532,0.108685645508684,0.00749463852093036,0.0939961540076601,0.123375137009707,3.1214573156978e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN3,Centrin-3,40449,0.112951645710845,0.00778960945227514,0.0976840111843861,0.128219280237305,3.21134995803869e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,42495,0.117651294132163,0.00812266737276188,0.101730866081549,0.133571722182776,3.47878331759586e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA11,Annexin A11,42570,0.0992274101894468,0.00685853613822787,0.0857846793585202,0.112670141020373,4.39168810752834e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.129652553098794,0.00896236226770348,-0.147218783143493,-0.112086323054095,4.45718029347918e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.119954039563024,0.00828715449622208,0.103711216750429,0.136196862375619,4.61679838995751e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0847043647544124,0.00585624166159862,0.0732261310976791,0.0961825984111457,5.5161369948711e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIFBP,KIF-binding protein,42587,0.121185428516038,0.00839131609572453,0.104738448968418,0.137632408063658,6.35909487890152e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM3,Dynamin-3,40482,0.0816356093634397,0.00565118785947928,0.0705592811588603,0.0927119375680191,6.97750901237592e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.106692541196776,0.00739263795365264,0.0922029708076166,0.121182111585935,8.67516280467768e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.122964788145969,0.0085275019324924,0.106250884358284,0.139678691933654,8.67758578778238e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0799011910413089,0.00553858494802194,0.0690455645431858,0.0907568175394319,9.36337689202991e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.112063173589447,0.00777556367945437,0.0968230687777161,0.127303278401177,9.83700587946127e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,40283,0.102185733399137,0.00708733260142516,0.0882945615003436,0.11607690529793,1.05220035954053e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4D,Semaphorin-4D,42711,0.0442661097591173,0.00307742068109295,0.0382343652241751,0.0502978542940595,1.43555976690118e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0433459480231789,0.0030143776474369,0.0374377678342025,0.0492541282121552,1.52161176937518e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6AP2,Renin receptor,42346,0.0598299835463126,0.00416170201741218,0.0516730475921847,0.0679869195004405,1.64005382672575e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0727186999280586,0.00506662829436209,0.0627881084711089,0.0826492913850083,2.26426394535145e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.120514204368662,0.00840066939015262,0.104048892363963,0.136979516373361,2.53100093297531e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRADD,Death domain-containing protein CRADD,42476,0.110293284095352,0.00770669220111114,0.0951881673811739,0.12539840080953,4.09128684456938e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.064282659720016,0.00449345002729837,0.0554754976665111,0.0730898217735208,4.41812287926024e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,42652,0.0526142141332688,0.0036813829532673,0.0453987035448649,0.0598297247216727,5.32915934719854e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0982777990921391,0.00687799185227366,0.0847969350616827,0.111758663122595,5.5600817190322e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,42754,0.0981374068165117,0.00686885156058844,0.0846744577577584,0.111600355875265,5.65958481548229e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.142490333797105,0.00999562614392863,0.122898906555004,0.162081761039205,1.03539821544084e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0869932266255775,0.00611844263332807,0.0750010790642544,0.0989853741869005,1.53591429489534e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOD,Apolipoprotein D,40033,-0.0639498859125777,0.00450139475627943,-0.0727726196348854,-0.05512715219027,2.12605995051851e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.136019384508012,0.00958371979334746,0.117235293713051,0.154803475302973,2.49098824046735e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PENK,Proenkephalin-A,40283,0.0479182226549063,0.00337915084654062,0.0412950869956867,0.0545413583141259,3.0025356851647e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.123160281871196,0.00869629852557641,0.106115536761066,0.140205026981326,3.36386341326933e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,40449,0.0852298704139554,0.00602284897863964,0.0734250864158217,0.0970346544120891,4.47395647154231e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.122575686188097,0.00867622526766718,0.105570284663469,0.139581087712725,6.27736608801654e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.113432240535455,0.00803756405093294,0.0976786149956264,0.129185866075284,6.6798921149101e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,42636,0.184093454371781,0.0130518300222958,0.158511867528081,0.209675041215481,7.40844362024028e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0750459361868605,0.00531947812028075,0.0646197590711103,0.0854721133026108,8.18744170414871e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGLL,Monoglyceride lipase,42654,0.124283868789222,0.00881937471427228,0.106997894349249,0.141569843229196,8.83220088114747e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED8,Protein TMED8,40449,0.147878071297608,0.0105009249566955,0.127296258382484,0.168459884212731,1.16581108037314e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRY2,Protein sprouty homolog 2,42370,0.1331275175176,0.00946595739060207,0.11457424103202,0.15168079400318,1.33137359894253e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF19,Fibroblast growth factor 19,42676,0.112276933860798,0.00798848203725579,0.0966195090677765,0.127934358653819,1.48349653866675e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,42594,0.120080533088966,0.00854509677410374,0.103332143411723,0.136828922766209,1.53820265425449e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACYBP,Calcyclin-binding protein,40267,0.147451524486388,0.0104869165741364,0.12689716800108,0.168005880971695,1.60213082863161e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.149834676990837,0.0106572147865131,0.128946536009271,0.170722817972403,1.62390993109001e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0873071804259974,0.00621533172536222,0.0751251302442874,0.0994892306077073,1.66052047974634e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESYT2,Extended synaptotagmin-2,40483,0.119029222322592,0.00846836720197937,0.102431222606712,0.135627222038471,1.68369067892728e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0840745677903533,0.00598610271738364,0.0723418064642814,0.0958073291164253,1.73327513492421e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RFC4,Replication factor C subunit 4,40451,0.030590872885732,0.0021774285897276,0.0263231128498659,0.0348586329215981,1.85134342231627e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0609058918289184,0.0043356017586477,0.0524081123819689,0.0694036712758679,1.88321259564071e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST3,Cystatin-C,42659,0.0437128276457279,0.0031139918805152,0.0376094035599182,0.0498162517315377,1.88887184911258e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0699911775846705,0.0049912537829894,0.0602083201700113,0.0797740349993298,2.66030768440936e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0627510833392804,0.0044792332788313,0.0539717861127711,0.0715303805657898,3.21958343540757e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD226,CD226 antigen,40199,0.061167753798239,0.00436957211169077,0.0526033924593251,0.0697321151371529,3.79969821013771e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,40058,0.0765666504898913,0.00547258794764593,0.0658403781125053,0.0872929228672773,4.26945174250934e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRAS,Ras-related protein R-Ras,40182,0.186683048343095,0.0133452030125756,0.160526450438446,0.212839646247743,4.35608098858549e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0935861912517415,0.006699099240659,0.0804559567400499,0.106716425763433,4.81087812403404e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0548872440909758,0.00393180060610858,0.047180914903003,0.0625935732789486,6.36438970974761e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL7,C-C motif chemokine 7,42594,0.0850068738767569,0.0060968237405669,0.0730570993452458,0.096956648408268,7.04561816852908e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.082532375392126,0.00591948418618746,0.0709301863871986,0.0941345643970534,7.19042875315513e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0288972200329868,0.00207179463445141,0.024836502549462,0.0329579375165115,7.4821138278031e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TADA3,Transcriptional adapter 3,40451,0.0567822115660433,0.0040724307072192,0.0488002473798937,0.064764175752193,8.0170461610335e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0947276813152137,0.00680791648632905,0.0813841650020087,0.108071197628419,1.20549359489505e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.132089309236527,0.00950563235198507,0.113458269826636,0.150720348646417,1.36237079788066e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,42346,0.065615231281376,0.00473405196940921,0.056336489421334,0.0748939731414181,2.22480067496589e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,40199,0.063896116110455,0.004616331959742,0.0548481054693606,0.0729441267515493,3.3014871022988e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.110923164545766,0.00802400256857226,0.0951961195113639,0.126650209580167,3.67002412613263e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,40283,0.168359934742158,0.0121751818821337,0.144496578253176,0.19222329123114,3.92938450656363e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0691197326797676,0.00500672104913845,0.0593065594234563,0.078932905936079,5.27299586397758e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,42716,0.0831726451616181,0.00602935290819153,0.0713551134615627,0.0949901768616735,5.367360288812e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0756919691119723,0.00548930334603739,0.064932934553739,0.0864510036702056,5.8338056450343e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,42611,0.0344811346095888,0.00250128928658168,0.0295786076078887,0.0393836616112888,6.12475702214623e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0859656163052039,0.00623805779367927,0.0737390230295926,0.0981922095808153,6.49250268151631e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0802353328464189,0.00582719394570374,0.0688140327128395,0.0916566329799982,7.64042811700093e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.120513219868771,0.00874820846909462,0.103366731269345,0.137659708468196,7.91342774012401e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCB,Tubulin-folding cofactor B,42495,0.141106365697078,0.0102508698195638,0.121014660850733,0.161198070543423,8.09887323953437e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18,Interleukin-18,42566,0.0658322467870845,0.0047834623403376,0.0564566606000228,0.0752078329741462,8.3888076425569e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,40482,0.0922163886517975,0.00671378788158862,0.0790573644038838,0.105375412899711,1.37053885504852e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0465727409738124,0.00339957821940913,-0.0532359142838543,-0.0399095676637705,1.95335444067482e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0881668544371415,0.00643225203636414,0.0755596404458677,0.100774068428415,2.04229856700445e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.134281634727842,0.00982761560611147,0.115019508139863,0.15354376131582,3.20771722232708e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,42587,0.04743405247967,0.00347222938258065,0.0406284828898119,0.0542396220695281,3.32947929589239e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINC1,Antithrombin-III,40516,0.0207472515848325,0.00151854893220929,0.0177708956777023,0.0237236074919627,3.66702195914095e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL11,Eotaxin,42754,0.0516342898512556,0.00378346140334081,0.0442187055007076,0.0590498742018036,3.97160334742399e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANG,Angiogenin,42618,0.0471634693977481,0.00345807313006475,0.0403856460628212,0.0539412927326751,4.49720794138611e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP10,Caspase-10,42311,0.100445190723527,0.00736470534460819,0.0860103682480946,0.114880013198959,4.56074544081568e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHD3,EH domain-containing protein 3,40223,0.164915812641414,0.0120861645623026,0.141226930099301,0.188604695183527,4.74161634592606e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO3,Forkhead box protein O3,42346,0.133399135528932,0.00978308393180424,0.114224291022595,0.152573980035268,4.74325837781611e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEPR,Leptin receptor,42636,-0.0437832343206825,0.00321377603258272,-0.0500822353445447,-0.0374842332968204,5.50667402039426e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG4A,Cysteine protease ATG4A,42346,0.0826232102474754,0.00606627399823204,0.0707333132109406,0.0945131072840102,5.85618113982383e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2,Prothrombin,40539,0.0209139304311688,0.00153513114005888,0.0179050733966534,0.0239227874656842,6.19762004400153e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARK7,Parkinson disease protein 7,42611,0.0725944461062575,0.00533505904551569,0.0621377303770467,0.0830511618354682,6.89408728787842e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,40451,0.07738650908844,0.00568891056629058,0.0662362443785105,0.0885367737983696,8.21586077304117e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTF1,Cardiotrophin-1,42357,0.117491698478767,0.00864725586660791,0.100543076980215,0.134440319977318,9.12505877037381e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATOX1,Copper transport protein ATOX1,42679,0.0973313922278203,0.00716482746272844,0.0832883304008726,0.111374454054768,9.30089631447953e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,40500,0.0666825047262887,0.0049102754894844,0.0570583647668993,0.0763066446856781,1.11340540135926e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0687564666526717,0.00506324357185925,0.0588325092518275,0.0786804240535158,1.13841115141067e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2,Microtubule-associated protein 2,40483,0.0650339603653473,0.00479029442583895,0.0556449832907029,0.0744229374399916,1.17623360602524e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,40223,0.085196146576817,0.00627962337981348,0.0728880847523826,0.0975042084012514,1.35278797082993e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0791789270204671,0.00584307235209327,0.0677265052103643,0.0906313488305699,1.46848093761835e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.101795501738066,0.00753093156143003,0.0870348758776629,0.116556127598469,2.34827817339392e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0714025119656752,0.00528521493708336,0.0610434906889918,0.0817615332423586,2.52640804870167e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS2,Trypsin-2,42689,0.0777617029205225,0.0057599496035144,0.0664722016976342,0.0890512041434107,2.88083298040839e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,42594,0.0780263001491701,0.0057845984975898,0.0666884870938941,0.0893641132044461,3.38775807811314e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.137450212923072,0.0102035917273228,0.11745117313752,0.157449252708625,4.93213743574625e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSZ,Cathepsin Z,42648,0.0446928272284164,0.00332297227701887,0.0381798015654594,0.0512058528913734,5.68880418973603e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIAPIN1,Anamorsin,42679,0.0857406107715956,0.006383371962781,0.0732292017245448,0.0982520198186464,7.20155767592486e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIF,Macrophage migration inhibitory factor,42586,0.0936276283805184,0.00697046109252431,0.0799655246391708,0.107289732121866,7.21345480159213e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0997188038114049,0.00742284780589954,0.0851700221118418,0.114267585510968,7.83653853235829e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MENT,Protein MENT,40283,-0.0321321958066054,0.00239203983288713,-0.0368205938790641,-0.0274437977341466,8.07639074102347e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0356238000992045,0.00265255841039095,0.0304247856148383,0.0408228145835708,8.4371042575527e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,40532,0.0648976915487475,0.00483364840420222,0.0554237406765112,0.0743716424209839,8.69293521313503e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0637194516072904,0.0047526607186501,0.0544042365987362,0.0730346666158446,9.99949561036001e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.124569664661555,0.00928980023638073,0.106361656198249,0.142777673124861,1.11208851065407e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GET3,ATPase GET3,40511,0.074710684031658,0.00557458852093442,0.0637844905306266,0.0856368775326895,1.2006541348951e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD22,B-cell receptor CD22,42754,0.0601974085916372,0.00449798185924534,0.0513813641475164,0.0690134530357581,1.37145267279501e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,42594,0.0705696728082126,0.00527791306625339,0.060224963198356,0.0809143824180693,1.62930654004246e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOF,Apolipoprotein F,40532,-0.0328570029108568,0.00245818770468007,-0.0376750508120297,-0.0280389550096838,1.92314590000969e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THTPA,Thiamine-triphosphatase,40436,0.121021321997145,0.0090551109561501,0.10327330452309,0.138769339471199,1.9702273241114e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0895005538122619,0.00670136718166794,0.0763658741361928,0.102635233488331,2.01507775356625e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB9,Serpin B9,42495,0.0452687656076366,0.00339041419047343,0.0386235537943087,0.0519139774209646,2.09878190039062e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.104968881627101,0.0078595650552817,0.0895641341187492,0.120373629135453,2.2618622924163e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBKS,Ribokinase,42317,0.0684007969431822,0.00512879744081269,0.0583483539591894,0.0784532399271751,2.59324371318151e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0870317216889253,0.0065253013114536,0.0742421311184762,0.0998213122593743,2.82749155289193e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,40473,0.0947948837932337,0.00710801676509094,0.0808631709336554,0.108726596652812,2.87010790535058e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE2,Glia-derived nexin,40511,0.0882576627230014,0.00661963713102599,0.0752831739461904,0.101232151499812,3.00396911974315e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0915991643771495,0.00687762279355826,0.0781190237017753,0.105079305052524,3.25171026959976e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.143405379847837,0.0107742298153567,0.122287889409737,0.164522870285936,4.06612269711594e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP2,Caspase-2,42594,0.0920999197748614,0.0069326139988605,0.0785119963370948,0.105687843212628,5.06380117966e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0379940576775656,0.00286325919724018,0.0323820696509748,0.0436060457041563,6.21379066948191e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN2,Centrin-2,42311,0.0917888087823816,0.00692703059695391,0.078211828812352,0.105365788752411,8.04381696922822e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PF4,Platelet factor 4,40463,0.133970967521746,0.0101174442737937,0.11414077674511,0.153801158298382,9.99047286227819e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0683258344100646,0.00515992552414614,0.0582123803827382,0.078439288437391,1.01470668556624e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.150699624558396,0.0114077020799416,0.12834052848171,0.173058720635081,1.36857774166908e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILP,Rab-interacting lysosomal protein,42674,0.0810004233218432,0.00613473839983943,0.0689763360581579,0.0930245105855284,1.4726420007497e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0433186250726729,0.00328346027682614,0.0368830429300936,0.0497542072152521,1.69430745146579e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,40182,0.109695490312749,0.00830942886688747,0.0934090097336499,0.125981970891849,1.72146845148891e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0539239381162237,0.00409299012938612,0.0459016774626269,0.0619461987698205,2.39353731409796e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,42346,0.0771609733185036,0.0058599625988187,0.0656754466248189,0.0886465000121882,2.39464238809476e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,42569,0.120208703815617,0.00913295619010089,0.102308109683019,0.138109297948215,2.54571358452644e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB1,Carboxypeptidase B,42794,0.0823809842846954,0.00625971889642074,0.0701119352477107,0.09465003332168,2.57521713598377e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMVK,Phosphomevalonate kinase,42303,0.146227920919095,0.0111269914620026,0.12441901765357,0.16803682418462,3.35816465959222e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIN2,Bridging integrator 2,42611,0.122210225667597,0.00930214973641354,0.103978012184226,0.140442439150967,3.48709601289409e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.124041569010283,0.0094395332481226,0.105540083843962,0.142543054176603,3.78849159571047e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,42721,0.0493033414209086,0.00375476639858269,0.0419439992796865,0.0566626835621306,3.80234715611487e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0986037557670392,0.00750669289853621,0.0838906376859082,0.11331687384817,3.98528662464526e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX4,Syntaxin-4,42587,0.080252349212156,0.00612321414763513,0.0682508494827912,0.0922538489415209,5.2689276386154e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0641787525402553,0.00489453154583528,0.0545854707104182,0.0737720343700925,5.39083482466209e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0810305555786357,0.00618127044680778,0.0689152655028925,0.093145845654379,5.69222268954093e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP7,Caspase-7,40483,0.112833239785331,0.00861194248106546,0.095953832522443,0.12971264704822,6.16897048665908e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,42618,-0.0463332154189009,0.00354572783287393,-0.0532828419713338,-0.039383588866468,8.72557325225649e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,42594,0.0446681211146937,0.00341896832656697,0.0379669431946225,0.051369299034765,9.02672791545613e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0379511497856747,0.00290829967065829,0.0322508824311844,0.0436514171401649,1.09718733311271e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RB,Interleukin-17 receptor B,42416,-0.0719607565089232,0.00551925654138069,-0.0827784993300293,-0.061143013687817,1.28471420924943e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0818095527704743,0.00627335342852733,0.0695137800505608,0.0941053254903879,1.3597711941693e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0530981980465934,0.00407463054698829,0.0451119221744963,0.0610844739186904,1.38033275956369e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS1,Galectin-1,42636,0.0470562945471328,0.00361740677110371,0.0399661772757696,0.0541464118184961,1.87295353297452e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0435084223709617,0.00335341530152543,-0.0500811163619516,-0.0369357283799719,2.89794440312636e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0711028998689927,0.0054835868348821,0.0603550696726238,0.0818507300653616,3.24582346182518e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGF,Pro-epidermal growth factor,42597,0.137005132202642,0.0105676479482831,0.116292542224007,0.157717722181277,3.296871443662e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0656303927969343,0.00506004152002749,0.0557127114176804,0.0755480741761882,3.4275406687565e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,40482,0.10262513107803,0.00791488267380463,0.0871119610373725,0.118138301118687,3.56662036643189e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICALL2,MICAL-like protein 2,40182,0.0920726618625507,0.00710163104245851,0.078153465019332,0.105991858705769,3.67894241913212e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.052607305219998,0.00406281777757872,0.0446441823759437,0.0605704280640523,4.0438483276702e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0890120504782925,0.00687482846057379,0.0755373866955679,0.102486714261017,4.62155929347293e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0400127947577345,0.0030935302210708,0.0339494755244357,0.0460761139910332,5.42044475343113e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,40449,0.115795902323952,0.0089579556334401,0.0982383092824092,0.133353495365494,5.93133966467835e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCA,Calcitonin,42476,0.0844505705350008,0.00653786245825706,0.071636360116817,0.0972647809531846,6.09487939374753e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB1,Heat shock protein beta-1,42448,0.0900147317547277,0.00697128985742186,0.0763510036341809,0.103678459875275,6.50141163833903e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD69,Early activation antigen CD69,42585,0.116072078647281,0.00900432290857191,0.0984236057464805,0.133720551548082,8.51888404812951e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK13,Kallikrein-13,42381,0.0613846119643074,0.00476313991116086,0.0520488577384321,0.0707203661901826,8.95510877088712e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0700132258162578,0.00543246706747568,0.0593655903640055,0.0806608612685102,9.72860417568424e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F12,Coagulation factor XII,40539,0.0552139216780032,0.0042848036157105,0.0468157065912106,0.0636121367647957,9.92450363365079e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.123932681816672,0.00962414038977115,0.10506936665272,0.142795996980623,1.01524335580097e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.131297287255018,0.010200325612987,0.111304649053564,0.151289925456473,1.08374053725273e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7,Interleukin-7,42594,0.0842200163845608,0.0065434999780733,0.0713947564275371,0.0970452763415845,1.09883967557399e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MESD,LRP chaperone MESD,42611,0.158858920479367,0.0123901110047417,0.134574302910073,0.18314353804866,2.06218222232689e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.118131362201022,0.00921181518819302,0.100076204432163,0.13618651996988,2.19305948422792e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0696449957049306,0.00543141968592902,0.0589994131205098,0.0802905782893515,2.23240239343843e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,42636,0.0858547737831424,0.00670013684661611,0.0727225055637748,0.09898704200251,2.26810509377011e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,42587,0.111376801150079,0.00869688241250871,0.0943309116215617,0.128422690678596,2.49556862550394e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,42311,0.0810247156846734,0.00633514236737123,0.0686078366446258,0.093441594724721,3.1225202062379e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0967072501123035,0.00755705213031866,0.081895427936879,0.111519072287728,3.13587918411142e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0972706454989316,0.00762000748105525,0.0823354308360633,0.1122058601618,4.67142102057025e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB6,Serpin B6,42679,0.0760301114778466,0.00596146348006039,0.0643456430569282,0.0877145798987649,4.87147852969193e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMT,Catechol O-methyltransferase,42214,0.109002467118043,0.00856285113814859,0.092219278887272,0.125785655348814,6.70944881950449e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.112938996540641,0.00887572924433689,0.0955425672217406,0.130335425859541,7.81991738552889e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,40482,0.0812342812110273,0.00638831227554473,0.0687131891509597,0.093755373271095,8.60433325613032e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WDR46,WD repeat-containing protein 46,40451,0.0471351984783237,0.00371067532804876,0.0398622748353481,0.0544081221212992,1.02149474160035e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CERT,Ceramide transfer protein,42311,0.079978498148995,0.0063002984843406,0.0676299131196875,0.0923270831783026,1.04408144512206e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARC,SPARC,42679,0.0915745206345132,0.00721503543860961,0.0774330511748383,0.105715990094188,1.05938640542862e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGT1,Protein SGT1 homolog,42346,0.104656271099204,0.00825856443828711,0.0884694848001615,0.120843057398247,1.37504926313132e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C19orf12,Protein C19orf12,42311,0.0830196903358324,0.00656437018023594,0.07015352478257,0.0958858558890949,1.89629569196737e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LARP1,La-related protein 1,40451,0.0798470026839738,0.0063173435445476,0.0674650093366605,0.092228996031287,2.26241892739739e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D5,TBC1 domain family member 5,42594,0.102020971673741,0.00808196004708253,0.0861803299814594,0.117861613366023,2.52855009372954e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,42346,0.0742142524220506,0.00588036376613355,0.0626887394404289,0.0857397654036724,2.63593081120695e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACYP1,Acylphosphatase-1,40250,0.0853030054947621,0.00675693718871225,0.0720594086048861,0.0985466023846381,2.75222682801853e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0476002932275925,0.00377656471607678,0.040198226384082,0.055002360071103,3.54579959611327e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM3,Junctional adhesion molecule C,40283,0.0659472012858139,0.00523409881929782,0.0556883675999901,0.0762060349716376,3.75529244277137e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,42624,0.0975981696718174,0.00775503041457714,0.0823983100592462,0.112798029284389,4.07472984959972e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C3,Complement C3,39989,0.0611504582683569,0.00485700351915222,0.0516307313708186,0.0706701851658953,4.28699703373974e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,40483,0.128474348712904,0.0102172203766175,0.108448596774733,0.148500100651074,5.09562584510546e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPSE,Heparanase,40408,0.121634092605039,0.00967455735483467,0.102671960189563,0.140596225020515,5.22542205663913e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.118101380289991,0.00939490873391424,0.0996873591715188,0.136515401408463,5.39979740518568e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD72,B-cell differentiation antigen CD72,40283,0.0575489841380299,0.00457958734180391,0.0485729929480943,0.0665249753279656,5.67809834178171e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,40116,0.0851641226591535,0.00677821070759691,0.0718788296722636,0.0984494156460435,5.87257963232105e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.137710035643754,0.0109688700201841,0.116211050404193,0.159209020883315,6.69452247171575e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMFG,Glia maturation factor gamma,40511,0.0924981691192398,0.007369154174542,0.0780546269371375,0.106941711301342,6.71320189211262e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.110922329575946,0.00884248649697397,0.0935910560418768,0.128253603110015,6.89737213988571e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0825139558119093,0.00659944459802374,0.0695790443997828,0.0954488672240358,1.23684455156667e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0699109101544211,0.00559496890725771,0.058944771096196,0.0808770492126462,1.37847531870795e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTD,Deoxycytidylate deaminase,40283,0.121031035098907,0.00969034809892174,0.102037952825021,0.140024117372794,1.47068598351035e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0755748635508545,0.00606167615550221,0.0636939782860702,0.0874557488156388,1.76912132289702e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0442311010298493,0.00354958873228356,0.0372739071145735,0.0511882949451251,2.08763116608568e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,40527,0.0769308940489671,0.00617698363173875,0.0648240061307592,0.0890377819671751,2.25334617187128e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,42721,0.160514626801818,0.0128975570146849,0.135235415053036,0.1857938385506,2.31472590321908e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA1,Carboxypeptidase A1,42794,0.0802470700199937,0.00644807357863402,0.0676088458058711,0.0928852942341164,2.31576622390364e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.115862670722039,0.00930537655501442,0.0976241326742109,0.134101208769867,2.34864427166617e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO9B,Unconventional myosin-IXb,42370,0.0847142647725604,0.00680966187160292,0.0713673275042187,0.0980612020409022,2.49312918549592e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTF2,Transcription termination factor 2,40182,0.0629025863381389,0.005057293901374,0.0529902902914458,0.0728148823848319,2.80716548406395e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0405712913560178,0.00326479911567399,0.0341722850892968,0.0469702976227388,2.90980797446026e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0969325918923529,0.00780347512902592,0.0816377806394621,0.112227403145244,3.10749650913448e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD2,Polycystin-2,40116,0.0748939839030281,0.00602649788327653,0.0630820480518061,0.0867059197542501,3.20770856285113e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.137869929742394,0.011099512096292,0.116114886033662,0.159624973451126,3.40658852160506e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FEN1,Flap endonuclease 1,42346,0.0815924772711144,0.00657783387289861,0.0686999228802331,0.0944850316619956,3.900242604971e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.14173683986515,0.0114352522757193,0.11932374540474,0.164149934325559,4.33477435738832e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0486848898807424,0.00392795906426844,0.0409860901147762,0.0563836896467085,4.39467108624433e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.118898997006723,0.00959459359997333,0.100093593550776,0.137704400462671,4.47868259183119e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.118970021106946,0.00960474083083438,0.100144729078511,0.137795313135382,4.79378329339517e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRD2,Protein ZNRD2,40449,0.0891547284755712,0.00719623215340589,0.0750501134548956,0.103259343496247,5.06368173045139e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XCL1,Lymphotactin,42721,0.0717508923820437,0.00580004069992884,0.0603828126101831,0.0831189721539042,5.81427614921183e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0735831250149404,0.00594883715650595,0.0619234041881888,0.0852428458416921,5.96092306798745e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0341559218398096,0.00276295867720575,-0.0395713208471328,-0.0287405228324863,7.02734556807356e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0977212552657252,0.00791741191689601,0.082203127908609,0.113239382622841,8.96357533324978e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.101556061736049,0.00823745608939211,0.0854106478008408,0.117701475671258,1.07652694538488e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12A_IL12B,Interleukin-12,42587,0.104308464573803,0.00846602270373786,0.0877150600744766,0.120901869073129,1.0783086383316e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0382894912868816,0.00310858420768565,0.0321966662398178,0.0443823163339455,1.12231735579709e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX8,Syntaxin-8,42594,0.0607173762667705,0.00493318425466872,0.0510483351276198,0.0703864174059212,1.2625102568016e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0451387667200995,0.00367000783256448,0.0379455513682731,0.0523319820719259,1.39726424694594e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA3,Annexin A3,42681,0.0880705932720328,0.00716173951384577,0.0740335838248951,0.102107602719171,1.43307795928999e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",42603,0.137657679220945,0.0112062156979778,0.115693496452909,0.159621861988982,1.69100997179828e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG6,Large proline-rich protein BAG6,42357,0.0450715732186799,0.00367043929057537,0.0378775122091521,0.0522656342282076,1.79937494194664e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,40449,0.104628546850922,0.00851827159313235,0.0879327345283828,0.121324359173462,1.86091772862375e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0474060037151435,0.00386821426505995,0.039824303755626,0.054987703674661,2.40071718183103e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0606746667440679,0.00495165545182967,0.0509694220584817,0.0703799114296541,2.65966593011691e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRGN,Neurogranin,40532,0.114663383940596,0.00936122293003452,0.0963153869977283,0.133011380883464,2.80833743216381e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.118758134236175,0.00970546863554046,0.0997354157105157,0.137780852761834,3.28316644319304e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDT,D-dopachrome decarboxylase,40527,0.0524864227631933,0.00429457470272833,0.0440690563458458,0.0609037891805408,3.90942556922328e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL8,C-C motif chemokine 8,42706,0.0762473908243825,0.00624233827319491,0.0640124078089205,0.0884823738398446,3.93337720081532e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DXO,Decapping and exoribonuclease protein,40483,0.0576057985980693,0.00471413451291337,0.0483660949527591,0.0668455022433795,4.00154502861149e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLG,Plasminogen,40285,0.0270475697358736,0.00221430862198805,0.022707524836777,0.0313876146349702,4.28406077464142e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP3,Caspase-3,42794,0.109069508302045,0.00893801203179717,0.0915510047197225,0.126588011884367,4.52106555420124e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBI,Acyl-CoA-binding protein,42562,0.0959904323063741,0.00787274308197173,0.0805598558657095,0.111421008747039,5.14891554013273e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.057586350281926,0.00472200386715754,0.0483312227022973,0.0668414778615548,5.44729740954252e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0558429674248736,0.00458023407710646,0.046865708633745,0.0648202262160023,5.64252196282784e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11,Coagulation factor XI,40383,0.0379434776379601,0.00311392170999039,0.031840191086379,0.0440467641895413,6.12045523503505e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCA,Tubulin-specific chaperone A,40283,0.106443553436841,0.0087369638869092,0.0893191042184993,0.123568002655183,6.29678106508396e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL4,C-C motif chemokine 4,42642,0.0858724469322326,0.00705782235467089,0.0720391151170777,0.0997057787473875,7.02029470965883e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB1,Beta-crystallin B1,40511,0.0800893538639027,0.00658505347234638,0.0671826490581038,0.0929960586697016,8.02113092083115e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,42679,0.104449930787357,0.00860124172598647,0.0875914970044234,0.12130836457029,9.30859248449119e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPBP,Platelet basic protein,40471,0.105469452296347,0.00868107224523821,0.0884545506956798,0.122484353897014,9.39367187034268e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0711684592847923,0.00586998914319733,0.0596632805641255,0.082673638005459,1.27464217776658e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.113028935309594,0.00933810476096822,0.0947262499780962,0.131331620641092,1.50406474392177e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0863448082236353,0.00713991369768534,0.072350577376172,0.100339039071099,1.87495492476243e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0294578512880677,0.00243858831676881,0.0246782181872008,0.0342374843889346,2.00064429514637e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM106A,Transmembrane protein 106A,40451,0.0873836465824327,0.00723178442086966,0.0732093491175282,0.101557944047337,2.08335329702891e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.086123256381351,0.00713259815885575,0.0721433639899937,0.100103148772708,2.3456920768294e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",40482,0.077368378362998,0.0064235608231882,0.0647781991495491,0.0899585575764469,3.31355095777386e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.155587340487205,0.0129672208752277,0.130171587571758,0.181003093402651,5.7387636990598e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0779947780764425,0.00651057695301338,0.0652340472485363,0.0907555089043487,6.67555589015292e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.120180486011021,0.0100344734376511,0.100512918073225,0.139848053948817,7.42834735730014e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,42495,0.0433755036152086,0.00362339186001709,0.0362736555695751,0.0504773516608421,7.43892389474544e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA1,Apolipoprotein A-I,40539,-0.034116664337411,0.00285647817687814,-0.0397153615640921,-0.0285179671107298,1.10057991850564e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSNAX,Translin-associated protein X,40116,0.0487865605368964,0.00408489459399738,0.0407801671326615,0.0567929539411313,1.12577755430371e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0419371897188117,0.00351455144597073,0.0350486688847091,0.0488257105529144,1.17372890004579e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,42676,0.10625736430567,0.00892654600895685,0.0887613341281143,0.123753394483225,1.65057356259416e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0753122373299549,0.00633135505388138,0.0629027814243474,0.0877216932355624,1.82127187796728e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,42754,0.0577062370396738,0.00486431345336401,0.0481721826710803,0.0672402914082672,2.65584134136053e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0814452395467311,0.00686583909724017,0.0679881949161403,0.0949022841773218,2.71147281407134e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0841009494519976,0.00709460766442386,0.0701955184297268,0.0980063804742683,3.22411937522738e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.143867107022884,0.0121478763716242,0.1200572693345,0.167676944711267,3.37865853393373e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,42794,0.0875465083161831,0.00739510974528501,0.0730520932154245,0.102040923416942,3.55384792541431e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,40223,0.0682617888505828,0.0057659807685476,0.0569604665442296,0.0795631111569361,3.852843770012e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2,Complement C2,42663,0.0279965870519175,0.00236702328321942,0.0233572214168074,0.0326359526870276,4.04465491027133e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC4,Syndecan-4,42636,0.0575488576876973,0.00486616896231088,0.048011166521568,0.0670865488538266,4.11711305347114e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL2,C-C motif chemokine 2,42475,0.0650151536043506,0.00550213017618208,0.0542309784590337,0.0757993287496675,4.64997488666095e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2R,Proteinase-activated receptor 1,42654,0.0681514318928676,0.00576872517526097,0.0568447305493561,0.0794581332363791,4.76055584810278e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,40482,0.104992928302554,0.0088845441329482,0.0875792218019756,0.122406634803133,4.89604150592328e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.124267902006751,0.0105173654639379,0.103653865697433,0.14488193831607,5.06246983358888e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,40429,0.105388948820267,0.00893037302081194,0.0878854176994758,0.122892479941059,5.94132169065084e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0584416816906904,0.00495643159573779,0.0487270757630443,0.0681562876183365,6.27953963507008e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLNK,B-cell linker protein,40199,0.049794491535835,0.00422130631675277,0.0415207311549995,0.0580682519166704,6.37145933755103e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON2,Spondin-2,42562,-0.0436846494729282,0.00370700713729669,-0.0509503834620297,-0.0364189154838266,6.76001027453983e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,40302,0.0909868037559191,0.0077331364864466,0.0758298562424838,0.106143751269354,9.03531213391054e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0405477030474578,0.00344856996530722,0.0337885059154557,0.04730690017946,9.17876941874968e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0634267836227407,0.00539556856302781,0.0528514692392062,0.0740020980062752,9.55521482077431e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.048810876245412,0.00415159635101906,0.0406737473974147,0.0569480050934093,9.92445155862831e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMTN,Smoothelin,40460,0.112002635747297,0.0095266438290759,0.0933304138423084,0.130674857652286,9.98494721517648e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,40223,0.0935128126106212,0.00797489525804985,0.0778820179048435,0.109143607316399,1.44518167385771e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOC1,Apolipoprotein C-I,40516,0.0446849435361818,0.00381580665927466,0.0372059624840035,0.0521639245883601,1.71071373931479e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0739772963933386,0.00632712195376044,0.0615761373639681,0.086378455422709,1.98793794664884e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,42495,0.0574618253204693,0.00491517894350915,0.0478280745911913,0.0670955760497472,2.02600147468457e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPB,Natriuretic peptides B,42357,-0.170745007689609,0.0146439047924438,-0.199447061082798,-0.142042954296419,2.91321348501511e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNMT,Histamine N-methyltransferase,42439,0.0578544776079355,0.00496717608463472,0.0481188124820515,0.0675901427338196,3.35902834994656e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0311655112210417,0.00267605093452913,0.0259204513893646,0.0364105710527188,3.3916319859426e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREH,Trehalase,40527,0.0894944929472272,0.00768149006849109,0.0744387724129847,0.10455021348147,3.42762769712802e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.1312715422577,0.0112898673667863,0.109143402218799,0.153399682296601,4.2446185252842e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBN,Nibrin,42370,0.0642733107507266,0.00553255070047325,0.0534295113777991,0.0751171101236542,4.76864838149172e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0679158973878729,0.00585662801222297,0.0564369064839158,0.0793948882918299,6.08417497207258e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLB,Beta-klotho,42311,-0.0894155937069382,0.0077179340782294,-0.104542744500268,-0.0742884429136086,6.90527775600668e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POSTN,Periostin,40527,-0.0462566365224884,0.00399287896993636,-0.0540826793035637,-0.0384305937414132,7.34353284543253e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1,Allograft inflammatory factor 1,42346,0.0623072553204791,0.00538225888828613,0.0517580278994382,0.0728564827415199,7.65613369613482e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBN1,Drebrin,40199,0.0598281796663097,0.00516622619199189,0.0497023763300056,0.0699539830026138,7.79486000164316e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN9,Septin-9,42587,0.0340404413348858,0.00294151588652235,0.028275070197302,0.0398058124724696,7.96869805768024e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,42689,0.0355368985944773,0.00307260353189885,0.0295145956719556,0.0415592015169991,8.5860722980212e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,40539,0.0366607834732925,0.0031682921903493,0.0304509307802079,0.0428706361663771,8.58957287825781e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.088269617481501,0.00763167083763383,0.0733115426397387,0.103227692323263,8.6113494496225e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRB1,Chymotrypsinogen B,42611,0.0693336775840748,0.00599868650471892,0.0575762520348257,0.0810911031333239,9.38909361356714e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SWAP70,Switch-associated protein 70,40449,0.0426446403919127,0.00368831716364878,0.0354155387511611,0.0498737420326643,9.56464507167611e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0635538192012093,0.00550256602562881,0.0527687897909769,0.0743388486114418,1.11095122791144e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.118278554255154,0.0102462287680684,0.0981959458697401,0.138361162640568,1.18145553668171e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0820419839283228,0.00710967434813165,0.0681070222059848,0.0959769456506609,1.25226119311365e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTNB,Dystrobrevin beta,40430,0.0509462608346581,0.004421083980901,0.0422809362320922,0.0596115854372241,1.49159510333638e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.047621896749508,0.00414148340221893,0.0395045892811589,0.0557392042178571,1.85243905666366e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMSB10,Thymosin beta-10,42611,0.0878663186144497,0.00764607348819481,0.0728800145775879,0.102852622651312,2.01562812706422e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF23,Fibroblast growth factor 23,42711,0.0646997344442067,0.00563030659076648,0.0536643335263044,0.075735135362109,2.01903641345673e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0723753255247476,0.00629769241343824,0.0600318483944087,0.0847188026550866,2.14941976489449e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP6,Bone morphogenetic protein 6,42342,0.0481372167073313,0.00419105060629905,0.0399227575189851,0.0563516758956774,2.17291444009016e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.075529050366906,0.00657609764030096,0.0626398989919161,0.0884182017418959,2.18273598851864e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN1,Ficolin-1,40515,0.0661200738484613,0.00575874194181992,0.0548329396424942,0.0774072080544283,2.40026930392873e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0641654628207232,0.00560756930328098,0.0531746269862925,0.075156298655154,3.78884840323296e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,40199,0.040765148435251,0.00356285242523597,0.0337819576817885,0.0477483391887135,3.82942267506727e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0357544359608359,0.00312645210468232,0.0296265898356585,0.0418822820860132,4.05092375908608e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0827372864075227,0.00725335845898618,0.0685207038279098,0.0969538689871356,5.63962545129766e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIP,Gastric inhibitory polypeptide,40223,0.0692093508313406,0.00606938636994534,0.0573133535462477,0.0811053481164334,5.94158327246811e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,40519,0.0233657079715036,0.00205194904838448,0.01934388783667,0.0273875281063372,7.04932496857377e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RP2,Protein XRP2,42587,0.0491767552543463,0.00433476464674903,0.0406806165467182,0.0576728939619744,1.07604497401893e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,40527,0.0401246586904411,0.00353558783283676,0.033194906538081,0.0470544108428011,1.08728964293564e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.070665620362307,0.00623550327498072,0.0584440339433448,0.0828872067812692,1.23884571275665e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0888576481237208,0.0078376805345831,0.0734957942759379,0.104219501971504,1.24211982944645e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT1,Angiopoietin-1,42554,0.0979830431917152,0.0086470121693775,0.0810348993397353,0.114931187043695,1.25179232908661e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0511817599189779,0.0045145510336973,0.0423332398929312,0.0600302799450246,1.253936871313e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0783069949127425,0.00691230768537561,0.0647588718494063,0.0918551179760786,1.36739805327174e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",40223,0.101254840128198,0.00896539425200446,0.0836826673942693,0.118827012862127,2.03829214685648e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0948510246562846,0.00840412729775002,0.0783789351526946,0.111323114159875,2.08291654016834e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX2,Heme oxygenase 2,42311,0.0532632868183273,0.00472029930662473,0.0440115001773429,0.0625150734593118,2.15317864413201e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,42679,0.0439445084427061,0.00390008509264945,0.0363003416611132,0.051588675224299,2.5651130025098e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0614514624911466,0.00545484505975127,0.0507599661740341,0.0721429588082591,2.80714564054424e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0780282534965059,0.00695065637061775,0.0644049670100951,0.0916515399829167,4.38326953701116e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML2,Trem-like transcript 2 protein,42611,0.040369077791671,0.00359830460070972,0.0333164007742799,0.0474217548090621,4.43594344629436e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL2,Chordin-like protein 2,42636,0.054774259391565,0.00488266279873564,0.0452042403060431,0.0643442784770868,4.47360618290221e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",40483,0.122116776503192,0.010894985345121,0.100762605226755,0.143470947779629,5.26763654518822e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POMC,Pro-opiomelanocortin,40223,0.0811612377560861,0.00724400522025327,0.0669629875243897,0.0953594879877825,5.59202396706696e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLF4,Krueppel-like factor 4,40136,0.0464509023224222,0.00415408523099945,0.0383088952696633,0.0545929093751812,7.16240737387947e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0545087520697493,0.00488136604840733,0.044941274614871,0.0640762295246277,8.39864998128607e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.023927370379629,0.00214445530741511,-0.0281305027821626,-0.0197242379770954,8.76978104293154e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,40449,0.0551726152932288,0.00494646577460883,0.0454775423749955,0.064867688211462,9.68911387382904e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,40449,0.111919200087017,0.0100417416478362,0.0922373864572579,0.131601013716776,1.06550145689607e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0494900869630935,0.00444444326469343,0.0407789781642944,0.0582011957618926,1.20225837995297e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0795829057549141,0.00714780613721656,0.0655732057259696,0.0935926057838585,1.2114895592957e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,40483,0.0779529795343357,0.00700435282485961,0.0642244479976108,0.0916815110710605,1.27385239342704e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN6,Dynactin subunit 6,42311,0.0824261007975653,0.00741240978392171,0.0678977776210788,0.0969544239740519,1.34559847054703e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFASC,Neurofascin,42754,0.0333671150354405,0.00300154442585248,0.0274840879607697,0.0392501421101114,1.38355512285183e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12B,Interleukin-12 subunit beta,42754,0.0652113898264032,0.00586809095419048,0.0537099315561899,0.0767128480966166,1.44267489126776e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0587960216272289,0.00529320068351539,0.0484213482875387,0.069170694966919,1.52874922786781e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1R,Complement C1r subcomponent,40539,0.0223350873792997,0.00201211471502269,0.0183913425378553,0.0262788322207442,1.7520952436296e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0370626594994454,0.00334017712318526,0.0305159123380022,0.0436094066608885,1.84031516862196e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABHD14B,Protein ABHD14B,42460,0.0652629892659135,0.00589540321490356,0.0537079989647025,0.0768179795671245,2.33056728283022e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,42495,0.0457455246648997,0.00414267161929877,0.0376258882910741,0.0538651610387253,3.15981905137284e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0693423326843835,0.00627660145249638,-0.0816444715312764,-0.0570401938374906,3.16012938024993e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.136236846636835,0.0123419480480601,0.112046628462637,0.160427064811033,3.29540080937437e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.135102054640927,0.0122552583967223,0.111081748183352,0.159122361098503,3.86141608249562e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0416235310258712,0.00378064752903759,0.0342134618689575,0.0490336001827848,4.53923900353167e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0323852377176304,0.00294119182399295,0.0266205017426042,0.0381499736926565,4.69794459989287e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,42711,0.0907781335271096,0.00824961371764652,0.0746088906405225,0.106947376413697,4.81177695380069e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0531161408887077,0.00482789470549038,0.0436534672659465,0.0625788145114688,4.95599805440212e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,40283,0.0264173650260355,0.0024010477265053,0.0217113114820851,0.0311234185699859,5.1914556229598e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLO1,Lactoylglutathione lyase,42357,0.0658200262801198,0.00598753962088337,0.0540844486231884,0.0775556039370512,5.47534547543908e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0434074531181976,0.00395279486763315,0.0356599751776367,0.0511549310587586,6.20949726812933e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0484357524643306,0.00441842480455227,0.0397756398474082,0.0570958650812531,7.60791596175856e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0592742636000782,0.00540816729258112,0.0486742557066192,0.0698742714935372,7.79456156555333e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL1,Growth-regulated alpha protein,42607,0.10812147647203,0.00986533902122367,0.0887854119904319,0.127457540953629,7.83104827236481e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0978565051755317,0.00894772699179543,0.0803189602716127,0.115394050079451,1.07101161270524e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOL1,Apolipoprotein L1,40532,0.0657922108929567,0.00601855484621147,0.0539958433943823,0.0775885783915312,1.1190896626051e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN4,CCN family member 4,42721,0.0452716912907692,0.00414319415621617,0.0371510307445856,0.0533923518369529,1.12055494590347e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG2,Secretogranin-2,42636,0.0386830060253981,0.00354148411016466,0.0317416971694753,0.0456243148813208,1.17173328009083e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APP,Amyloid-beta precursor protein,42592,0.0749529776293417,0.00686308803178753,0.0615013250870382,0.0884046301716453,1.19406541333438e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK3,NT-3 growth factor receptor,42711,-0.0245827192356701,0.00225371899238831,-0.0290000084607512,-0.020165430010589,1.3810215147447e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB10,Ras-related protein Rab-10,40511,0.0602973039921499,0.00552766308439699,0.0494630843467318,0.0711315236375681,1.44305006463657e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0430724513273721,0.00396326072995744,0.0353044602966556,0.0508404423580887,2.23870467086854e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0275310085718706,0.00253724129169032,0.0225580156401575,0.0325040015035836,2.5694022131651e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0539085280852345,0.00497190069753892,0.0441636027180582,0.0636534534524108,2.8154549107595e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.134318191623572,0.0124038025010019,-0.158629644525535,-0.110006738721608,3.26543463817368e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP3,Stromelysin-1,42611,-0.0565694442889531,0.00522774332368529,-0.0668158212033763,-0.04632306737453,3.54447804418551e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,39838,-0.126736981640408,0.011722460377051,-0.149713003979428,-0.103760959301388,4.20020156126897e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0648304936182214,0.0060037066300029,0.0530632286234157,0.0765977586130271,4.5480519900115e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0588251979146385,0.00546555430451983,0.0481127114777796,0.0695376843514973,6.63798762758725e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF6,SLAM family member 6,42346,0.0432430756199241,0.00401882975643188,0.0353661692973176,0.0511199819425306,6.87120108348175e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OCLN,Occludin,40482,0.0500330072286535,0.00465910817176421,0.0409011552119956,0.0591648592453113,9.01478051170103e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,42475,0.0451254273843822,0.00420405477605076,0.0368854800233227,0.0533653747454417,9.09533499037645e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX9,Sorting nexin-9,42636,0.0739945979622382,0.0069126125579101,0.0604458773487344,0.087543318575742,1.24403960702305e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,42676,0.0278247095296855,0.00260036344529804,0.0227279971769014,0.0329214218824697,1.29713263219564e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB2,Lysosome membrane protein 2,42302,0.0388156740531572,0.00362849282771368,0.0317038281108383,0.045927519995476,1.34666288873586e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA4,Ephrin-A4,42475,0.0375302023443421,0.00352093119143687,0.0306291772091258,0.0444312274795583,2.02040979201225e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP5,Platelet glycoprotein V,40283,0.0398480820615458,0.00373875540714079,0.0325201214635499,0.0471760426595417,2.14427907718971e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,40116,0.0772632299066277,0.00726538341372013,0.0630230784157362,0.0915033813975192,2.77032281251679e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,40511,0.0313303614484579,0.00295816841315621,0.0255323513586717,0.0371283715382441,4.33903910208355e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,42346,0.0565173233644015,0.00533866359090737,0.0460535427262231,0.0669811040025799,4.38690416466136e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0441438314034259,0.00417232928877685,0.0359660659974233,0.0523215968094285,4.66087800528113e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FADD,FAS-associated death domain protein,42636,0.0824350919412869,0.00779225765600303,0.0671622669355209,0.0977079169470528,4.71566757063484e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.106082764081486,0.0100337857885708,0.0864165439358874,0.125748984227085,5.31894195219959e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL18,C-C motif chemokine 18,42477,0.0759823904410123,0.00720205628576746,0.061866360120908,0.0900984207611165,6.42536379212138e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP6,Platelet glycoprotein VI,42590,0.0947606974765835,0.0089859609777874,0.0771482139601202,0.112373180993047,6.73736700307983e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0418188171086907,0.00396408580596983,0.0340492089289898,0.0495884252883916,6.7784282498231e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0394606661626464,0.00374541796430474,0.0321196469526091,0.0468016853726837,7.86426983961685e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPLAH,5-oxoprolinase,40223,0.0736812120872113,0.00700000239335181,0.0599612073962418,0.0874012167781809,8.69733612093659e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAP3,Cytosol aminopeptidase,42370,0.0526711781201466,0.00501078792221523,0.0428500337926047,0.0624923224476884,9.66202217018617e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0624165099758871,0.00594993896905419,0.0507546295965408,0.0740783903552333,1.2012301178846e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,42794,0.0453493373461393,0.00432338501492969,0.0368755027168771,0.0538231719754015,1.21178764238442e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0715714051841699,0.0068235774359525,0.058197193409703,0.0849456169586368,1.21863388999732e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMB1,Laminin subunit beta-1,40223,0.0330472193099517,0.00315019974658993,0.0268728278066354,0.0392216108132679,1.26071505511001e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0409731976176949,0.00390716651935298,0.0333151512397631,0.0486312439956267,1.31048329517214e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.038128923659911,0.00363961078551419,0.0309952865203032,0.0452625607995188,1.46741821262689e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP7,Matrilysin,42333,0.0546047567293035,0.00522009613269752,0.0443733683092164,0.0648361451493907,1.65213502198547e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSTB,Cystatin-B,42437,0.0460588178382078,0.00440648719381566,0.0374221029383291,0.0546955327380865,1.79290318979249e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ING1,Inhibitor of growth protein 1,42292,0.050904022674751,0.00487555588312512,0.0413479331438257,0.0604601122056762,2.0342759828886e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,42311,0.0617887128759036,0.00592074106049598,0.0501840603973315,0.0733933653544757,2.13557790205885e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0924369771451671,0.00885777057053361,0.0750757468269212,0.109798207463413,2.22225834935805e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0343051718761057,0.00329418652357081,-0.0407617774623045,-0.027848566289907,2.75945291559937e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRN1,Secernin-1,42594,0.059456573489382,0.00571434109085327,0.0482564649513096,0.0706566820274545,2.94204522283159e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0451474674118655,0.00433835638548257,0.0366442888963196,0.0536506459274113,3.02351382083048e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.046504864521766,0.00447451433928967,0.0377348164167582,0.0552749126267737,3.45572465947119e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX16,Syntaxin-16,42346,0.0618611685479008,0.00598792231386865,0.0501248408127183,0.0735974962830833,6.35494988113393e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSPN,Persephin,42594,0.0995271040306485,0.00964213465362165,0.0806285201095501,0.118425687951747,6.93852531386562e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0304243888213391,0.0029523868271329,0.0246377106401586,0.0362110670025196,8.68520885518704e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.127393927645177,0.0123718768129336,0.103145049091827,0.151642806198527,8.98564762159594e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,40451,0.046312245235818,0.00449621602279523,0.0374996618311394,0.0551248286404967,9.04987814503504e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,42346,0.0424358266447689,0.0041222448775429,0.0343562266847849,0.050515426604753,9.27699144307547e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0934665521329798,0.00908035308417043,0.0756690600880057,0.111264044177954,9.72642671221157e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSTN,Growth/differentiation factor 8,42357,0.056743566572747,0.00551650418230202,0.045931218375435,0.0675559147700589,1.00932894664223e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCOF1,Treacle protein,40511,0.0343220955503035,0.00333686367858564,0.0277818427402756,0.0408623483603313,1.04963404483232e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,42587,0.0771829589537363,0.00752141324192493,0.0624409889995635,0.0919249289079092,1.29235659085925e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0918384506156344,0.00896642458193894,0.0742642584350341,0.109412642796235,1.57567458562994e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1F,Protein phosphatase 1F,40511,0.0549432427345526,0.00538535672168698,0.0443879435600461,0.0654985419090591,2.46651759932336e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,42689,-0.0619629991846609,0.00608142398917365,-0.0738825902034413,-0.0500434081658806,2.72150607326772e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164,Sialomucin core protein 24,42611,0.0288168398251736,0.00283128786989059,0.023267515600188,0.0343661640501591,3.04511865172175e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,40511,0.0288550118635006,0.00283559840158834,0.0232972389963874,0.0344127847306137,3.22651789080625e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA13,Carbonic anhydrase 13,42483,0.107796929983158,0.0106043398532094,0.0870124238708674,0.128581436095448,3.47030543169246e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,42501,0.0307786791316683,0.00302953455263701,0.0248407914084998,0.0367165668548368,3.68108836775877e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,42711,0.0484200365806663,0.00477076381101563,0.0390693395110757,0.057770733650257,4.07141140813067e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,40404,0.0506988585368532,0.00499755339027338,0.0409036538919173,0.060494063181789,4.44284694088705e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,40451,0.0635130309469376,0.00626315255913031,0.0512372519310422,0.075788809962833,4.62186666965648e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA12,Serpin A12,42249,0.108184161219287,0.0107022718931848,0.0872077083086449,0.129160614129929,6.20270640848151e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0674382971946964,0.0066740088529821,0.0543572398428514,0.0805193545465413,6.69599163573107e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNF,Tumor necrosis factor,42339,0.040197266700977,0.00398128727197472,0.0323939436479065,0.0480005897540474,6.99210664274786e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0543980757154687,0.00539514287020076,0.0438235956898752,0.0649725557410622,8.0392302350542e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID1,Nidogen-1,42652,0.0399692670859196,0.00396619890776421,0.0321955172267018,0.0477430169451375,8.43981357105565e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0627850416408581,0.00623264108960924,0.0505690651052239,0.0750010181764922,9.10409409512499e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0479981733197514,0.0047728323345655,0.038643421944003,0.0573529246954998,1.08230427931085e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0757470435340639,0.00754105973561806,0.0609665664522525,0.0905275206158753,1.17846443054309e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,42346,0.0450329682816064,0.00448412360874019,0.0362440860084756,0.0538218505547371,1.20299660998168e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,40527,0.0871977977604692,0.00868121694693093,0.0701826125444846,0.104212982976454,1.22067293131028e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0682663368502161,0.00681303895056781,0.0549127805071032,0.081619893193329,1.51239488483704e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLMH,Bleomycin hydrolase,42794,0.0324160397414696,0.00323747270891371,0.0260705932319988,0.0387614862509405,1.61590465896074e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARD3,Partitioning defective 3 homolog,40302,0.0770146650451305,0.00769801675732632,0.0619265522007709,0.0921027778894901,1.83059651336831e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0337285599763865,0.00337431995551781,0.0271148928635716,0.0403422270892015,1.99228183719239e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,42346,0.0499619569979452,0.00500288748780282,0.0401562975218517,0.0597676164740387,2.11315174543428e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,42754,0.0747252596896571,0.00748353185631094,0.0600575372512877,0.0893929821280266,2.12922658893115e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSS,Cathepsin S,39872,0.0252878020452319,0.00253410774786401,0.0203209508594184,0.0302546532310453,2.38391909908224e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX,Glutaredoxin-1,42546,0.0576802828403351,0.00579688357702926,0.0463183910293577,0.0690421746513124,3.03150489192486e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,42454,0.025689457990754,0.00258288861096733,0.020626996313258,0.03075191966825,3.1653733828475e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO1A,Coronin-1A,42353,0.0916958026569521,0.0092234126899123,0.073617913784724,0.10977369152918,3.31147646431142e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.073790128205174,0.00743507166828593,0.0592173877353336,0.0883628686750144,3.91574525460439e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0443862379835429,0.00447617709561033,0.0356129308761467,0.0531595450909392,4.2569917510047e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,40482,0.0608908711492717,0.0061421340723051,0.0488522883675537,0.0729294539309897,4.51206836115917e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPL14,60S ribosomal protein L14,40223,0.0411531370790171,0.00415213864121256,0.0330149453422405,0.0492913288157938,4.64075351480517e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL24,C-C motif chemokine 24,42654,0.0847453925597635,0.00856227916782103,0.0679633253908343,0.101527459728693,5.11349889807774e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSNL1,Visinin-like protein 1,40483,0.0393592158950543,0.00397705885186036,0.031564180545408,0.0471542512447006,5.34436077998632e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRIB,Protein scribble homolog,40223,0.0930412790618606,0.00940787566424474,0.0746018427599409,0.11148071536378,5.74798881380319e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSA,Arylsulfatase A,42611,0.0455430164291501,0.00460692427708003,0.0365134448460733,0.054572588012227,5.74900788855682e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD84,SLAM family member 5,42594,0.0320704407304527,0.00324572404820831,0.0257088215959645,0.038432059864941,6.03926058940109e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA4,Carbonic anhydrase 4,42794,-0.0246614271028947,0.00249777425654677,-0.0295570646457263,-0.019765789560063,6.48569938943468e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH7,Protocadherin-7,40449,0.0371235305239706,0.00376116085131446,0.0297516552553943,0.044495405792547,6.93987838906537e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0389075331361372,0.00394301138410674,0.031179230823288,0.0466358354489864,7.12773533181971e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TST,Thiosulfate sulfurtransferase,42277,0.0760077423746484,0.00770846345330916,0.0608991540061625,0.0911163307431344,7.43210333411752e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0700524860850779,0.00710507467529184,0.0561265397215059,0.0839784324486499,7.73769345888896e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARFIP1,Arfaptin-1,40482,0.0696398821223305,0.00707370017348052,0.0557754297823087,0.0835043344623523,8.90600473145347e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0390963260316111,0.00397524011685476,0.0313048554025758,0.0468877966606465,9.53573108194969e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0575714071542437,0.00585937498814765,0.0460870321774743,0.0690557821310131,1.04656184172062e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.030530772377048,0.00311091964834874,0.0244333698662844,0.0366281748878115,1.16739898252982e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,42480,0.0480929726705679,0.00490133088979077,0.038486364126578,0.0576995812145578,1.19077276907937e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0359839506483579,0.00366601083857999,-0.0431693318919747,-0.0287985694047412,1.19470090059633e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0282638533573132,0.00288740906215232,0.0226045315954947,0.0339231751191318,1.55695615111745e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA,Lymphotoxin-alpha,42594,0.041383039967499,0.00422956333825333,0.0330930958245224,0.0496729841104755,1.56550714515919e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,42346,0.073655620846534,0.00753669945986656,0.0588836899051955,0.0884275517878725,1.75480812368515e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0379506687016533,0.00389091840008438,0.0303244686374879,0.0455768687658187,2.11935347043679e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0883948984152957,0.00906706553366082,0.0706234499693205,0.106166346861271,2.21753632396164e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0829261439316891,0.00850546310906647,0.0662554362379189,0.0995968516254594,2.26579405373216e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC3B,Tetranectin,40269,0.0211733598534289,0.00217907479969282,0.016902373246031,0.0254443464608268,3.14036523326392e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA2,Integrin alpha-2,40283,0.0350601555472774,0.00361578974786251,0.0279732076414668,0.0421471034530879,3.82368253142049e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH1,Acid ceramidase,40418,0.0459175397381744,0.00473633723238602,0.0366343187626978,0.055200760713651,3.87672177404401e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0302334858608586,0.00312224628688027,-0.0363530885831439,-0.0241138831385733,4.19656302932498e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA2,Annexin A2,40054,0.0727944962447118,0.00752544460709671,0.0580446248148023,0.0875443676746214,4.81336184530496e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0327399185477352,0.0033892470482558,0.0260969943331538,0.0393828427623166,5.42399916692221e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,42437,0.0341664167012846,0.00354098754445716,0.0272260811141486,0.0411067522884206,5.8713453005095e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0232912973998049,0.00241527799622662,0.0185573525272007,0.0280252422724091,6.36825770494435e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0519309761851223,0.00538904615579237,0.0413684457197692,0.0624935066504753,6.60054420723606e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0787631767761021,0.00819079133167692,-0.0948171277861889,-0.0627092257660154,8.04034584454925e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0662171543807212,0.00689653341826576,0.0526999488809203,0.0797343598805221,9.28850762434501e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAL,Integrin alpha-L,40199,0.0444069253296148,0.00462615246292738,0.0353396665022771,0.0534741841569524,9.80975230073378e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0248895855459368,0.00259632036431668,0.0198007976318761,0.0299783734599975,1.06986563264816e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR3,Toll-like receptor 3,42754,0.0605735899518008,0.00632031933222676,0.0481857640606364,0.0729614158429653,1.09418464879512e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0656798865086834,0.00686515348992348,0.0522241856684334,0.0791355873489335,1.28672600432791e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40LG,CD40 ligand,42754,0.0765992864524179,0.00801617268806022,0.0608875879838199,0.0923109849210159,1.43675194836645e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0908489651198572,0.00950424413359848,0.0722206466180042,0.10947728362171,1.43787848343406e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100P,Protein S100-P,42357,0.0538682726649488,0.00563992920746813,0.0428140114183113,0.0649225339115863,1.50516364269493e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTC,Probetacellulin,42346,0.07385885321324,0.00774311767124545,0.0586823425775989,0.0890353638488811,1.69830497878184e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0398614404084105,0.00417768949402538,0.0316731690001207,0.0480497118167002,1.70463494908555e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0342344459922317,0.00358932795631976,0.027199363197845,0.0412695287866185,1.70553244713321e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA1,BolA-like protein 1,40136,0.0535752459105744,0.00561934002691232,0.0425613394578263,0.0645891523633226,1.8320053777989e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC79,Protein unc-79 homolog,40080,0.0549312842104407,0.00576510104020628,0.0436316861716364,0.066230882249245,1.93900282428836e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.115419712237974,0.0121167258380744,0.0916709295953478,0.139168494880599,1.97516783436207e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP2,Retinol-binding protein 2,42587,-0.0760703665606759,0.00800423841711727,-0.0917586738582258,-0.0603820592631261,2.36371919969375e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0354072754548318,0.00372709604195276,0.0281021672126044,0.0427123836970592,2.44949497094146e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,40136,0.0466729242270485,0.00491543536391198,0.037038670913781,0.056307177540316,2.65518528915636e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0236087818578108,0.00248817642283862,-0.0284856076465745,-0.0187319560690471,2.73402307647291e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOE,Apolipoprotein E,40539,0.0714203105792692,0.00753920273108406,0.0566434732263444,0.0861971479321939,3.25099359568568e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0723334658785827,0.00764400558733182,0.0573512149274123,0.087315716829753,3.59077833071776e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDCP1,CUB domain-containing protein 1,42495,0.0532033354287274,0.00563370269145655,0.0421612781534725,0.0642453927039822,4.18741595003712e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG2,Bone marrow proteoglycan,40527,-0.0517022492322064,0.00548486631386833,-0.0624525872073884,-0.0409519112570245,5.0691786602697e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,40302,0.0336313472988472,0.0035690962480217,0.0266359186527247,0.0406267759449697,5.25422993221263e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN2,Dynactin subunit 2,42587,0.0911913260179786,0.009687990981555,0.0722028636941308,0.110179788341826,5.60696417833643e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0930223797180312,0.00988250260138873,0.0736526746193092,0.112392084816753,5.61311887695247e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,42441,0.0352978394834585,0.00375038253625987,0.0279470897123892,0.0426485892545279,5.6707775784825e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,40302,0.0681413823924959,0.00724003520851054,0.0539509133838152,0.0823318514011765,5.83965058942753e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF2,Fibroblast growth factor 2,42594,0.066537750973298,0.00708108871815605,0.0526588170857121,0.0804166848608839,6.5384864285709e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,42587,0.0579405940748765,0.00617280324787449,0.0458418997090425,0.0700392884407105,7.19341703181297e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0432990636707151,0.00461284186088952,0.0342578936233717,0.0523402337180586,7.41193074802733e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGLAP,Osteocalcin,40527,0.0880835697788327,0.00938800805720583,0.0696830739867093,0.106484065570956,7.6620173673877e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,42679,0.0244831559687481,0.00261079340334374,0.0193660008981943,0.0296003110393018,7.80488070117852e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPPK1,Epiplakin,40223,0.0705809952414018,0.00752467574089994,0.0558326307892379,0.0853293596935657,7.8910960884472e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0294884558706823,0.00314588466135241,0.0233225219344316,0.0356543898069331,8.33343519536754e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1B,Meprin A subunit beta,42636,0.114530259298129,0.0122254204598796,0.0905684351967648,0.138492083399493,8.53617282171942e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,42711,0.0299372617625164,0.00319636244797563,0.0236723913644842,0.0362021321605487,8.70486445586571e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,42457,0.0429343317181981,0.00458394142902915,0.0339498065173009,0.0519188569190952,8.71197991003043e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.028962583590746,0.00309226759003503,0.0229017391142774,0.0350234280672147,8.72136567147946e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA11,Integrin alpha-11,42594,-0.0329547193693019,0.00351877409865067,-0.0398515166026573,-0.0260579221359466,8.76874067513729e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,42594,-0.0474477864066476,0.00507003422953008,-0.0573850534965265,-0.0375105193167686,9.35869653840858e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.056662395256024,0.00605796125255365,0.0447887912010189,0.0685359993110291,1.01281220325326e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRBP,Acrosin-binding protein,40451,0.0378156263724155,0.00406051654828352,0.0298570139377798,0.0457742388070512,1.4729141423941e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UMOD,Uromodulin,42764,-0.0532320591186178,0.0057204440472582,-0.0644441294512439,-0.0420199887859918,1.53397493379225e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,42611,-0.0262228490604291,0.00281828564566264,-0.0317466889259278,-0.0206990091949303,1.55147736360433e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0538426542529085,0.00578786814653382,0.0424984326857022,0.0651868758201148,1.62518186065207e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0296990767064147,0.0031944212719443,0.0234380110134039,0.0359601423994255,1.66209735445026e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KITLG,Kit ligand,42636,-0.0361035504496452,0.00388584257078879,-0.0437198018883912,-0.0284872990108992,1.75942809606935e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,40482,0.0348837054820501,0.00375391129306315,0.0275260393476463,0.0422413716164539,1.78077779170841e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENR,Density-regulated protein,40199,0.0548570241904924,0.00590758884281203,0.0432781500585808,0.066435898322404,1.90499306640179e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA9,Serpin A9,42538,0.0689089501695017,0.0074306157458418,0.0543449433076518,0.0834729570313516,2.07150707917552e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0557494095340147,0.00601864627203422,0.0439528628408276,0.0675459562272018,2.35134571892128e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGF,Hepatoma-derived growth factor,42700,0.0890849859988962,0.00962934188890845,0.0702114758966357,0.107958496101157,2.54377939574386e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPAG1,Sperm-associated antigen 1,40482,0.054941398301759,0.00594234141906717,0.0432944091203873,0.0665883874831306,2.75444231473932e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFB,Complement factor B,40344,0.0310062500616832,0.00335536965685384,0.0244297255342497,0.0375827745891167,2.89012643538265e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,42679,0.0664486480477904,0.0071948539141463,0.0523467343760636,0.0805505617195171,2.94741844655795e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0418958834297684,0.00454273205648606,0.0329921285990557,0.0507996382604811,3.42744171259004e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP1,Guanylate-binding protein 1,40466,0.0626640843449761,0.00680033342455477,0.0493354308328487,0.0759927378571034,3.66827536571321e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,42778,0.0227698694763866,0.00247280687773906,0.0179231679960181,0.0276165709567552,3.79849125409048e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMS,Spermine synthase,40136,0.0608055406759115,0.00661751098855016,0.0478352191383532,0.0737758622134698,4.6986595476882e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGRN,Neugrin,40483,0.0220741387996079,0.00240270343021591,0.0173648400763847,0.026783437522831,4.73445869030332e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.065119661760401,0.00709978854807717,0.0512040762061697,0.0790352473146322,5.30981576511347e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,40483,0.0216371944704326,0.00236016172984024,0.0170112774799457,0.0262631114609194,5.66826158897979e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0600551010514528,0.00655372812906644,0.0472097939184826,0.072900408184423,5.88654964810393e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0752639004550282,0.00821394761888071,0.059164563122022,0.0913632377880344,5.92359730026276e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0322750170451019,0.00352802050035224,0.0253600968644115,0.0391899372257923,6.61511192082262e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA6,Carbonic anhydrase 6,42581,-0.0592862989537543,0.00648231122631341,-0.0719916289573286,-0.04658096895018,6.75883694850311e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD302,CD302 antigen,42587,0.0303879015365721,0.00332266828409155,0.0238754716997526,0.0369003313733915,6.7725010402298e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADM,Pro-adrenomedullin,42721,0.0254265521824542,0.0027805295417755,0.0199767142805742,0.0308763900843341,6.83438721263283e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB8,Serpin B8,42754,0.0546232866632956,0.00597431396714185,0.0429136312876976,0.0663329420388936,6.92564614217293e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.052304974364527,0.00571992314289707,0.0410939250044488,0.0635160237246053,7.02723118427866e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,42578,0.0784523526563454,0.00858463754469752,0.0616264630687383,0.0952782422439526,7.21928806880327e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0833023282937364,0.00912976808276627,0.0654079828515145,0.101196673735958,8.46966031104843e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.018599526804127,0.00203951246868154,-0.0225969712427428,-0.0146020823655112,8.60168338531019e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0769243456598203,0.00843731218811627,0.0603872137711124,0.0934614775485282,8.79504740829788e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHPS,Deoxyhypusine synthase,40451,0.0382323513456492,0.00419273034304379,0.0300145998732834,0.046450102818015,8.88878245927416e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,42357,0.0478936578756051,0.00525822572483868,0.0375875354549213,0.0581997802962889,9.55882735932063e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS27,Serine protease 27,42603,0.0380045105138333,0.00417481601371808,0.0298218711269458,0.0461871499007207,9.98709270131492e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0252626462742872,0.00277483131702487,0.0198239768929185,0.0307013156556559,1.0143104631808e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,42679,0.0250533391575551,0.00275414999245962,0.0196552051723343,0.030451473142776,1.06108385633054e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0258865680782068,0.00284554495559608,0.0203092999652385,0.0314638361911751,1.08628520244477e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN2,Matrilin-2,42638,0.0278606471732616,0.00306421918552156,0.0218547775696393,0.0338665167768838,1.10435536597603e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDA,Cytidine deaminase,40494,0.0442241699371698,0.00486363062279803,0.0346914539164857,0.0537568859578539,1.12573121668655e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0381881728626885,0.00420012550083115,0.0299559268810595,0.0464204188443176,1.13877379988305e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0389943256308215,0.00429640706952677,0.0305733677745491,0.047415283487094,1.31340938201562e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK7,Kallikrein-7,40009,0.0368415607028026,0.00405957835190906,0.0288847871330609,0.0447983342725444,1.33104943802219e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0458345579288858,0.00505191112065522,0.0359328121324015,0.05573630372537,1.35327723568573e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIT2,Slit homolog 2 protein,42311,0.0493504172953813,0.00544635043660226,0.0386755704396409,0.0600252641511217,1.4710315147923e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,42545,0.0422478806430052,0.00466364987688416,0.0331071268843123,0.0513886344016982,1.49761632601216e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,42636,0.0590300007290436,0.00651875684421673,0.0462532373143788,0.0718067641437084,1.54572043505996e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0399130964982529,0.0044267922390059,0.0312365837098013,0.0485896092867044,2.27015371896021e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO2,Gamma-enolase,42711,0.0600777285034022,0.00666644466722216,0.0470114969556468,0.0731439600511577,2.29239540347307e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL26,C-C motif chemokine 26,42594,0.0870963413442691,0.00966634342139023,0.0681503082383443,0.106042374450194,2.33034118065728e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.05395805041537,0.00599703770323037,0.0422038565170385,0.0657122443137016,2.6230634224155e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NADK,NAD kinase,42636,0.0509178093447822,0.00566064994763044,0.0398229354474265,0.0620126832421379,2.67373172755413e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD83,CD83 antigen,42594,0.0329244245043012,0.00366191852775556,0.0257470641899003,0.0401017848187021,2.77371455322577e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM1,Dynamin-1,40449,0.106142347831184,0.0118031535021196,0.0830081669670298,0.129276528695338,2.79718090410773e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,42611,-0.0268905284952321,0.00299388746055735,-0.0327585479179245,-0.0210225090725397,3.01439042145716e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPA1,Inositol monophosphatase 1,42495,0.0562635021050838,0.00626506986029341,0.0439839651789087,0.0685430390312589,3.0533771295898e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0902294923400558,0.0100522249231896,0.0705271314906043,0.109931853189507,3.17476599131121e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FST,Follistatin,42654,0.045659853595977,0.00508707711907912,0.035689182442582,0.0556305247493721,3.18546069490604e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,42616,-0.0919098289171262,0.0102424674319779,-0.111985065083803,-0.0718345927504496,3.25193200565427e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPR,Nucleoprotein TPR,40116,0.0451855432834221,0.0050393400513719,0.0353084367827331,0.055062649784111,3.55742611451917e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,42587,0.0218064564916659,0.00243312177488639,0.0170375378128885,0.0265753751704432,3.5944751684416e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0318370386601581,0.00355223741862916,0.024874653319645,0.0387994240006713,3.67647725517311e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,40223,0.0486854258494269,0.00543712936418615,0.038028652295622,0.0593421994032317,3.9685374897683e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN4,Cerebellin-4,42721,0.0301682533902601,0.0033728175690145,0.0235575309549917,0.0367789758255285,4.21498350028508e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,40116,0.047729936881543,0.00533668692207072,0.0372700305142843,0.0581898432488016,4.36831270433921e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,42370,0.0322989487422975,0.00361532393003951,0.0252129138394201,0.039384983645175,4.65247982038588e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",40490,0.020760890496314,0.00233178048984613,0.0161906007362156,0.0253311802564124,6.23913683180387e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM3,Myomesin-3,40283,-0.0854661648916568,0.00961137562707383,-0.104304461120722,-0.0666278686625921,6.91846820581761e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD276,CD276 antigen,42618,-0.0337826032860911,0.00380419829450676,-0.0412388319433244,-0.0263263746288579,7.50203810290609e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0398177789566288,0.00448815174136156,0.0310210015435601,0.0486145563696974,8.11856947190751e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.103989180986901,0.0117229268120772,0.08101224443523,0.126966117538573,8.37292965766562e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXN,"Frataxin, mitochondrial",42721,0.0670954725315481,0.00757144069647434,0.0522554487664584,0.0819354962966378,8.85703562271638e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0299948676898047,0.00338586950405948,0.0233585634618481,0.0366311719177613,9.09525223277867e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA6,Integrin alpha-6,42594,0.0466567091471956,0.00526763292620047,0.0363321486118427,0.0569812696825485,9.2222633765362e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMMT,MICOS complex subunit MIC60,40451,0.0414537653750576,0.00468341325040287,0.032274275404268,0.0506332553458472,9.95193315822683e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MET,Hepatocyte growth factor receptor,42654,-0.0181858928622557,0.00205715843428858,-0.0222179233934613,-0.01415386233105,1.07192711052283e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,40102,0.0497404074090314,0.00563991959346893,0.0386861650058323,0.0607946498122305,1.32633301585543e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX7,Syntaxin-7,40199,0.0457054602070948,0.00518748349624978,0.0355379925544452,0.0558729278597444,1.42995812244321e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP8,Caspase-8,42674,0.0558429598459749,0.00634501541451565,0.0434067296335243,0.0682791900584256,1.51828433903107e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,42346,0.041182989456466,0.00468197227627446,0.0320063237949681,0.050359655117964,1.59150076775295e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0410271472089606,0.00467098049346919,0.031872025441761,0.0501822689761602,1.82065336237834e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB2,Calretinin,42311,0.0291589389007355,0.00332275359101682,0.0226463418623426,0.0356715359391285,1.90919493937331e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,42689,0.0419222651204701,0.00477840632861828,0.0325565887163782,0.0512879415245619,1.94145205345355e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,42636,0.077672632615589,0.00885556951692631,0.0603157163624135,0.0950295488687646,1.98084974437773e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0378931783575274,0.00432206642546807,0.02942192816361,0.0463644285514448,2.0968187473129e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRG,Histidine-rich glycoprotein,40479,0.0280464574154429,0.00320447363814684,0.0217656890846751,0.0343272257462107,2.38768010046461e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSE,Cathepsin E,40283,0.046478095747141,0.0053145054969435,0.0360616649731317,0.0568945265211503,2.54007376090437e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTN,Pleiotrophin,42357,0.044678425604704,0.00512470247107398,0.034634008761399,0.054722842448009,3.16077145330326e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL1,Fc receptor-like protein 1,42636,0.0424480293763974,0.00486972568534927,0.0329033670331129,0.051992691719682,3.19606461156236e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAP,Prosaposin,40440,0.0261735821466797,0.00300874535415545,0.020276441252535,0.0320707230408244,3.80766754299675e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0357701364480244,0.00411516346393656,0.0277044160587088,0.0438358568373401,3.9571863392621e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7,Complement component C7,40251,-0.0297066869588723,0.00342275858563605,-0.036415293786719,-0.0229980801310256,4.54528865890318e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXN,Thioredoxin,40384,0.0399985997050971,0.00461425343455181,0.0309546629733755,0.0490425364368186,4.98147810554023e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APLP1,Amyloid-like protein 1,42636,-0.046291549318147,0.00534537529779474,-0.0567684849018247,-0.0358146137344693,5.24519640357643e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM2,Paralemmin-2,40483,0.0338932328842594,0.00391503414531674,0.0262197659594386,0.0415666998090802,5.49041252925285e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPA,Apolipoprotein(a),40324,-0.162834526364175,0.0188650313330317,-0.199809987776917,-0.125859064951433,6.87507338409264e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0254330478948111,0.00294909076489913,0.0196528299956088,0.0312132657940134,7.17636073936512e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0630124440536983,0.00730784484033069,0.0486890681666501,0.0773358199407464,7.43587100162292e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRSF1,G-rich sequence factor 1,40014,0.0720645156193077,0.00837086065017109,0.0556576287449724,0.088471402493643,8.39294867350062e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX6,Syntaxin-6,42346,0.0589350090366119,0.00685528371782021,0.0454986529496843,0.0723713651235395,9.09824983491956e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSL,Cathepsin L1,42636,0.0220900954440646,0.00256958775067076,0.0170537034527499,0.0271264874353793,9.098975275311e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFP,Alpha-fetoprotein,42459,0.0593900942894392,0.00695158218142751,0.0457649932138413,0.0730151953650371,1.44444427259627e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,40302,0.0309050101031219,0.00362045383760691,0.0238089205814124,0.0380010996248315,1.56707530859575e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN3,Calsyntenin-3,40483,0.0271787156937273,0.00318507255858427,0.0209359734789022,0.0334214579085525,1.60584598119178e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0367056585121287,0.00430439971063884,0.0282690350792766,0.0451422819449809,1.65275635735336e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0803886345855144,0.00942746408700622,0.0619108049749822,0.0988664641960466,1.69530460909092e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0673575404371072,0.00790313656029667,0.0518673927789257,0.0828476880952886,1.75725731408012e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLTA,Clathrin light chain A,42357,0.0419668060363813,0.00493559032451301,0.0322930490003358,0.0516405630724268,2.04703396476498e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3C,Protein FAM3C,42613,0.0273893720482789,0.0032233931881849,0.0210715213994365,0.0337072226971213,2.14778749912702e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0290524376345597,0.00342119550276207,0.022346894449146,0.0357579808199733,2.24943562208711e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0628957939250881,0.00741154011731284,0.0483691752951549,0.0774224125550212,2.36141211548623e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY75,Lymphocyte antigen 75,42594,0.0342417554123777,0.00403962287024121,0.026324094586705,0.0421594162380505,2.56184243052999e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR1,Complement receptor type 1,40509,0.0317367262466588,0.00375145548182907,0.0243838735022738,0.0390895789910438,3.00615590378967e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVR,Poliovirus receptor,42711,0.0321894058942742,0.0038071483370068,0.0247273951537409,0.0396514166348075,3.07478786527111e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0388059484038252,0.00458855698349515,0.0298123767161747,0.0477995200914757,3.08609243455001e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP2,Neuropilin-2,42611,-0.0251411514776835,0.00297906495838568,-0.0309801187961195,-0.0193021841592476,3.51768485180579e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,42370,0.058001200578541,0.00687555111691713,0.0445251203893834,0.0714772807676986,3.62774187566963e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX6,Peroxiredoxin-6,42721,-0.0530443553937418,0.00628858201662907,-0.0653699761463348,-0.0407187346411488,3.64433261566333e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,42711,-0.0265040294817887,0.00314247538528958,-0.0326632812369562,-0.0203447777266211,3.67264673426827e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMD,Dystrophin,40223,0.0451207951471592,0.00534880645023803,0.0346371345046926,0.0556044557896257,3.70348315367659e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0520685121311914,0.00617327064491123,0.0399689016671654,0.0641681225952174,3.7340893378856e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,40223,0.0207995343324351,0.0024678599888587,0.015962528754272,0.0256365399105981,3.94735688940583e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOM,Apolipoprotein M,42663,0.0246294137837549,0.00292337977657191,0.018899589421674,0.0303592381458359,3.97089796213067e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0269052253661652,0.0031980856500265,0.0206369774921133,0.0331734732402171,4.3985206162288e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPH,Hephaestin,40511,0.0231322724250942,0.00274911265758671,0.0177440116162243,0.0285205332339642,4.42132750924805e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0385631871520352,0.00460019021513913,-0.0475795599737079,-0.0295468143303625,5.66882737515551e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA2,Carbonic anhydrase 2,42573,0.0603126359426088,0.00719950662966064,0.046201602948474,0.0744236689367437,5.94970534080855e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,42292,0.057621223177927,0.00688145606421059,0.0441335692920742,0.0711088770637797,6.1625827467317e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPQ,Carboxypeptidase Q,40516,0.0309820169953461,0.00370910166027397,0.0237121777412091,0.038251856249483,7.43153955811817e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0473988762927934,0.0056849711909665,0.0362563327584991,0.0585414198270878,8.31751067440218e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,40116,0.052299672975537,0.00627270155983232,0.0400051779182657,0.0645941680328084,8.48633556641629e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0304323828849063,0.00365013514527578,0.0232781180001658,0.0375866477696468,8.50285379607004e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAT,Catalase,40361,0.0468770970110962,0.00562416898187781,0.0358537258066157,0.0579004682155767,8.66142735542434e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0405985192967562,0.00487459412946886,0.0310443148029973,0.0501527237905152,9.1243567372842e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0582295370973589,0.00699563000633167,0.0445181022849488,0.0719409719097689,9.50973782001422e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0425129213079128,0.00510713906156501,0.0325029287472453,0.0525229138685802,9.51369454471574e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK4,Dickkopf-related protein 4,42477,0.0400598131471914,0.00481434318875445,0.0306237004972327,0.0494959257971501,9.57335134347388e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0626124107822415,0.0075342021836928,0.0478453745022036,0.0773794470622794,1.04675913361642e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPT,Dermatopontin,42794,0.0217001782397739,0.00262209181749196,0.0165608782774897,0.0268394782020582,1.39273559548803e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0454743009415204,0.00549561405767368,0.03470289738848,0.0562457044945608,1.43295503008005e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDHB,Succinate dehydrogenase,40449,0.0569828829392851,0.00688948138090131,0.0434794994327186,0.0704862664458517,1.47777566727592e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMM2,Phosphomannomutase 2,40116,0.0515738484366547,0.00623812866180607,0.0393471162595148,0.0638005806137946,1.5261727529936e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0488059672681287,0.00591101589301524,0.0372203761178189,0.0603915584184386,1.66542056567397e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0421182693665854,0.00510224720299746,0.0321178648487104,0.0521186738844604,1.69058340129892e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0276585099949549,0.00335824992238438,0.0210763401470815,0.0342406798428283,1.94471892375425e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C5,Complement C5,40539,0.0128132508208596,0.00156294598730348,0.00974987668574476,0.0158766249559744,2.70372031328634e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.032518371705238,0.00397044793009111,0.0247362937622594,0.0403004496482166,2.84487230348783e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN5,CCN family member 5,42611,0.0327686720522656,0.00400636703162434,0.0249161926702819,0.0406211514342493,3.11398268086243e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA4,Annexin A4,42584,0.0604020904149025,0.00738640483073823,0.0459247369466556,0.0748794438831494,3.15803355776718e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0462206082702482,0.00565573470453031,0.0351353682493688,0.0573058482911277,3.29438723087939e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0444429400363563,0.00544235903301464,0.0337759163316476,0.055109963741065,3.46453186782475e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,42595,0.0246044619137703,0.00302214533795495,0.0186810570513786,0.030527866776162,4.25069583667608e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,40116,0.098590625974064,0.0121098451771277,0.0748553294268938,0.122325922521234,4.33331825623275e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP9,Caspase-9,40199,0.0528402354837317,0.00649169202323029,0.0401165191182003,0.0655639518492631,4.39048543528792e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3B,Protein FAM3B,42587,0.029654634318721,0.00365865480523418,0.022483670900462,0.03682559773698,5.7135758767034e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_E,,42594,0.0258801218776132,0.00319737839864613,0.0196132602162668,0.0321469835389596,6.25987122511063e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF2,Growth/differentiation factor 2,42636,0.0300288212249982,0.00371520385849042,0.0227470216623569,0.0373106207876394,6.87380861977619e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0397647114355965,0.00492513364057033,-0.0494179733711143,-0.0301114495000786,7.38956283422595e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP1,Interstitial collagenase,42136,0.0763797987304767,0.00946042028782277,0.0578373749663441,0.0949222224946093,7.42486615831702e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0271545127088087,0.00336479627727851,0.0205595120053429,0.0337495134122746,7.60479658205023e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0214858205691441,0.00266712918465084,0.0162582473672285,0.0267133937710598,8.69307135155261e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0319307792246146,0.00396428792386834,0.0241607748938327,0.0397007835553966,8.78789887540979e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0435278078979676,0.00541934279043273,0.0329058960287195,0.0541497197672157,1.04071820391947e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0221914318049951,0.00276347442553776,0.0167750219309411,0.0276078416790492,1.05254687337464e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0757921090981291,0.00949113409914864,0.0571894862637978,0.0943947319324604,1.53766890452197e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX1,Heme oxygenase 1,42500,-0.0399793917701524,0.00501229096860788,-0.0498034820686238,-0.0301553014716809,1.63084012130349e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TF,Serotransferrin,40539,0.0176367647843271,0.00221267830541246,0.0132999153057187,0.0219736142629355,1.7276959898549e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,40223,0.0515338105279173,0.00647363944975787,0.0388454772063919,0.0642221438494427,1.88049249433465e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP6,Gastrotropin,42334,0.0484522328094587,0.00609189957782736,0.0365121096369171,0.0603923559820004,1.95997343198849e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL20,C-C motif chemokine 20,42754,0.075575506576879,0.00950359232955949,0.0569484656109424,0.0942025475428156,1.97484849402014e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX5,Sorting nexin-5,40223,0.0240061142678036,0.00301851691380695,0.018089821116742,0.0299224074188653,1.99906664098174e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0537949145150867,0.00676966643863657,0.040526368295359,0.0670634607348144,2.10057187599404e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0544237186179681,0.00687083841968209,0.0409568753153912,0.067890561920545,2.57754768971599e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,40199,0.0516131286670391,0.00652760679705696,0.0388190193448075,0.0644072379892707,2.89096668662569e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,40527,0.0319489275590018,0.0040431523984333,0.0240243488580725,0.0398735062599311,2.99874402185313e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAP,Prolyl endopeptidase FAP,42794,0.0223725153910129,0.00283244478055658,0.016820923621122,0.0279241071609038,3.03453505410687e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIT,Citron Rho-interacting kinase,40182,0.037145113903036,0.0047111110781368,0.0279113361898878,0.0463788916161841,3.45465007943399e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17D,Interleukin-17D,42370,0.0281752702367091,0.00357657121713408,0.0211651906511263,0.0351853498222919,3.59404880229344e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPK2,Death-associated protein kinase 2,40199,0.0442617297514313,0.00562013897938267,0.0332462573518413,0.0552772021510214,3.71118627051309e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF22,Kinesin-like protein KIF22,40116,0.102153186548718,0.0129772556333439,0.0767177655073635,0.127588607590072,3.82911153414035e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.028675570334095,0.00365148603967222,0.0215186576963374,0.0358324829718525,4.3662854696353e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH5,Cadherin-5,42794,-0.0244505041544195,0.0031252247291676,-0.030575944623588,-0.018325063685251,5.51055923064057e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0307859013052192,0.00394164978931237,0.023060267718167,0.0385115348922715,6.13077033290666e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,40283,0.0200560956753156,0.00256774680805689,0.0150233119315241,0.0250888794191071,6.19615438122586e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COLEC12,Collectin-12,42618,0.0226545158861447,0.00290167659309746,0.0169672297636736,0.0283418020086157,6.26960316636996e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD46,Membrane cofactor protein,42580,0.0233681818995957,0.00299769014001704,0.0174927092251623,0.0292436545740291,6.89316862762043e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,42524,0.0349849550198637,0.00449556041099978,0.0261736566143042,0.0437962534254233,7.65585591413955e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,42495,0.0420626985827445,0.0054068723099782,0.0314652288551872,0.0526601683103017,7.81679575907687e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0207585101900344,0.00266843974601809,0.015528368287839,0.0259886520922299,7.8252211523316e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,42794,0.030625174103687,0.00393778375245722,0.0229071179488708,0.0383432302585031,7.9425872576341e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA,Adenosine deaminase,42754,0.027927472616576,0.00359228916655804,0.0208865858501222,0.0349683593830298,8.1325126348269e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID2,Nidogen-2,42611,0.0595464978838453,0.00766378899383823,0.0445254714559224,0.0745675243117682,8.42707144059232e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300A,CMRF35-like molecule 8,40283,0.0251161768985164,0.00323668984340024,0.0187722648054519,0.0314600889915809,9.2505119898142e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0366564398557309,0.0047296639149632,0.027386298582403,0.0459265811290588,9.82405676396532e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2,Brorin,42456,0.0330879684801195,0.00427909503772161,0.0247009422061851,0.0414749947540539,1.13063594005647e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0418070307805788,0.0054188162399918,0.0311861509501949,0.0524279106109627,1.31248218602437e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,40451,0.0231301004789049,0.00299918915233495,0.0172516897403284,0.0290085112174814,1.34174091480955e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,42613,0.0646781300256946,0.00839410921013791,0.0482256759738243,0.0811305840775649,1.39805073800907e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA2,Carboxypeptidase A2,42670,0.0526704524381246,0.00684763104199598,0.0392490955958124,0.0660918092804367,1.55147936105051e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0469534946495759,0.0061070714907469,0.034983634527712,0.0589233547714398,1.59442215855244e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0355109473637145,0.00464531333835027,-0.044615761506881,-0.026406133220548,2.23990858561629e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0437975685862656,0.00572891374040583,0.0325688976550702,0.055026239517461,2.26358327507992e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0447181737820243,0.00585896302586148,0.0332346062513358,0.0562017413127128,2.49346838134907e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0271357441571639,0.00356289735833647,0.0201524653348244,0.0341190229795034,2.78731456609927e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0262374643686851,0.0034451293618217,-0.0329899179178556,-0.0194850108195146,2.82864474882378e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS2,Growth arrest-specific protein 2,40302,0.0415941114430866,0.00547390765900528,0.0308652524314363,0.052322970454737,3.23388643123601e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL19,C-C motif chemokine 19,42711,0.103253928118176,0.0135920562577821,0.0766134978529235,0.129894358383429,3.23859815438146e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,40482,0.0528060849797152,0.00695170860914126,0.0391807361057983,0.066431433853632,3.29215809539739e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C4BPB,C4b-binding protein beta chain,42679,0.0316261601761998,0.0041786048495111,0.023436094671158,0.0398162256812415,4.01727433105646e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,40080,0.0413711357753807,0.00547559915692524,0.0306389614278073,0.0521033101229542,4.50574586845948e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0169741091805916,0.00225442688125394,0.0125554324933339,0.0213927858678493,5.42984878574116e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN2,Nectin-2,42613,0.0246013564786687,0.00326939186326911,0.0181933484266612,0.0310093645306761,5.61802454963892e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSHB,Thyrotropin subunit beta,42636,0.0618472545819781,0.00822262560393883,0.045730908398258,0.0779636007656982,5.75414091391971e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.037197868425406,0.00495499499771363,0.0274860782298872,0.0469096586209247,6.43166025657016e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS22,Brain-specific serine protease 4,40199,0.0285023020547466,0.00380092089902792,0.0210524970926519,0.0359521070168413,6.93655459841813e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0301541814863036,0.00403533972828046,0.0222449156188739,0.0380634473537333,8.35341406296926e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0398644923652385,0.00534077260859654,0.0293965780523893,0.0503324066780877,8.99584450811624e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0529919900986484,0.0071072468034156,0.0390617863639539,0.066922193833343,9.45859513628252e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGN,Biglycan,42328,-0.0928632082287005,0.0124747783020122,-0.117313773700644,-0.0684126427567567,1.03700307873726e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0353845634934205,0.00475692086807802,0.0260609985919876,0.0447081283948534,1.09439668543521e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA4,Laminin subunit alpha-4,42676,0.0255197540584413,0.00343168298954601,0.0187936553989312,0.0322458527179515,1.09615527961318e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD93,Complement component C1q receptor,42141,-0.0248881265336882,0.00334862568893146,-0.0314514328839939,-0.0183248201833826,1.1338835815916e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB2,Plexin-B2,42743,0.0185747918619761,0.00250272855738571,0.0136694438895001,0.023480139834452,1.22404659040661e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SBSN,Suprabasin,40511,-0.0269717743521371,0.00363931485266513,-0.0341048314633608,-0.0198387172409134,1.34056813392516e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0518502672222797,0.0070078719038313,0.0381148382907703,0.065585696153789,1.45548506450834e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0297902271116632,0.00403757493884373,0.0218765802315295,0.0377038739917969,1.69984656982947e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300C,CMRF35-like molecule 6,42711,0.0275079006499219,0.003729647240352,0.020197792058832,0.0348180092410118,1.73298648043503e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,40223,0.0619068929101944,0.00839769128661965,0.0454474179884199,0.0783663678319689,1.80266927780318e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDK2,Protein sidekick-2,40283,0.0309602668461903,0.00420051755002868,0.0227272524481341,0.0391932812442465,1.81971373543643e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,40199,0.0306464292182972,0.00415837743224721,0.0224960094510927,0.0387968489855017,1.83128654111119e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0297407305948369,0.00403689447713419,0.0218284174196539,0.0376530437700199,1.84472181563324e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGMN,Legumain,42676,0.0272140760978758,0.00369592793288069,0.0199700573494297,0.034458094846322,1.89877493300591e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDK,Midkine,42638,0.0389707887941481,0.00529452343336464,0.0285935228647534,0.0493480547235428,1.93736406941681e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGR1,Prostaglandin reductase 1,40511,0.0640405227840258,0.00870182820910645,0.0469849394941771,0.0810961060738744,1.97484047617577e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0163297218781706,0.00222561279412469,0.0119675208016862,0.020691922954655,2.30632897441285e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A12,Protein S100-A12,42434,0.0571213703641391,0.00780104887144374,0.0418313145761093,0.0724114261521688,2.57893252202141e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFC1,Cryptic protein,42346,0.0360191288542349,0.00491982878411141,0.0263762644373766,0.0456619932710933,2.60012610667687e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFA,Protransforming growth factor alpha,42594,0.0360132451947426,0.00492008259683713,0.0263698833049418,0.0456566070845433,2.62793174914181e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML1,Trem-like transcript 1 protein,40532,0.0396739581787037,0.0054388704640873,0.0290137720690925,0.0503341442883148,3.19709446846824e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0764927614280156,0.0104969672318725,0.0559187056535455,0.0970668172024857,3.34482469776813e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0312665558153384,0.00430289417418019,-0.0397002283967316,-0.0228328832339452,3.89618661430096e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,40527,0.021158383916486,0.00291199805945858,0.0154508677199471,0.0268659001130248,3.9479779287456e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNLY,Granulysin,42611,0.0402150652741115,0.00555875754248311,0.0293199004908446,0.0511102300573784,4.92448115878591e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0367948508688993,0.00509345295945135,0.0268116830683747,0.046778018669424,5.32175521926477e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0728151178988932,0.0101113818324415,0.0529968095073079,0.0926334262904785,6.28004385625229e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0281254280055329,0.00391455381421264,0.0204529025296761,0.0357979534813896,7.15394055163876e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARCO,Macrophage receptor MARCO,42636,0.0195184880525104,0.00271934864718912,0.0141885647040198,0.0248484114010011,7.4649531036248e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0332683713941125,0.00463893943277956,0.0241760501058646,0.0423606926823605,7.88064988006651e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0544937705633279,0.00760109528145057,0.0395956238116848,0.069391917314971,8.02273152128114e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0394196641062077,0.0055005366301835,0.028638612311048,0.0502007159013673,8.10340111874047e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0407435445306269,0.00570978782623279,0.0295523603912106,0.0519347286700431,1.02373091614126e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0389495825039748,0.00546384401416358,-0.0496587167717354,-0.0282404482362141,1.06576325622862e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH3,Cadherin-3,42711,0.0276793811951272,0.00389290232456497,0.0200492926389799,0.0353094697512746,1.21679447207437e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAM,Signal transducing adapter molecule 1,40451,0.0276211267289427,0.00388563454768039,0.0200052830154892,0.0352369704423963,1.24388679237344e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0310669258383681,0.00437415476661917,0.0224935824957945,0.0396402691809417,1.28923225001434e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,42587,0.0284261692448264,0.0040048787848765,0.0205766068264685,0.0362757316631843,1.33058499219343e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0393582615256743,0.0055462994733114,0.028487514557984,0.0502290084933646,1.34511794634566e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0494203342695435,0.00696492689664398,0.0357690775521213,0.0630715909869657,1.36772659173717e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0285686971347936,0.0040357056199335,0.020658714119724,0.0364786801498633,1.54059686587365e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,42594,-0.0387587668568163,0.00547765866764277,-0.0494949778453961,-0.0280225558682365,1.55983399464237e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0396531437789212,0.00560860776527529,0.0286602725589816,0.0506460149988607,1.62538114574498e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XRCC4,DNA repair protein XRCC4,42311,0.0270094450476861,0.00382305423721028,0.019516258742754,0.0345026313526182,1.68861090758731e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,40532,0.0197467705250078,0.00279804057191905,0.0142626110040465,0.0252309300459691,1.79601509728434e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0200256871457103,0.00284211875549926,0.0144551343849317,0.0255962399064888,1.94831661891249e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBD,Thrombomodulin,42636,0.0220616503240235,0.00313204939390906,0.0159228335119617,0.0282004671360853,1.96111926743162e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST5,Cystatin-D,42357,0.0417957173555664,0.00593388105330447,0.0301653104910897,0.0534261242200432,1.96683927752015e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0267168838249541,0.00379467727628473,0.019279316363436,0.0341544512864721,2.0059526238402e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0432483489867273,0.00614462330605226,0.0312048873068648,0.0552918106665897,2.03917367067354e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOB,Elongin-B,40116,0.0293366321782652,0.00417186377947927,0.0211597791704858,0.0375134851860446,2.15728334835547e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL14,C-C motif chemokine 14,42618,0.0293991160558374,0.00418174542624053,0.021202895020406,0.0375953370912689,2.1598096661713e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA1,Carbonic anhydrase 1,42362,0.0438643983449704,0.00623930955989836,0.0316353516075696,0.0560934450823712,2.1620473432734e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,40539,0.0134824145785733,0.00191954254793847,0.00972011118461393,0.0172447179725327,2.283229130009e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0383085083885789,0.0054541261810529,0.0276184210737152,0.0489985957034426,2.28350911035415e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0346043661288196,0.00493460874776231,0.0249325329832055,0.0442761992744338,2.45384683273181e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRDT,Bromodomain testis-specific protein,40116,0.0270525383564246,0.00386992819839388,0.0194674790875726,0.0346375976252766,2.89994083961532e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0115538870200046,0.0016556450675951,0.00830882268751816,0.0147989513524909,3.12205824002384e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA7A,Semaphorin-7A,42760,0.0205857280168929,0.00295310149915261,0.0147976490785538,0.026373806955232,3.29512733286785e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI2,Serpin I2,40449,0.0405505368732266,0.00582004106747249,0.0291432563809805,0.0519578173654727,3.40884065866785e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.028432627154433,0.00408329938642985,0.0204293603570305,0.0364358939518355,3.51759715864823e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB1A1,Uteroglobin,42646,0.0402110490347737,0.00578408287957736,0.028874246590802,0.0515478514787453,3.76703351042625e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0302139697755388,0.00435007915211306,0.0216878146373972,0.0387401249136804,3.9752900789572e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0152738604065426,0.00220371087327519,0.0109545870949232,0.019593133718162,4.3708342847862e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL5,Insulin-like peptide INSL5,40449,0.0709723467447704,0.0102446533337041,0.0508928262107103,0.0910518672788304,4.50932932671145e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCOR1,REST corepressor 1,42357,0.0318217640864943,0.00459650999656437,0.0228126044932282,0.0408309236797605,4.62590930849358e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0374942940448657,0.00543462161185113,0.0268424356856374,0.0481461524040939,5.47072507722926e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0346537386096175,0.00502632043218359,0.0248021505625377,0.0445053266566973,5.65502336846119e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0415903855047585,0.006036464649867,0.0297589147910192,0.0534218562184978,5.83881828856427e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL15,C-C motif chemokine 15,42794,0.0319657626335049,0.00464063536299804,0.0228701173220288,0.0410614079449811,5.89738123052786e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0425507605304164,0.00617986514330218,0.0304382248495441,0.0546632962112887,6.02426246430784e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHCY,Adenosylhomocysteinase,42636,0.0478452788197775,0.00695027756644723,0.0342227347895409,0.0614678228500141,6.08033988147752e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0253403412756029,0.00368881814113206,-0.0325704248322218,-0.0181102577189841,6.73225404529568e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYGD,Gamma-crystallin D,40483,0.0694480444667924,0.0101133848597495,0.0496258101416834,0.0892702787919014,6.90356958421661e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0182489128002139,0.00265836620993107,0.013038515028749,0.0234593105716788,7.01023851606362e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN1,Tetraspanin-1,42357,0.0483035784947835,0.00704597072161015,0.0344934758804276,0.0621136811091394,7.42371227363952e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD248,Endosialin,40527,-0.0290449343044472,0.00423999164277278,-0.0373553179242818,-0.0207345506846125,7.75474538885737e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0408736046141354,0.00596854342436768,0.0291752595023747,0.052571949725896,7.81236090162479e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.044544290632402,0.00650574160364688,0.0317930370892541,0.0572955441755499,7.94823093735069e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,40136,0.0537569079795661,0.00788308695521035,0.0383060575473538,0.0692077584117784,9.63267922451674e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,40182,0.0432146492908458,0.00634094767909008,0.0307863918398292,0.0556429067418623,9.90807027145631e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LF,CMRF35-like molecule 1,42721,0.0430882943893372,0.00632657453207467,0.0306882083064708,0.0554883804722035,1.0123921400096e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,42311,0.0251170484071428,0.00369408241988414,0.0178766468641699,0.0323574499501157,1.09705936413599e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0442124965410269,0.00651663344111238,0.0314398949964467,0.0569850980856072,1.21437591553346e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CABP2,Calcium-binding protein 2,40182,0.0455713400572552,0.00672066620071319,0.0323988343038574,0.0587438458106531,1.25663879591609e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0305737236386744,0.00451141742427097,0.0217313454871033,0.0394161017902455,1.28855739336903e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0211543959702475,0.00312421196370354,-0.0272778514191065,-0.0150309405213886,1.33091060827829e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASET2,Ribonuclease T2,42749,0.0194212603185872,0.00287086396464611,0.0137943669478808,0.0250481536892935,1.38823760326812e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,40419,0.0362611601118408,0.005364185673547,0.0257473561916887,0.046774964031993,1.44970712549055e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0480167187818697,0.00711142575724988,0.0340783242976599,0.0619551132660795,1.53109365580048e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0303329307512456,0.00449750338350913,0.0215178241195677,0.0391480373829235,1.59950145431585e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,40223,0.0228970679158682,0.00339516693295735,0.0162425407272717,0.0295515951044646,1.61769933137549e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTB,Lymphotoxin-beta,40451,0.0250998012525961,0.00372434349395041,0.0178000880044532,0.0323995145007389,1.6682189000237e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0394555498754756,0.00587072148492948,0.0279489357650138,0.0509621639859374,1.89666252761644e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,40283,-0.0222283173868038,0.00330954579031669,-0.0287150271358245,-0.0157416076377831,1.95347915203258e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAM,Integrin alpha-M,42611,-0.0220285227411522,0.00328552567482123,-0.0284681530638018,-0.0155888924185026,2.09868867259692e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZU1,Azurocidin,42216,0.0531502906415726,0.00792935280606074,0.0376087591416935,0.0686918221414516,2.126251294027e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC3,Membrane primary amine oxidase,42689,-0.0209870152373178,0.00313722700589595,-0.0271359801688738,-0.0148380503057617,2.32489785864321e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0241971339791348,0.00361769871717358,0.0171064444934746,0.031287823464795,2.34260307272256e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENAH,Protein enabled homolog,42370,0.032744342852224,0.00490029483288868,0.0231397649797622,0.0423489207246858,2.44984017320394e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL3,Fc receptor-like protein 3,42370,0.0391936208823303,0.00586556077337814,0.0276971217665092,0.0506901199981515,2.45194871368577e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0195445685748377,0.00292529839096386,0.0138109837285486,0.0252781534211269,2.46257555193219e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0406655212989284,0.00608594753384912,0.0287370641325841,0.0525939784652727,2.47303020653078e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL8,Interleukin-8,42494,0.0482858621582278,0.00723199450657011,0.0341111529253504,0.0624605713911052,2.54082286169253e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,42311,0.0398396756249566,0.00596768192900033,0.028143019044116,0.0515363322057973,2.55599059493979e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,40199,0.0205254668011144,0.00307727597568363,0.0144940058887745,0.0265569277134543,2.68048990896849e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PER3,Period circadian protein homolog 3,40199,0.0853155424400997,0.012796004889707,0.060235372856274,0.110395712023925,2.72919573471308e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOBR,Apolipoprotein B receptor,40223,-0.029529311197315,0.00443537909791203,-0.0382226542292226,-0.0208359681654074,2.91406437343657e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,40516,0.0126440257073828,0.00190187984444994,0.00891634121226087,0.0163717102025046,3.10398025450413e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR15L,Protein GPR15L,40449,0.0419382160517253,0.00632302404041317,0.0295450889325155,0.0543313431709351,3.44892350294608e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRN,Progranulin,42552,0.0168974249477151,0.00254917462030541,0.0119010426919165,0.0218938072035137,3.51929470851577e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,40116,0.042399374651978,0.00640454380657961,0.029846468791082,0.0549522805128741,3.7553100115651e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP12,Macrophage metalloelastase,42592,0.0385303936195703,0.0058219896767989,0.0271192938530445,0.0499414933860962,3.77736334115463e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMB,RGM domain family member B,42711,0.0195445628589303,0.00295718276438877,0.0137484846407283,0.0253406410771323,4.00936863349429e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0399754008346279,0.00606851916867758,0.0280811032640199,0.0518696984052359,4.64461270858466e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL3,Myosin light chain 3,40223,-0.0502865740444461,0.00763744499933397,-0.0652559662431406,-0.0353171818457515,4.78074191348798e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPF,Centromere protein F,40302,0.0373085000435811,0.00566996284487433,0.0261953728676274,0.0484216272195348,4.91529454916894e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN2,Alpha-actinin-2,40116,-0.0406419525049694,0.0061974955952158,-0.0527890438715924,-0.0284948611383464,5.70722966149361e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0404197746663782,0.00616609481873767,0.0283342288216524,0.0525053205111041,5.75866267728482e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0289193304732893,0.00441348696817685,0.0202688960156627,0.0375697649309159,5.865388388476e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0573157061883964,0.00875658179084228,0.0401528058783455,0.0744786064984472,6.15258107842151e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0338282969174198,0.00516846800123136,0.0236980996350063,0.0439584941998333,6.16482194846545e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VGF,Neurosecretory protein VGF,40482,0.0214707478680073,0.00328033861679613,0.0150412841790869,0.0279002115569277,6.19556612737308e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F3,Tissue factor,42636,-0.0185513414048174,0.00283499528109481,-0.0241079321557632,-0.0129947506538716,6.21928935406409e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0254515573520038,0.00389211618100774,0.0178230096372287,0.033080105066779,6.45846064462638e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRELP,Prolargin,42618,0.0165052965944127,0.00252715410107133,0.0115520745563128,0.0214585186325125,6.76041824119106e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRH,Corticoliberin,42322,0.058254520636492,0.00892710406413216,0.040757396670793,0.075751644602191,7.02267399550737e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPB2,Coatomer subunit beta',40116,0.029440609382139,0.00451150812333717,0.0205980534603981,0.0382831653038798,7.06962884173426e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL2,Fc receptor-like protein 2,42681,0.0355841901325765,0.00546806296970506,0.0248667867119545,0.0463015935531984,7.90377784109992e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0255044521750187,0.00392837259718338,0.0178048418845392,0.0332040624654981,8.80403949198279e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,40116,-0.0296109512422325,0.00456717096193516,-0.0385626063276254,-0.0206592961568395,9.35266427724916e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAM,Basal cell adhesion molecule,42611,-0.0165825218501868,0.00256070721932274,-0.0216015080000594,-0.0115635357003143,9.76232079019234e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,42663,-0.0187817960701643,0.00290192358514878,-0.0244695662970559,-0.0130940258432727,9.99381482622159e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0239050748922153,0.00369378143998082,-0.0311448865145777,-0.0166652632698529,1.00927168874622e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0208214213059568,0.0032245264442677,-0.0271414931367215,-0.0145013494751921,1.10401370671648e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM,Paralemmin-1,40384,0.0211677565040816,0.003278293877246,0.0147423005046794,0.0275932125034838,1.11263753464273e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR2,Complement receptor type 2,42689,0.0320932136192604,0.00497576090457305,0.0223407222462972,0.0418457049922236,1.1573096179602e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,42594,0.0415923727628483,0.00646202044079513,0.0289268126988898,0.0542579328268067,1.26476944986218e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,40483,0.0325916171983093,0.00507999636115701,0.0226348243304416,0.0425484100661771,1.45807381985517e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX2,Sorting nexin-2,40451,0.0545086993982648,0.0085310105132735,0.0377879187922488,0.0712294800042809,1.73024592592711e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0248289023621106,0.00390165686904134,0.0171816548987895,0.0324761498254316,2.03364638766136e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,40511,0.0230555842830527,0.00362590021761924,0.015948819856519,0.0301623487095864,2.11466905113006e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE3,Eosinophil cationic protein,42578,0.0724229526373182,0.0113938580657549,0.0500909908284386,0.0947549144461978,2.13353886257324e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0224817851652488,0.00354045842180796,0.0155424866585052,0.0294210836719924,2.22366747415013e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0367844090348725,0.00579353290672483,0.0254290845376918,0.0481397335320532,2.23394643257427e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALY,RNA-binding protein Raly,40451,0.0312703040824166,0.00492623473320097,0.0216148840053427,0.0409257241594905,2.26950346813999e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNC,Tenascin,42689,-0.031801414577188,0.00501517153358521,-0.0416311507830151,-0.021971678371361,2.35487053462995e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0200176251922476,0.00316607540699872,-0.0262231329899651,-0.0138121173945301,2.65421631011293e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,40449,0.0285589844862331,0.00453117340539691,0.0196778846116552,0.0374400843608111,3.03288596363388e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFIC,Nuclear factor 1 C-type,40482,0.0311177395245596,0.00494034392851189,0.0214346654246763,0.0408008136244429,3.1131661372721e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0426756757115091,0.00679566817652199,0.029356166085526,0.0559951853374922,3.51855084181991e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0442308858887347,0.00704866865203723,0.0304154953307417,0.0580462764467277,3.60203363592088e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0356286683626787,0.00568010541885402,0.0244956617417249,0.0467616749836326,3.68567199539427e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0266583387445597,0.00425073453557501,0.0183268990548327,0.0349897784342868,3.70776714889171e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,42679,-0.0182908093907416,0.00291724119989829,-0.0240086021425423,-0.012573016638941,3.72296683943211e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.017268454591088,0.00276020655017304,-0.0226784594294271,-0.0118584497527488,4.06430324247603e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENSA,Alpha-endosulfine,40451,0.0345303895617694,0.00552074817425577,0.0237097231402281,0.0453510559833107,4.1283786249871e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL,Podocalyxin,42587,0.00991194321180082,0.0015863121458647,0.006802771405906,0.0130211150176956,4.27186132314173e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0195940925582352,0.00313549073514009,0.0134485307173606,0.0257396543991097,4.28006511710887e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0279120758672337,0.00446961156784191,0.0191516371942636,0.0366725145402039,4.37305339526202e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR2,Complement factor H-related protein 2,40451,0.0375450920488041,0.00601417793300001,0.0257573033001241,0.0493328807974841,4.45380577555551e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0181454450193303,0.00290958661505772,0.0124426552538171,0.0238482347848434,4.61024143792057e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,40116,0.0296348731940171,0.00475629403441476,0.0203125368865641,0.03895720950147,4.81567425590696e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEK,Angiopoietin-1 receptor,42679,0.0141938426406734,0.00227897177395009,0.00972705796373125,0.0186606273176156,4.85902633875203e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO1,Roundabout homolog 1,42638,0.015817652421577,0.00254434132987751,0.010830743415017,0.0208045614281369,5.22412065473865e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0138056336841944,0.00222154349773711,-0.0181598589397591,-0.00945140842862966,5.30641096471333e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0540724467103479,0.00871037860372752,0.037000104647042,0.0711447887736539,5.56754291734279e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.036216792184468,0.00583468582651946,0.0247808079644898,0.0476527764044461,5.59013419083917e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0190023919839239,0.00306371762753965,0.0129975054339462,0.0250072785339016,5.72308782168504e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,42636,0.0483046512017959,0.00780833806273882,0.0330003085988278,0.063608993804764,6.33829735480906e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI3,Elafin,42446,0.0364966437667902,0.00590359508660646,0.0249255973970415,0.0480676901365388,6.51088991749095e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPO,Myeloperoxidase,42611,0.0298029263904112,0.0048271647980129,0.020341683386306,0.0392641693945165,6.85024148581513e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0253910080125585,0.00412069025087124,0.0173144551208509,0.0334675609042661,7.40027028281424e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,42616,0.0281044150072495,0.00456861419141163,0.0191499311920827,0.0370588988224163,7.8870565910819e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0274752177952345,0.00447587790640786,0.0187024970986751,0.0362479384917939,8.56906691775217e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB6,Integrin beta-6,42370,0.0199093975516537,0.00324490363528736,0.0135493864264904,0.0262694086768169,8.72747854458811e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX1,Peroxiredoxin-1,42261,-0.0570900762896407,0.00931391201318343,-0.0753453438354802,-0.0388348087438012,9.06652500422964e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASS1,Argininosuccinate synthase,40116,0.0493868332046349,0.00808453286018183,0.0335411487986785,0.0652325176105913,1.03798668471877e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYZL2,Lysozyme-like protein 2,40080,0.022877178012783,0.00374714271904701,0.0155327782834508,0.0302215777421151,1.06150680251789e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH15,Cadherin-15,42692,0.0394870854729213,0.00647716293407678,0.0267918461221309,0.0521823248237118,1.11472372738957e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0644883054288386,0.0105861097970089,0.0437395302267011,0.085237080630976,1.15306707461761e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDM1,Nuclear protein MDM1,40182,0.0198138878361365,0.00325936811699348,0.0134255263268293,0.0262022493454437,1.2490440084708e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0219751834275554,0.00362268882107237,0.0148747133382536,0.0290756535168573,1.34665809832767e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.020460557699272,0.00337305821848229,0.0138493635910467,0.0270717518074973,1.35538864358513e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0338980468847086,0.00560588554162225,0.0229105112231289,0.0448855825462882,1.5168815979548e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0229174564156041,0.0037906537159187,0.0154877751324034,0.0303471376988048,1.53512444836877e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1,Programmed cell death protein 1,42689,0.0282627394304515,0.00467975066319231,0.0190904281305946,0.0374350507303085,1.58783562307691e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMBS,Porphobilinogen deaminase,42721,0.027021824639963,0.00448351205836173,0.018234141005574,0.035809508274352,1.71445253792548e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMD,Osteomodulin,42676,-0.0263876170315763,0.00438437383234152,-0.0349809897429657,-0.0177942443201869,1.80541077634932e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0303908230889974,0.00505545750910765,0.0204821263711464,0.0402995198068484,1.8964528248975e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0270618110927796,0.00450978251553445,0.0182226373623321,0.0359009848232271,2.02667005719261e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0215393626223245,0.00359694444159915,0.0144893515167901,0.0285893737278588,2.17488946262736e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,40223,0.0274169038275657,0.00458117298562428,0.0184378047757421,0.0363960028793893,2.23542050604975e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0242466852231118,0.00407129846514181,0.0162669402314338,0.0322264302147897,2.67236662214756e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPG,Macrophage-capping protein,42461,0.0361176601455019,0.00607545804524939,0.0242097623768131,0.0480255579141907,2.83668458487643e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.029618057733527,0.0049844977409678,0.0198484421612301,0.0393876733058239,2.89817073331245e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0242666096176153,0.00411157713744059,0.0162079184282317,0.0323253008069988,3.67761308744271e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNG,Interferon gamma,42370,0.0691901275342253,0.0117392280042217,0.0461812406459508,0.0921990144224998,3.86350277725974e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A11,Protein S100-A11,42531,0.0278353831731452,0.00472511679529135,0.0185741542543742,0.0370966120919162,3.93259812182595e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1A,Protein phosphatase 1A,42346,0.0194880588425761,0.00330952227965652,0.0130013951744493,0.0259747225107029,3.99274815868744e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0702480805695793,0.0119311364199078,0.04686305318656,0.0936331079525985,4.00860993872288e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSG,Basigin,42746,0.0132689296420963,0.00225672247872546,0.00884575358379438,0.0176921057003982,4.2059846152119e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,42600,0.0293812907431984,0.00500046679280943,0.0195803758292919,0.0391822056571049,4.31030062523893e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCT,Secretin,40182,0.0305627889007545,0.0052025851639888,0.0203657219793365,0.0407598558221726,4.36319473627407e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK3,Dickkopf-related protein 3,42794,-0.0184045325416959,0.00313431806465208,-0.024547795948414,-0.0122612691349778,4.40771964368217e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD209,CD209 antigen,42668,-0.0236306958951247,0.00403390967449157,-0.0315371588571282,-0.0157242329331212,4.7936978662132e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0285573654868337,0.00487523356941047,0.0190019076907892,0.0381128232828782,4.80761313564223e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARCL1,SPARC-like protein 1,42644,-0.0168263676884058,0.00287498115763711,-0.0224613307573745,-0.0111914046194371,4.94959170539351e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,42587,0.0254265434011213,0.00435952364955157,0.0168818770480003,0.0339712097542424,5.58922624272961e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.022440707231072,0.0038519579135606,0.0148908697204932,0.0299905447416508,5.84350081480779e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO2,Roundabout homolog 2,42711,0.0141476919843161,0.00243172015464203,0.00938152048121776,0.0189138634874145,6.09128358993835e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GC,Vitamin D-binding protein,40539,0.0156487164033867,0.00269048481090876,0.0103753661740055,0.0209220666327678,6.17819558881614e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0348184971674246,0.00599955036413108,-0.0465776158811216,-0.0230593784537277,6.64068201019058e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM2,Myomesin-2,40116,-0.0304471910510901,0.00525399110523124,-0.0407450136173433,-0.0201493684848369,7.01856548850135e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOC,Brother of CDO,42357,-0.014089596275577,0.00243380693797748,-0.0188598578740128,-0.0093193346771411,7.23707012452993e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLU,Clusterin,40539,0.018980689452945,0.00328054758993523,0.012550816176672,0.0254105627292181,7.40634608237872e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",42587,0.0604119003870237,0.0104692708512003,0.0398921295186711,0.0809316712553762,8.08327620808809e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0251137467390484,0.00435250726739011,0.0165828324949638,0.033644660983133,8.10868307189602e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0221795621954527,0.00384930284198992,-0.0297241957657529,-0.0146349286251524,8.53069899430098e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPP1,Osteopontin,42771,-0.0282596275303961,0.00490848926784884,-0.0378802664953799,-0.0186389885654124,8.73207671727324e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0245992813411006,0.00427801892816454,0.0162143642418982,0.0329841984403031,9.14734075224186e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0210436285783375,0.00366239077040923,0.0138653426683354,0.0282219144883395,9.34386065529026e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTPN,Myotrophin,42357,0.0197898532789198,0.00344817868158354,0.0130314230630161,0.0265482834948236,9.72109020724773e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD6,Programmed cell death protein 6,42636,-0.04196980003014,0.00731390489841283,-0.0563050536310291,-0.0276345464292508,9.76614204289057e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN4,Contactin-4,42611,-0.0143264936469555,0.00249948351521364,-0.0192254813367743,-0.00942750595713679,1.01519336349193e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0183141476502509,0.00320442406677213,-0.0245948188211243,-0.0120334764793775,1.12407867740968e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOB,Apolipoprotein B-100,40532,0.0132510508467212,0.00231992311300574,0.00870400154522995,0.0177981001482125,1.14566350201733e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0139286554474542,0.0024573055704249,-0.018744974365487,-0.00911233652942141,1.47872769007994e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH1,Protocadherin-1,42721,0.0127705652875422,0.00225601967949532,0.00834876671573135,0.017192363859353,1.53853771572596e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSR,Insulin receptor,40199,0.0102231111049108,0.00180806644084515,0.00667930088085433,0.0137669213289673,1.60504214558958e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,42346,0.0319250923046587,0.00564808871576558,0.0208548384217581,0.0429953461875592,1.61538506001723e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICOSLG,ICOS ligand,42587,0.0113621222519434,0.00201101136580129,0.00742053997497288,0.0153037045289139,1.63759935611876e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0199348278215264,0.00352888850071808,0.0130182063601189,0.0268514492829338,1.64599468484333e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,42679,0.0210066160530669,0.00372695488206771,0.0137017844842142,0.0283114476219197,1.77119770675819e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0200132268614665,0.00355622839909956,0.0130430191992314,0.0269834345237016,1.86303404958384e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0168690845785089,0.00300294095911794,-0.0227548488583801,-0.0109833202986378,1.97560414424167e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CX3CL1,Fractalkine,42495,-0.0200899750443971,0.00358123492997668,-0.0271091955071514,-0.0130707545816428,2.06613426804812e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0231291901669268,0.00412278180093156,-0.0312098424967527,-0.015048537837101,2.06959814609454e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.048312968927883,0.00864067717016944,0.031377241674351,0.0652486961814151,2.29728448327089e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK6,Kallikrein-6,42656,0.0183896252536909,0.00329502980983921,0.0119313668264061,0.0248478836809758,2.43731283792196e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,40532,-0.0158396315105318,0.00284160179882263,-0.0214091710362241,-0.0102700919848394,2.5436679197162e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0206529626012782,0.00370809894258918,0.0133850886738034,0.027920836528753,2.60046756037439e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0201790460415766,0.00362278792301174,0.0130783817124736,0.0272797103706796,2.60673879339894e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFAP1,Actin filament-associated protein 1,40283,0.0480031263693414,0.00863715715751874,0.0310742983406047,0.0649319543980781,2.79594989329209e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PZP,Pregnancy zone protein,40539,0.0293590054124169,0.00530091190171092,0.0189692180850635,0.0397487927397703,3.11900574340432e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG3,Desmoglein-3,42651,0.020198224676564,0.00365353831965363,0.0130372895700428,0.0273591597830851,3.29179525274351e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0192211450646151,0.00348429762678993,0.0123919217161068,0.0260503684131234,3.5345122720889e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LUZP2,Leucine zipper protein 2,40451,0.0263840614869504,0.00478304781462893,0.0170092877702777,0.0357588352036231,3.54141548985939e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0171986856980139,0.00312161658118996,0.0110803171988816,0.0233170541971463,3.6635768067734e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3,Galectin-3,42669,0.0170818209585766,0.00310419956501055,0.0109975898111559,0.0231660521059972,3.80609634749408e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB6,Heat shock protein beta-6,42721,0.022503725842266,0.00409720101380466,0.0144732118552089,0.0305342398293232,4.03522370704489e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSH,Pro-cathepsin H,42332,0.0424055829634358,0.00773523620900105,0.0272445199937937,0.0575666459330778,4.27987576843395e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPOCK1,Testican-1,42495,0.014682223318573,0.00267874873525032,0.00943187579748237,0.0199325708396636,4.30630469897141e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB44,Ras-related protein Rab-44,40451,0.023857381014501,0.00436483857784103,0.0153022974019326,0.0324124646270694,4.70619485877277e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0189106177256763,0.0034637158922045,0.0121217345769554,0.0256995008743971,4.87191967675165e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAST,Gastrin,40483,0.0825921443693433,0.0151348966026717,0.0529277470281066,0.11225654171058,4.94289411656044e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECM1,Extracellular matrix protein 1,40269,0.0212078703508222,0.00388629487115081,0.0135907324033666,0.0288250082982778,4.9441806300548e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D17,TBC1 domain family member 17,42311,0.0255998911450566,0.00471082651869327,0.0163666711684178,0.0348331111216954,5.6004904068073e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA14,Carbonic anhydrase 14,42721,-0.0202885713639465,0.00373804111903613,-0.0276151319572573,-0.0129620107706356,5.81030972911635e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD59,CD59 glycoprotein,42130,0.0140857743057769,0.00259802781617959,0.00899363978606493,0.0191779088254889,6.00886593512363e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMH,Granzyme H,42357,0.0436536595510784,0.00806086081179968,0.027854372359951,0.0594529467422058,6.21880939722246e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0324816236902139,0.00599812682588349,0.0207252951114823,0.0442379522689456,6.22632026403873e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0133588009604999,0.00246712397341518,0.00852323797260611,0.0181943639483936,6.24393893168036e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF16,Fibroblast growth factor 16,40199,0.0266925027177917,0.00493123470029993,0.0170272827052039,0.0363577227303796,6.32982260689309e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVALB,Parvalbumin alpha,42654,0.0616164175483996,0.0114050491363449,0.0392625212411637,0.0839703138556356,6.68155533573304e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,42794,-0.0140484045218739,0.00260519481793793,-0.0191545863650322,-0.00894222267871552,7.06617758964722e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0191248895136347,0.00354859949186774,-0.0260801445176955,-0.0121696345095739,7.18783821819641e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMPD3,AMP deaminase 3,40483,0.0396508918012036,0.00736659824726029,0.0252123592365734,0.0540894243658338,7.49188797831578e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF7,SLAM family member 7,42594,-0.0332046542842001,0.00618303719967724,-0.0453234071955675,-0.0210859013728327,7.99258878207091e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0241039063245806,0.00449162969206054,0.0153003121281419,0.0329075005210192,8.16488447307424e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0159212799281952,0.00297153775994112,0.0100970659187106,0.0217454939376798,8.55563641540918e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0489948690297763,0.00916393218815551,0.0310335619409915,0.0669561761185611,9.11410844966115e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0254257945167489,0.00475556134629144,0.0161048942780176,0.0347466947554801,9.140517223045e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROK1,Prokineticin-1,42594,0.0307024690564886,0.00574357834213185,0.0194450555059102,0.0419598826070671,9.16310624108636e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAX,Apoptosis regulator BAX,42292,0.0491650939022604,0.00921795463464659,0.0310979028183531,0.0672322849861678,9.78734247786988e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,40302,0.0248166830026731,0.00465959780425831,0.0156838713063268,0.0339494946990194,1.0239977821079e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0273952230927013,0.00514763912013383,-0.0374845957681636,-0.017305850417239,1.0465171481763e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0150606516997777,0.00283551257636912,0.00950304705009424,0.0206182563494612,1.10491029888015e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,40327,-0.00451039068072199,0.000852261351224408,-0.00618082292912183,-0.00283995843232215,1.23108210206349e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,40080,0.0337892460823493,0.00638592309840475,0.021272836809476,0.0463056553552227,1.23871276936753e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,40428,0.0152614715236262,0.00288463494388502,0.00960758703361157,0.0209153560136409,1.24203578197622e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE6,Ribonuclease K6,40468,0.0187197110825098,0.00353925769487228,0.0117827660005601,0.0256566561644594,1.25177669380807e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0146818737238126,0.00278078664788334,-0.020132215553664,-0.00923153189396128,1.31801673754589e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,42734,-0.0197771336442756,0.00374761206168192,-0.0271224532851721,-0.012431814003379,1.33151316951246e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDI2,Protein DDI1 homolog 2,40283,0.0426808768481786,0.00815072007953506,0.0267054654922898,0.0586562882040673,1.66686897190158e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0153561886555108,0.00293461697210015,0.00960433939019452,0.0211080379208271,1.69488544943059e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR2,Folate receptor beta,42711,-0.0160577611768494,0.00307549736315893,-0.0220857360086409,-0.0100297863450579,1.8041154799943e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18BP,Interleukin-18-binding protein,42689,0.0175262779867419,0.0033576848241847,0.0109452157313399,0.0241073402421439,1.81822262332893e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0153640393517801,0.00294336230286098,0.00959504923817255,0.0211330294653876,1.82280315128367e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0419103086130869,0.00803656910715625,0.0261586331630607,0.0576619840631132,1.86656058650657e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR5,Complement factor H-related protein 5,40382,0.0229162243603401,0.00439654562609263,0.0142989949331985,0.0315334537874817,1.89811625204036e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0358450628030949,0.00688323316039345,0.0223539258087237,0.049336199797466,1.94684011278669e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ULBP2,UL16-binding protein 2,42495,0.0216325051471781,0.00415842017257263,0.0134820016089357,0.0297830086854205,1.99979963869225e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPL,Periplakin,40199,0.0180180681548469,0.00346750240238173,0.0112217634461787,0.0248143728635151,2.06970071699599e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBS,Cystathionine beta-synthase,40223,0.0276406373656899,0.00534395316229441,0.0171664891675928,0.0381147855637869,2.35260956445842e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA7,Carbonic anhydrase 7,40302,-0.0189257514382936,0.00366948136401355,-0.0261179349117602,-0.0117335679648271,2.54431298088108e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,42676,0.014890944506749,0.00289005003800075,0.0092264464322675,0.0205554425812304,2.60684502858464e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B2M,Beta-2-microglobulin,40539,0.0168193969871689,0.00326603019284988,0.0104179778091831,0.0232208161651547,2.6513816458476e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP4,Guanylate-binding protein 4,42311,0.0263328452339096,0.00513243091452237,0.0162732806414458,0.0363924098263735,2.9282408471306e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNU13,NHP2-like protein 1,40116,0.0338583001585802,0.00660420816550744,0.0209140521541857,0.0468025481629748,2.99789955529917e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL3,Follistatin-related protein 3,42574,0.0180092306432206,0.00351544239309946,0.0111189635527456,0.0248994977336955,3.05071582679016e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN1,Nectin-1,40199,0.0174347001289138,0.00340691188118677,0.0107571528417877,0.0241122474160399,3.14918251868806e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAA4,Serum amyloid A-4 protein,40539,0.0172456595883845,0.00337022940443227,0.0106400099556972,0.0238513092210717,3.15413130977962e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0404142513209762,0.00792732133275561,0.0248767015087752,0.0559518011331772,3.48796444810327e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGA,Chromogranin-A,40527,-0.0518077767843328,0.0101940438983653,-0.0717881028251288,-0.0318274507435367,3.79112584437097e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0211944582363446,0.00417946955719236,0.0130026979042475,0.0293862185684416,4.01842245097656e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A13,Protein S100-A13,40199,0.0187279572524326,0.00370512428247324,0.0114659136587851,0.0259900008460802,4.3820476612089e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,42587,-0.0124566896628966,0.00246789584877414,-0.0172937655264939,-0.00761961379929929,4.53516744643202e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0184987293290536,0.00366745118056797,0.0113105250151404,0.0256869336429668,4.61793153742674e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,40199,0.0166430091287719,0.00330005972182269,0.0101748920739994,0.0231111261835443,4.64996853844172e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,40116,0.0188525283520675,0.00374459943996323,0.0115131134497395,0.0261919432543954,4.86507386245063e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA12,Carbonic anhydrase 12,42587,-0.0173204656897489,0.00344092771673154,-0.0240646840145427,-0.0105762473649551,4.87446363246268e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0143744279654886,0.00287101252749004,0.0087472434116081,0.0200016125193691,5.60574185302958e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHISA5,Protein shisa-5,40527,0.0144956788970349,0.0028976678127427,0.00881624998405921,0.0201751078100106,5.74301824375651e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,40483,0.124794689982965,0.0249592495270494,0.0758745609099487,0.173714819055982,5.82103012248916e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRL,Prolactin,42711,-0.0388761907124546,0.0077777669209705,-0.0541206138775568,-0.0236317675473524,5.85393577614017e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC1,Glypican-1,42721,0.0154910874913352,0.00310692996384733,0.00940150476219445,0.021580670220476,6.24125665655901e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2,Ataxin-2,40136,0.0573753354865984,0.0115069555631659,0.0348217025827932,0.0799289683904036,6.25408639905847e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL21,C-C motif chemokine 21,42676,0.0218420376229475,0.00438232837434501,0.0132526740092313,0.0304314012366637,6.30179648473907e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,42311,0.0442699807622405,0.00889529176234782,0.0268352089080388,0.0617047526164422,6.54682282763562e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIF,Leukemia inhibitory factor,42311,0.026520479498114,0.00534676166216227,0.0160408266402759,0.037000132355952,7.13387027648618e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0235800249253332,0.00475565395548713,-0.0329011066780879,-0.0142589431725784,7.19672376703602e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH1,Neurexophilin-1,42311,0.0200244965312973,0.00404536961441695,0.0120955720870401,0.0279534209755546,7.51434051974502e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAP,Cartilage-associated protein,40182,0.024707955258775,0.00499369645934204,0.0149203101984646,0.0344956003190854,7.61580387167091e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE1,Ribonuclease pancreatic,40532,0.0135842886306101,0.00274889685124807,0.00819645080216393,0.0189721264590564,7.85415598325992e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XG,Glycoprotein Xg,42734,0.0176958791464568,0.00358260722930756,0.010673968977014,0.0247177893158996,7.93043059102452e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,42476,0.0172099504551043,0.00349692788317969,0.0103559718040721,0.0240639291061365,8.69366163047911e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC16,Mucin-16,42587,0.0979998460590778,0.0199522682725393,0.0588934002449008,0.137106291873255,9.13493299549446e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0136272446483054,0.00277638812192069,0.00818552392934082,0.0190689653672699,9.29773589785987e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLASP1,CLIP-associating protein 1,40080,0.0370527468354786,0.00757135620316937,0.0222128886772666,0.0518926049936905,1.00322374106602e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLGN,Calmegin,40182,0.0236887243215477,0.00484081526365074,0.0142007264047923,0.0331767222383032,1.00444345745676e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0352243598021433,0.00720234046919849,0.0211077724825142,0.0493409471217723,1.01905312791346e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0154224355912004,0.00316011039243582,0.00922861922202615,0.0216162519603746,1.07127408286816e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG1,Arginase-1,42488,0.0262523929032555,0.00538260113255663,0.0157024946834445,0.0368022911230665,1.0880982571513e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0510379219471524,0.0104696712699507,0.030517366258049,0.0715584776362558,1.10432143683932e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0197963363897362,0.00406820095024109,-0.0277700102522087,-0.0118226625272636,1.15351968848825e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0187332954781565,0.00385374780319139,0.0111799497839013,0.0262866411724116,1.18369117901263e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB37,Ras-related protein Rab-37,42370,0.0408181322993274,0.00840441739079372,0.0243454742133718,0.0572907903852831,1.20700771675605e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0403691746220125,0.00831539791101898,0.0240709947164153,0.0566673545276097,1.22214250776079e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,40199,0.0284041863722065,0.00585792665415612,0.0169226501300605,0.0398857226143525,1.25880677731253e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMB,Granzyme B,42594,0.0334041755049818,0.00689914483293996,0.0198818516324195,0.0469264993775441,1.30114448777198e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA1,Annexin A1,40235,0.0209320088294348,0.00432447774073051,0.012456032457603,0.0294079852012666,1.31362789796891e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,40451,0.0296220273253023,0.00612429349494782,0.0176184120752046,0.0416256425754,1.33689023361758e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,40223,0.015587522420743,0.0032253101367029,0.00926591455280535,0.0219091302886807,1.36388936556657e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,42215,0.0507603058120814,0.0105332203583907,0.0301151939096357,0.0714054177145271,1.4585764030968e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0279285708959505,0.00579822920719912,0.0165640416498402,0.0392931001420608,1.47824049766097e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,42676,0.0338825135051799,0.00703501668266503,0.0200938808071565,0.0476711462032034,1.47859365309023e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD1,Leiomodin-1,40482,-0.0179223785219909,0.00372265646070382,-0.0252187851849704,-0.0106259718590114,1.49554200119739e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,42551,0.0300806059567111,0.00624983272705805,0.0178309338116773,0.0423302781017448,1.50289123239732e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,42701,-0.0109668123408167,0.00228883236146214,-0.0154529237692825,-0.00648070091235086,1.67346317108856e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300E,CMRF35-like molecule 2,42677,0.0215266009082423,0.00449362546282372,0.0127190950011078,0.0303341068153768,1.68158343724037e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0197001959869486,0.00411522899551277,0.0116343471557436,0.0277660448181537,1.71012694059793e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0257881510715614,0.0053875924500968,0.0152284698693717,0.0363478322737511,1.7145766558942e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,40483,0.0192637943886537,0.00403065090764773,0.0113637186096641,0.0271638701676432,1.78102149835496e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REN,Renin,42636,-0.0423570027701721,0.00888398664183233,-0.0597696165881635,-0.0249443889521808,1.88208654634664e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,42292,0.0356087463207297,0.00746974193833867,0.0209680521215859,0.0502494405198735,1.88939432713481e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX3,Syntaxin-3,40483,0.019236458552164,0.00404162409157739,0.0113148753326723,0.0271580417716557,1.96398011644151e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPS,Colipase,42590,0.0360513743434199,0.00757633915140834,0.0212017496066595,0.0509009990801802,1.97155348201333e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCP1,Plastin-2,40527,0.0237623486266788,0.00499390261142425,0.0139742995082873,0.0335503977450704,1.97668467504544e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR3,Small proline-rich protein 3,40483,0.0347010059421367,0.00729578816371199,0.0204012611412612,0.0490007507430122,1.9960761669839e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROCR,Endothelial protein C receptor,40116,-0.0173238728976623,0.00364391732766631,-0.0244659508598883,-0.0101817949354363,2.01789621724866e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLVRB,Flavin reductase,42611,0.0324431474954736,0.00683039237876071,0.0190555784331027,0.0458307165578446,2.05703680068569e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.0122132212492273,0.0025791610589517,-0.0172683769247727,-0.00715806557368202,2.20888459566114e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,42416,0.0403653968318242,0.00856170064280691,0.0235844635719227,0.0571463300917258,2.4460205333267e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCC,Netrin receptor DCC,40182,0.011381955443787,0.00241623932996855,0.00664612635704863,0.0161177845305253,2.50005889432751e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,42713,0.014153962269019,0.00300670036598975,0.00826082955167906,0.0200470949863589,2.53295311948839e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SATB1,DNA-binding protein SATB1,40482,0.0143513287443578,0.00305029688168287,0.00837274685625936,0.0203299106324562,2.57011045256671e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0524891199162314,0.0111592015929791,0.0306170847939924,0.0743611550384704,2.58105392831986e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0219229934327597,0.00466226835760656,-0.0310610394136685,-0.0127849474518508,2.59915725729752e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,40182,0.0271605455184371,0.00577813781961899,0.0158353953919838,0.0384856956448903,2.62588523567947e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0198619988543823,0.00422730869187116,0.0115764738183149,0.0281475238904498,2.65163832262134e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,40080,0.0274816489059391,0.00586046239988808,0.0159951426021584,0.0389681552097197,2.77431316604325e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0188798363465573,0.00403211492521874,0.0109768910931285,0.026782781599986,2.86978494368958e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL6,Fc receptor-like protein 6,42594,0.03402943657618,0.00728559459362349,0.019749671172678,0.048309201979682,3.02968264156853e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99,CD99 antigen,42611,-0.00981106038861812,0.00210074553519166,-0.0139285216375938,-0.00569359913964246,3.0371386779126e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOSB,Protein fosB,42311,0.0186112839038883,0.003987734722746,0.0107953238473061,0.0264272439604704,3.08456235838678e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.016667597953313,0.00357330170866052,0.00966392660433839,0.0236712693022876,3.12959509589836e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRUNE2,Protein prune homolog 2,40302,0.014604532871622,0.00313264975387151,0.00846453935403384,0.0207445263892101,3.16739400713301e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD1,Bromodomain-containing protein 1,40302,-0.0148577491390251,0.00318794536094257,-0.0211061220464725,-0.00860937623157765,3.18951176742075e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0199386348044212,0.00428111767517085,-0.028329625447756,-0.0115476441610863,3.24095630436311e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK8,Kallikrein-8,42154,0.0180897692767834,0.0038908012963976,0.0104637987358441,0.0257157398177227,3.36239517740925e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,42416,0.0201465220994191,0.00433734852045456,0.0116453189993282,0.0286477251995101,3.43531693220528e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL4,Delta-like protein 4,40223,0.0415017107105112,0.00893505745730028,0.0239889980942027,0.0590144233268198,3.44313404330058e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC2,Stanniocalcin-2,42591,0.0119571533919562,0.0025860465024863,0.00688850224708301,0.0170258045368293,3.80442772648318e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.0389230800854899,0.00843476977687686,0.0223909313228113,0.0554552288481686,3.97509657191292e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD109,CD109 antigen,42611,-0.0161298618313694,0.00349777299579743,-0.0229854969031324,-0.00927422675960645,4.03532569285468e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1B,Interleukin-1 beta,42293,0.0272310924937407,0.00591152000728781,0.0156445132794566,0.0388176717080248,4.13471189681158e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0134350799497144,0.00291827101791764,0.00771526875459585,0.019154891144833,4.18785000724961e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0205513526143275,0.00446632382238676,0.0117973579224494,0.0293053473062055,4.24228621296186e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0173821774232348,0.00379032359299533,-0.0248112116655057,-0.00995314318096395,4.56082186478472e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,40182,-0.0151168259125671,0.00329867713079563,-0.0215822330889265,-0.00865141873620764,4.64083550616556e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,42443,0.0145984093166047,0.00318755239743426,0.00835080661763351,0.0208460120155758,4.69621280859917e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH1,Cadherin-1,42188,0.0188975071045111,0.00413556640416921,0.0107917969523394,0.0270032172566827,4.93371350712936e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX5,Syntaxin-5,40199,0.0195425004309377,0.00427657420355589,0.0111604149919681,0.0279245858699072,4.93827169785841e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,40527,0.0262451237874233,0.00574644228050913,0.0149820969176254,0.0375081506572212,4.99506083249821e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0208729263313844,0.00458722190689142,0.0118819713938772,0.0298638812688915,5.41550524289927e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0193883150183214,0.00427963534152517,0.011000229748932,0.0277764002877107,5.93999173559566e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIT,Vitrin,40511,0.0181682013141861,0.00401154294112249,0.010305577149586,0.0260308254787862,5.9874853248752e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN2,Calsyntenin-2,42754,-0.0186585739634112,0.00412168471721005,-0.0267370760091429,-0.0105800719176795,6.03565149330092e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0210036899307484,0.00464852850134829,0.0118925740681058,0.0301148057933911,6.29721576968924e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB2,Lamin-B2,40483,0.0134753607135734,0.00298473954366356,0.00762527120799279,0.0193254502191539,6.40326549742343e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0205294357466367,0.00455565438867138,0.0116003531448408,0.0294585183484326,6.65346587052761e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0184323629385684,0.004094414319303,-0.0264574150044022,-0.0104073108727345,6.79385433030051e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KEL,Kell blood group glycoprotein,42311,0.0169451518541673,0.00377053006532591,0.00955491292612856,0.0243353907822061,7.04616360873136e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCA2A,Guanylin,42563,-0.0169921075596921,0.00378795684159852,-0.0244165029692252,-0.00956771215015903,7.32382832297167e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN1,Contactin-1,42794,-0.0129452705552786,0.00289258328534542,-0.0186147337945557,-0.00727580731600162,7.69123400485072e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.0187513375017958,0.0041960274685412,0.0105271236634551,0.0269755513401366,7.92857580046668e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF5,Fibroblast growth factor 5,42370,-0.0153449012837817,0.00343820236278404,-0.0220837779148384,-0.00860602465272494,8.14680019325575e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN2,Prefoldin subunit 2,42311,0.0256710826814781,0.00575704602313678,0.01438727247613,0.0369548928868262,8.29989452989084e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A14,Protein S100-A14,40482,0.0254574451808212,0.0057100147392413,0.0142658162919082,0.0366490740697341,8.33763402407832e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,40370,0.03035261553075,0.00681117949647208,0.0170027037176647,0.0437025273438353,8.42001907303857e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0254564271852477,0.00571556844386421,0.0142539130352739,0.0366589413352216,8.50294151812741e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFLAM,Pikachurin,40449,0.0143676741572604,0.00322644132104482,0.00804384916801258,0.0206914991465083,8.54537825343027e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG4,Regenerating islet-derived protein 4,42638,0.0243207780767069,0.00546755288461847,0.0136043744228547,0.0350371817305591,8.72873069718107e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.0209530110356679,0.00471537148465318,0.0117108829257477,0.0301951391455882,8.91997450112945e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.0138240320713524,0.00311600181243279,0.00771666851898416,0.0199313956237207,9.21911969455898e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.049681842753633,0.0112028731554497,0.0277242113689515,0.0716394741383145,9.30785058912902e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBI3_IL27,Interleukin-27,42689,-0.0142103593905269,0.00320745190843122,-0.0204969651310521,-0.00792375365000169,9.47903429623183e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,40182,0.0312381028414232,0.00707321799935458,0.0173745955626882,0.0451016101201581,1.01321648502761e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS1,Nephrin,40199,0.0154238234420826,0.00350109415944622,0.00856167888956803,0.0222859679945972,1.06572809285422e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPS10,40S ribosomal protein S10,40116,-0.0186579169337502,0.00424742244778873,-0.0269828649314161,-0.0103329689360843,1.12974185954037e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL1,Chordin-like protein 1,42654,0.0147304219394747,0.00335729459674404,0.0081501245298564,0.021310719349093,1.15487075127407e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0231370836721994,0.00531708932754463,0.0127155885902119,0.0335585787541869,1.36428681764403e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0151543777802511,0.00348713107234576,0.00831960087845338,0.0219891546820488,1.40013762132037e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN10,Ataxin-10,42311,0.0325998477343535,0.00750675480562162,0.0178866083153352,0.0473130871533719,1.41775932754544e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",40302,0.0205266100217486,0.00473042812352908,0.0112549708996316,0.0297982491438656,1.44219878233533e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0221777289959641,0.0051207300730061,0.0121410980528722,0.0322143599390561,1.49778892831302e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0252744706851414,0.00584758905134278,0.0138131961445095,0.0367357452257732,1.55806092384865e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0152099593254301,0.00352527058649788,-0.0221194896749659,-0.00830042897589424,1.61074320196022e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR4,Complement factor H-related protein 4,40509,0.0334594025629384,0.00776274918375702,0.0182444141627747,0.0486743909631022,1.64448130286879e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPO,Erythropoietin,42594,0.0330592104331742,0.00768371049647371,0.0179991378600857,0.0481192830062626,1.70074393821868e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0159049979739688,0.0036970466422206,0.00865878655521646,0.0231512093927212,1.70398241263076e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.0144086861339465,0.00335850144714397,0.00782602329754433,0.0209913489703487,1.79752109564401e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD9,Enhancer of filamentation 1,40199,0.0148540437010005,0.00346888886256376,0.00805502153037553,0.0216530658716255,1.86728678363224e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,42441,0.0125443855818115,0.00293004538506509,0.00680149662708395,0.0182872745365391,1.87117381248385e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,42721,0.0372582007924531,0.00874351299547269,0.0201209153213266,0.0543954862635795,2.04672581430252e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0148207189711316,0.00349160951351055,0.00797716432465092,0.0216642736176123,2.20710150010069e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0192930195748222,0.00454843356629644,0.0103780897848812,0.0282079493647632,2.23366287773234e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERC2,ERC protein 2,40182,0.033555308312128,0.0079125693450489,0.0180466723958321,0.0490639442284238,2.24587682575862e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,40116,0.0407525788674816,0.00962994767350322,0.0218778814274153,0.0596272763075479,2.33661388912347e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALCAM,CD166 antigen,42794,0.00863552547728492,0.00204241669743736,0.00463238875030769,0.0126386622042622,2.37221705422704e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTL1,Cytokine-like protein 1,40527,0.0112574415942434,0.0026636595252059,0.00603666892483988,0.016478214263647,2.39419219004768e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMS1,PMS1 protein homolog 1,40182,0.022901535963329,0.00542088335851225,0.012276604580645,0.033526467346013,2.4120349097566e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MILR1,Allergin-1,42370,-0.0225819340517332,0.00535802055018599,-0.0330836543300978,-0.0120802137733687,2.51884447637368e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0114903394519375,0.00272665439170885,-0.0168345820596868,-0.00614609684418812,2.52821492843793e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL25,C-C motif chemokine 25,42754,0.0209127148885211,0.00497742922643862,0.0111569536047014,0.0306684761723408,2.66837923510718e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,40342,0.0189626371099461,0.00451535421425802,0.0101125428500004,0.0278127313698919,2.6947709981222e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0171206367075966,0.00407812747483886,0.00912750685691239,0.0251137665582807,2.70829011893269e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,42346,0.0154755116628353,0.00368737490597804,0.00824825684711838,0.0227027664785523,2.72381552452052e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD48,CD48 antigen,42654,0.0135079808889458,0.00322215419749095,0.00719255866186354,0.019823403116028,2.78003002122505e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGCR6,Protein DGCR6,40136,0.0193416363045507,0.00462011500671648,0.0102862108913864,0.028397061717715,2.85635153610391e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB2A2,Mammaglobin-A,40116,-0.0138723212933176,0.00331652202761907,-0.020372704467451,-0.00737193811918422,2.90201113097278e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,40482,0.0141686055118262,0.00338791616283958,0.00752828983266059,0.0208089211909917,2.91010572524814e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0187425233898468,0.00448890262410264,0.00994427424660562,0.027540772533088,2.99504768213179e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0281632177746323,0.00674671780036107,0.0149396508859246,0.04138678466334,3.01121718524169e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD3,Extracellular superoxide dismutase,40532,-0.0253505205367467,0.00607863589363962,-0.0372646468882804,-0.013436394185213,3.06289149799737e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0144655772378963,0.00346917287955673,-0.0212651560818275,-0.00766599839396509,3.06852165793309e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,42439,0.0125860304422184,0.00301907594491475,0.00666864159018545,0.0185034192942513,3.08106937296086e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.02098212443184,0.00504187145406486,0.0111000563818728,0.0308641924818071,3.18468380254035e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0164256571656422,0.00395274144183968,-0.024173030391648,-0.00867828393963639,3.27021340109293e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA1,Ephrin-A1,42590,0.012988893456121,0.00315106699483729,0.00681280214623994,0.0191649847660021,3.77757630557966e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD7,T-cell antigen CD7,40166,0.0191744941642025,0.00465568589625272,0.0100493498075472,0.0282996385208578,3.84124326522304e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,42370,0.0209134531863071,0.00508154816847279,0.0109536187761004,0.0308732875965138,3.88579284290913e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIM,Vimentin,42357,0.0495582019794281,0.0120436074483209,0.0259527313807192,0.0731636725781371,3.89711272186444e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0189915278355836,0.00462364241341448,0.00992918870529126,0.028053866965876,4.02825567390148e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,42636,0.0195267129579813,0.00476462089202852,0.0101880560096054,0.0288653699063572,4.18689670505155e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM2,Junctional adhesion molecule B,42711,0.0121102099324311,0.00295533414909303,0.00631775500020878,0.0179026648646535,4.1962660062661e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB1,Calbindin,42587,0.0193924313815546,0.00474265384980381,0.0100968298359391,0.0286880329271701,4.35878809621239e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5L,CD5 antigen-like,40479,0.0202644309739683,0.00497033088362936,0.0105225824420548,0.0300062795058819,4.59178677585315e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,42370,0.0238810099420575,0.00587384927339966,0.0123682653661942,0.0353937545179209,4.81772951456623e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0137644036118286,0.00338827994696231,-0.0204054323078747,-0.00712337491578242,4.8919298697392e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0277172694162313,0.00686609874482644,0.0142597158763714,0.0411748229560911,5.45372209956095e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,40223,0.0396089184795295,0.00984598381180832,0.0203107902083851,0.0589070467506738,5.78816319901471e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX2,Neuronal pentraxin-2,40527,-0.0137616027582323,0.003422226037917,-0.0204691657925497,-0.00705403972391502,5.82670772281536e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,42590,-0.00982425244613224,0.0024503973336462,-0.0146270312200788,-0.00502147367218568,6.12423662608627e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0106444201309811,0.00265751049985669,0.005435699551262,0.0158531407107002,6.22430895737764e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF8,SLAM family member 8,42346,0.0230458002581239,0.00575773401209696,0.0117606415944138,0.0343309589218339,6.29987680752717e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWF,von Willebrand factor,42794,-0.0297425478858498,0.00746766402260841,-0.0443791693701623,-0.0151059264015374,6.84497148269983e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI1,Neuroserpin,40267,0.0125163265028074,0.00314633293165718,0.00634951395675931,0.0186831390488555,6.99199342084115e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0153087725390637,0.00385839411554095,0.00774632007260339,0.0228712250055239,7.29681042216527e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP1,Dipeptidase 1,42476,-0.0206290110708519,0.00520135472368478,-0.0308236663292741,-0.0104343558124297,7.34463850635235e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0151661170455582,0.00382783230795005,0.00766356572197607,0.0226686683691402,7.47770402572219e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAFB2,Scaffold attachment factor B2,40482,0.0113143615460463,0.00286169436223149,0.00570544059607263,0.0169232824960201,7.74124044307581e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0290757024865709,0.00736574779954188,-0.043512568173673,-0.0146388367994688,7.94769662470503e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD160,CD160 antigen,42754,0.020076189691829,0.00509868234854556,0.0100827722886797,0.0300696070949783,8.27379706169556e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0209725256671425,0.00534302910585567,0.0105001886196654,0.0314448627146197,8.71817499416328e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL3,Insulin-like 3,40483,0.0318401186447031,0.00814674119188151,0.0158725059086153,0.0478077313807908,9.34807974355605e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX2,Peroxiredoxin-2,40333,0.0254141293150587,0.00650721956228603,0.0126599789729781,0.0381682796571393,9.45748958648362e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,42464,0.0145305462732625,0.00372250270713841,0.00723444096727123,0.0218266515792538,9.53060365303456e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAN,Versican core protein,42711,-0.0123532183445175,0.00317771193441576,-0.0185815337359724,-0.00612490295306261,0.000101784057921019
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL34,Interleukin-34,42292,0.0147517023272641,0.00380350544450369,0.00729683165603687,0.0222065729984913,0.000105638468734147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSB,Cathepsin B,42659,-0.0216416355439244,0.00558250919642308,-0.0325833535689136,-0.0106999175189351,0.000106391543777555
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCC1,Regulator of chromosome condensation,40451,0.0211722993160097,0.00546713087683138,0.0104567227974202,0.0318878758345992,0.000108266306494211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,42370,0.0118735668313466,0.00306669485657682,0.00586284491245605,0.0178842887502372,0.000108565285116689
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,40223,0.0159773496866638,0.0041265763604169,0.00788926002024666,0.0240654393530809,0.00010865030009845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP1,Caspase-1,42311,0.0278032872457647,0.0071874746913809,0.0137158368506582,0.0418907376408713,0.000110127874163243
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK11,Kallikrein-11,42543,0.0131484428713679,0.0034047469847485,0.00647513878126089,0.019821746961475,0.000113087132945116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLFM4,Olfactomedin-4,39870,0.0496400794372421,0.012853672556177,0.0244468812271351,0.0748332776473491,0.000113155573848289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0153583367334094,0.00399352809288924,0.00753102167134645,0.0231856517954723,0.000120837264214761
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00806879702881519,0.00210017809196348,-0.0121851460890636,-0.00395244796856678,0.000122614660831986
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0216968528140847,0.00566529181249121,0.0105928808616019,0.0328008247665675,0.000128948786252364
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.0088554644382632,0.00231414474914508,0.00431974072993884,0.0133911881465876,0.00013047873443343
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS4,Thrombospondin-4,42652,0.0181751735934771,0.00475469284029087,0.00885597562650701,0.0274943715604472,0.00013265974224331
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP13,Collagenase 3,42311,-0.0132299050431539,0.00346972502484818,-0.0200305660918564,-0.00642924399445149,0.000137943780490173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGA4,Pepsin A-4,40532,0.0320181354309988,0.00839731839777748,0.0155593913713549,0.0484768794906427,0.000138073223547818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDRG1,Protein NDRG1,42311,0.0256799342075627,0.00677431813960491,0.0124022706539371,0.0389575977611883,0.00015084883437493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSM,Oncostatin-M,42534,0.0275494595296693,0.00727101019527251,0.0132982795469351,0.0418006395124034,0.000151953192549897
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY2,Protein canopy homolog 2,42357,0.0242878144426309,0.00641344949814453,0.0117174534262676,0.0368581754589942,0.000153147188926386
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,42587,0.00836760984532898,0.00221470554532718,0.00402678697648771,0.0127084327141703,0.000158647487348363
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.029978618118948,0.00795071069901932,0.0143952251488702,0.0455620110890259,0.000163733193487558
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGT,Angiotensinogen,40532,0.00934931673027055,0.00248552640861499,0.00447768496938517,0.0142209484911559,0.000169744957040382
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.026416070269323,0.00703723872224066,0.0126230823737313,0.0402090581649147,0.000175093120932463
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFR,Epidermal growth factor receptor,42794,0.0063422507417269,0.00169342124929742,0.00302314509310397,0.00966135639034983,0.000180972885393158
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,40483,0.0111885906410399,0.00299570162701151,0.00531701545209733,0.0170601658299824,0.000188727817318432
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK2,Protein AHNAK2,40223,0.0117547479225104,0.00314994438938876,0.0055808569193084,0.0179286389257123,0.000191122773878583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO3,R-spondin-3,42721,0.0115322905379106,0.00309158081024571,0.00547279214982898,0.0175917889259922,0.000192091041657552
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,40116,0.0171345450831373,0.0045958078085689,0.00812676177834228,0.0261423283879324,0.000193750820572926
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.0112278122081154,0.00301698075455848,0.00531452992918075,0.01714109448705,0.000199009187816769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO4,Roundabout homolog 4,40223,-0.00705924472897692,0.0018975502034462,-0.0107784431277315,-0.00334004633022238,0.000200062085472702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,40199,0.0220640374042341,0.00593360980293461,0.0104341621904822,0.0336939126179859,0.000201416617001229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0158715728482565,0.00426951772942475,0.00750331809858398,0.024239827597929,0.000202245312847594
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO1,R-spondin-1,42495,0.0130923075400521,0.00353119815737189,0.00617115915160317,0.020013455928501,0.000210074009302807
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,40136,0.0171164519475752,0.00463344877132463,0.00803489235577895,0.0261980115393715,0.000221736645918597
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0246909078460838,0.00670567011640272,0.0115477944179344,0.0378340212742331,0.000232434730850168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0156751778211808,0.00427013043927268,0.0073057221602063,0.0240446334821552,0.000242825468097259
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.0103825031891313,0.00282846009542116,-0.0159262849761568,-0.0048387214021058,0.000242972954584077
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YY1,Transcriptional repressor protein YY1,40199,0.0107528910125968,0.00293874023140408,0.00499296015904478,0.0165128218661488,0.000254371002510484
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPJ,Centromere protein J,40302,0.0269786310137721,0.00738666091811718,0.0125007756142624,0.0414564864132818,0.000261051819537031
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTG,Protogenin,42721,0.0094479896035326,0.00258804826094,0.00437541501209021,0.014520564194975,0.000262590409125902
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.00893322542871948,0.00245566111691005,0.00412012963957579,0.0137463212178632,0.000276007526264148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.0151383830489306,0.0041634977944625,0.00697792737178407,0.0232988387260771,0.000277964697223569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,40449,0.0307238823868558,0.0084641437121933,0.0141341607109569,0.0473136040627546,0.000284803073044989
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTP1,Glutathione S-transferase P,42237,-0.0263975455520648,0.0072969938546302,-0.04069965350714,-0.0120954375969896,0.000298480065153357
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0104924279571996,0.00290127953409279,-0.0161789358440215,-0.00480592007037774,0.000299931853667444
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0135260718279136,0.00374133132725719,-0.0208590812293377,-0.00619306242648951,0.000301081260034506
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLC,Galectin-10,42611,-0.0247343983434335,0.0068429642710393,-0.0381466083146705,-0.0113221883721964,0.000301943538794779
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0245673694639093,0.00679978908944,-0.0378949560792117,-0.0112397828486069,0.000303812191715974
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPE,Carboxypeptidase E,42588,-0.0145005421145829,0.00401505108215918,-0.0223700422356149,-0.00663104199355094,0.000305489557170777
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH12,Protocadherin-12,40482,0.00970132973951805,0.00268775846420582,0.00443332314967465,0.0149693363293615,0.000308175230120785
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C8B,Complement component C8 beta chain,40539,0.0114098088164561,0.00316194424801084,0.00521239809035484,0.0176072195425573,0.000309322900429839
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00807687234995286,0.00224221817795795,0.00368212472115528,0.0124716199787505,0.000316920053520245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,42587,0.00978699186391818,0.00271892926781335,0.00445789049900402,0.0151160932288323,0.000319887547648231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0270825217151563,0.00754906296534637,0.0122863583030774,0.0418786851272352,0.000335232383337416
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0112157570749111,0.00312961257678984,0.00508171642440301,0.0173497977254192,0.000339921109230165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN3,CCN family member 3,42779,0.0132119392146372,0.00368921106915386,0.0059810855190956,0.0204427929101787,0.000343165379861613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0141037098183913,0.0039504126809717,0.00636090096368679,0.0218465186730959,0.00035821274179227
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGN,Mimecan,42611,0.0164422054599827,0.00460963994352956,0.0074073111706648,0.0254770997493007,0.000362463197401364
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSAP,Gamma-secretase-activating protein,42346,0.0317416834949362,0.00891117536880652,0.0142757797720754,0.049207587217797,0.000369329280084619
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0255658467724251,0.00717797078423061,0.0114970240353331,0.0396346695095171,0.000369735383311303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRTN,Neurturin,42370,0.0181137142304512,0.00512110068927364,0.00807635687947488,0.0281510715814276,0.000405976236589604
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0267958728077689,0.00758496866762166,0.0119293342192305,0.0416624113963074,0.000412625015653156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,42689,-0.0111008990016912,0.00314257150210314,-0.0172603391458133,-0.00494145885756901,0.000413141577451854
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP2,Guanylate-binding protein 2,42370,0.0223044392247502,0.00631748373026643,0.00992217111342796,0.0346867073360724,0.000416050710880536
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST6,Cystatin-M,42332,0.0184952896844646,0.0052752930170436,0.00815571537105913,0.02883486399787,0.000456375897578009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,40199,0.02318653362316,0.00665353498810602,0.0101456050464722,0.0362274621998478,0.000494340677325754
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0135159043291247,0.00387958415492753,-0.0211198892727827,-0.00591191938546675,0.000496174510021564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,42357,0.020079632235647,0.00576548521026585,0.00877928122352592,0.031379983247768,0.000497939041969055
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.0117944941329806,0.00338733649491756,-0.0184336736630191,-0.0051553146029422,0.000499743045882271
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171B,Protein FAM171B,40451,0.00956674485525356,0.00275242759098889,0.00417198677691533,0.0149615029335918,0.000511350790593998
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN8,Septin-8,40470,0.0117133555604045,0.0033806488531163,0.00508728380829656,0.0183394273125125,0.000532550455128581
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LXN,Latexin,42461,-0.0244219873041782,0.00705091985867064,-0.0382417902271727,-0.0106021843811838,0.000534562027868197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.0103974354297242,0.00300364901184295,0.00451028336651199,0.0162845874929363,0.000538965345934633
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG4,Desmoglein-4,42543,0.0180048937683285,0.00520729007773977,0.00779860521595854,0.0282111823206985,0.00054664321982775
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0208474424634085,0.00603700009919071,0.00901492226899466,0.0326799626578223,0.000555557505262145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST1,Cystatin-SN,39042,0.0396739472323273,0.0114893597977712,0.0171548020286957,0.0621930924359589,0.000556507129086001
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,40483,0.0147305422011033,0.00427380345424154,0.00635388743078988,0.0231071969714167,0.000569533786491915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0194010388650289,0.00563495041097658,0.00835653605951478,0.030445541670543,0.000577422715269302
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",40511,0.0187787705311238,0.00546372077578919,0.00806987781057698,0.0294876632516706,0.00059032566297384
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.0113092145461541,0.00329491132440708,-0.017767240741992,-0.00485118835031621,0.000600205759031879
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.013876203608186,0.00407078739081763,-0.0218549468941886,-0.0058974603221835,0.000655025310631596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH17,Protocadherin-17,42636,0.0131581161659427,0.00386991189392591,0.00557308885384796,0.0207431434780375,0.000675552378515646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,40511,0.0112307688786752,0.00330947885586778,0.00474419032117434,0.017717347436176,0.000692381980871267
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0526488421018059,0.0155301967712978,0.0222096564300621,0.0830880277735496,0.000700743289114486
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.00995221255709419,0.00293988373155331,0.0041900404432497,0.0157143846709387,0.000713208194316234
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.00999544022382893,0.00295800405824295,0.00419775226967274,0.0157931281779851,0.000729646581687668
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.0119163605813353,0.0035295687762562,0.00499840577987317,0.0188343153827975,0.000737552350561198
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,40199,0.0136211192853171,0.00403660645569174,0.00570937063216124,0.0215328679384729,0.000742326242205288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE,Angiotensin-converting enzyme,40532,-0.00942147637175948,0.00279412130024025,-0.0148979541202304,-0.00394499862328859,0.000749031424319447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.0069303898578246,0.00205899254962991,-0.0109660152550992,-0.00289476446054998,0.00076543930333235
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.024925374935094,0.00741845480647933,0.0103852035143946,0.0394655463557935,0.000781822473073799
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EP300,Histone acetyltransferase p300,40199,0.0108206633500608,0.00322729260000309,0.00449516985405474,0.0171461568460669,0.000802505833088681
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEO1,Neogenin,40482,0.00774803284376774,0.00231564243975711,0.0032093736618438,0.0122866920256917,0.000822675495179274
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0143066237498183,0.00427638208473954,0.00592491486372883,0.0226883326359078,0.00082401987566213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.063644262108368,0.0190335200391486,0.0263385628316367,0.100949961385099,0.00082866580787934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,42346,0.0165264208955766,0.00494971433804117,0.00682498079301591,0.0262278609981373,0.000843555349124449
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,42794,-0.00914149933843678,0.00274375862257344,-0.0145192662386807,-0.00376373243819284,0.000865338273928021
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB1,Lamin-B1,40434,0.0207013990652727,0.00622240499796993,0.00850548526925161,0.0328973128612937,0.000880955202868079
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD9,COMM domain-containing protein 9,40451,0.0137209519082269,0.0041358406789613,0.00561470417746272,0.021827199638991,0.000910911151180403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,40080,0.0127485219969758,0.00384427583240766,0.00521374136545682,0.0202833026284948,0.000915376939731688
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST2,Bone marrow stromal antigen 2,42711,0.0176108287408393,0.00531492159194972,0.00719358242061784,0.0280280750610607,0.000923883587021793
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.0133087988716394,0.00402602853199837,0.00541778294892264,0.0211998147943562,0.00094992558172653
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.018082615321428,0.00546999405169938,0.00736142698009723,0.0288038036627588,0.000950166482829565
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF4,Neurotrophin-4,42346,0.0134275180800889,0.0040631568258787,0.00546373070136667,0.0213913054588112,0.00095332020134099
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,40483,0.0196581744656884,0.0059488138141937,0.00799849938986873,0.031317849541508,0.000954240810082481
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.00993783189872778,0.00301009327229085,-0.0158376147124178,-0.00403804908503771,0.000964160816671234
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOC,Myocilin,42611,-0.0152980047542734,0.00464897114595526,-0.0244099882003457,-0.00618602130820104,0.00100224189526782
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GM2A,Ganglioside GM2 activator,40269,0.0140059346222699,0.00426422304731594,0.0056480574495307,0.0223638117950092,0.00102472643705472
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0194088124568145,0.00591476339961355,0.00781587619357197,0.0310017487200571,0.00103555006361737
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXTL1,Exostosin-like 1,40116,0.0161850377407347,0.00493949294366031,0.00650363157116052,0.025866443910309,0.00105370623231863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK4,Kallikrein-4,42721,-0.0216673074705267,0.00661306204748033,-0.0346289090835882,-0.00870570585746529,0.0010538901175767
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST7,Cystatin-F,42642,0.0317655740490981,0.00973521796280325,0.0126845468420037,0.0508466012561924,0.0011053224629976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSC2,Desmocollin-2,42488,-0.0120235396723524,0.00368520562557684,-0.019246542698483,-0.00480053664622177,0.00110653818463451
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,42587,-0.013920216238488,0.00426979180686847,-0.0222890081799502,-0.00555142429702583,0.0011162633646505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0290469523372943,0.00893831229870931,-0.0465660444427645,-0.011527860231824,0.00115815565187454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00728662821454854,0.00224972497517743,0.00287716726320078,0.0116960891658963,0.00120285836756541
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200,OX-2 membrane glycoprotein,42594,-0.00924202420559496,0.00285518333661086,-0.0148381835453522,-0.00364586486583768,0.00121117371851155
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0150538072558828,0.00466626915030569,0.00590791972128361,0.0241996947904819,0.00125863288057267
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1A,Lithostathine-1-alpha,42575,-0.0174796138882707,0.00542826642798459,-0.0281190160871205,-0.00684021168942095,0.00128447470961048
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0167562789499399,0.00520812342875685,0.0065483570295765,0.0269642008703034,0.00129753433808715
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0123911579461512,0.00385272944654652,0.00483980823092002,0.0199425076613824,0.00130263768482436
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEG1,Protein LEG1 homolog,39926,-0.0234726265880526,0.00730397417316481,-0.0377884159674557,-0.00915683720864963,0.00131433529591821
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRK1,Protein BRICK1,42311,0.0149971503642196,0.00467298719585223,0.00583809546034921,0.02415620526809,0.00133365534997037
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0281204281280408,0.00876948286352889,0.0109322417155242,0.0453086145405574,0.00134687298903338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,40136,0.0261696349061306,0.00816449331934857,0.0101672280002074,0.0421720418120538,0.00135310041665424
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.0118320100175747,0.00369526699545244,0.00458928670648791,0.0190747333286615,0.00136895290839888
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WIF1,Wnt inhibitory factor 1,42721,-0.0114780085765499,0.00358601943621343,-0.0185066066715282,-0.00444941048157158,0.0013737947109026
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0211340622564068,0.00660870638733839,0.0081809977372236,0.0340871267755901,0.00138806917708844
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSN,Gelsolin,40488,-0.0064524074404405,0.00201940421504971,-0.0104104397019379,-0.00249437517894307,0.00140116444234166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC1,Syndecan-1,42636,0.0134959684903641,0.00422508361299333,0.00521480460889716,0.021777132371831,0.00140518664615867
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0234016977102612,0.00734425818119567,-0.0377964437454047,-0.00900695167511764,0.00144451850741008
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,42741,0.017352934582021,0.00544857448313488,0.00667372859507665,0.0280321405689654,0.00145153153882493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.029122956556158,0.00914618059797081,0.0111964425841352,0.0470494705281808,0.00145581190447096
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSF,Cathepsin F,42679,0.0130493083197316,0.00411544695443436,0.0049830322890403,0.021115584350423,0.00152353767422207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0285374416770128,0.00900387421455886,0.0108898482164775,0.0461850351375482,0.00153135545501135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.0141498980275758,0.00447726916169096,0.00537445047066148,0.02292534558449,0.0015791051419108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAD,Chondroadherin,40283,0.0170522465833713,0.00541028604523862,0.00644808593470359,0.027656407232039,0.00162688421253889
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,40116,-0.00895348046160831,0.00284271963835519,-0.0145252109527845,-0.00338174997043213,0.00163924998912897
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0112037789281814,0.00355830842044089,0.00422949442411731,0.0181780634322456,0.001644011950733
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNXB,Tenascin-X,42611,-0.00843463528727109,0.00268515216523122,-0.0136975335311243,-0.0031717370434179,0.00168615186191532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA11,Serpin A11,42794,-0.0133263369317056,0.0042497406232306,-0.0216558285532376,-0.00499684531017365,0.0017175112916913
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN2,Neuroligin-2,40136,-0.015625084773194,0.00501551702401436,-0.0254554981402621,-0.00579467140612583,0.0018420254837214
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0263296845331028,0.00845671683750803,0.00975451953158711,0.0429048495346186,0.00185381980987971
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0232460522590649,0.00746906935083025,-0.0378854281866922,-0.00860667633143764,0.00186092405046448
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,40449,0.0184577268521799,0.00595867590342072,0.00677872208147528,0.0301367316228845,0.00195560099891165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA4,Carboxypeptidase A4,40060,0.0142305089281223,0.00460435111629162,0.00520598074019068,0.0232550371160538,0.00200213484927483
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.0158306543905225,0.00513016356235845,-0.0258857749727451,-0.00577553380829996,0.00203418148867084
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",40116,0.0181469953389074,0.00589076633371923,0.0066010933248177,0.0296928973529971,0.00207109200771688
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL28,C-C motif chemokine 28,42538,0.0187437251886849,0.006106908554445,0.00677418442197269,0.0307132659553971,0.0021501628924725
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00925420119794021,0.00302085829758415,-0.0151750834612051,-0.00333331893467527,0.00219336120143512
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,42594,-0.00769134629122647,0.00251143399434594,-0.0126137569201445,-0.00276893566230843,0.0021990832340769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPACAM2,HEPACAM family member 2,40483,-0.0134277018443003,0.00439098961038778,-0.0220340414806604,-0.00482136220794028,0.00223331716024907
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSV,Cathepsin L2,42677,0.0132422299610635,0.00435574258267685,0.0047049744990169,0.0217794854231102,0.00236892405985542
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.0180170771213331,0.00592784873657212,-0.0296356606450145,-0.00639849359765178,0.00237510207329512
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD1,Polycystin-1,40511,0.00849042048005965,0.002795305363659,0.003011621967288,0.0139692189928313,0.0023918349598147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLN,Mesothelin,42553,0.0188078772649715,0.0061985069735958,0.00665880359672369,0.0309569509332192,0.0024159061001184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,40302,0.0223928337379772,0.00738222921666309,0.00792366447331755,0.0368620030026369,0.00242419049437292
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN2,Transcobalamin-2,42771,-0.00972542852075372,0.00320770137703071,-0.0160125232197339,-0.00343833382177352,0.00243478354085346
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RETN,Resistin,42598,0.0136524263357357,0.0045119670624175,0.00480897089339736,0.0224958817780739,0.00248425332171362
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00661036860989937,0.00218955693039964,-0.0109019001934827,-0.00231883702631608,0.00254153454239487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA6C,Semaphorin-6C,40199,0.00823768610315566,0.00273645134889979,0.00287424145931208,0.0136011307469993,0.00261535328203156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00854258755273597,0.00284197016864108,-0.0141128490832725,-0.00297232602219946,0.002654082004923
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM25,Transmembrane protein 25,40482,-0.0142789892227584,0.00475371931570901,-0.0235962790815481,-0.00496169936396875,0.00267258176626193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,40109,-0.0196004167508935,0.00655229138886487,-0.0324429078730686,-0.00675792562871833,0.00278336755316611
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0184262457085758,0.00616294826382113,0.00634686711148636,0.0305056243056652,0.00279745125042623
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0176066728946097,0.00589549621615956,0.00605150031093695,0.0291618454782824,0.00282746298399161
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.0108021218257563,0.00361741023959222,0.00371199775615555,0.017892245895357,0.00283031941730856
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGA,Fibrinogen alpha chain,40284,0.00957792798171505,0.00322265196773398,0.00326153012495646,0.0158943258384736,0.00296440097880682
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0257583342861068,0.00868033391838566,0.00874487980607088,0.0427717887661427,0.00300940962365336
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6,Seizure protein 6 homolog,40182,-0.00971280752840482,0.00327385125389373,-0.0161295559860365,-0.00329605907077311,0.00301580790324331
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.00959880377373158,0.00323957686490912,0.00324923311850971,0.0159483744289535,0.00305205328226052
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00751215234607605,0.0025365990253812,0.0025404182563289,0.0124838864358232,0.00306792712308296
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JCHAIN,Immunoglobulin J chain,42370,-0.0193045594332872,0.00651959847161613,-0.0320829724376548,-0.0065261464289196,0.00307184214417768
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,40116,0.0138583457908749,0.00468222369454273,0.00468118734957119,0.0230355042321787,0.00308521241194511
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0179009387420109,0.00605718856734656,0.00602884915001162,0.0297730283340101,0.00313012789656359
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTN,Titin,40116,-0.0202169068424705,0.00685003665142472,-0.0336429786792629,-0.00679083500567801,0.00317052910361863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAVL4,ELAV-like protein 4,40136,0.0261363646327736,0.0088631888183177,0.00876451454887092,0.0435082147166763,0.00319615756780372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0130343458722144,0.00442944604484931,-0.0217160601201191,-0.00435263162430981,0.00326093879745465
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0190369206028459,0.00647103564229306,0.00635369074395153,0.0317201504617403,0.00326809462126323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0175301584807482,0.00597532816056074,0.00581851528604911,0.0292418016754472,0.00335571418709698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH6,Cadherin-6,42636,-0.0117846880025745,0.00402263426205016,-0.0196690511561928,-0.00390032484895616,0.00339974831126998
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.00948239880640198,0.00323771155776393,0.00313648415318468,0.0158283134596193,0.00341042596709179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.015877239080118,0.00543271396228651,0.00522911971403648,0.0265253584461996,0.00347897219260501
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,40283,0.00886805688864534,0.00303722090397493,0.00291510391685448,0.0148210098604362,0.00350968794769021
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUK1,Guanylate kinase,40116,-0.0117042704965302,0.00401001405951029,-0.0195638980531704,-0.00384464293989002,0.00352143431085458
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0150107292256687,0.00515210444831461,0.00491260450697208,0.0251088539443654,0.00358086816802511
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00774371395413511,0.00267322156383025,-0.0129832282192424,-0.00250419968902782,0.00377764794077902
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.0145798447045795,0.00503871087512367,-0.0244557180198219,-0.00470397138933711,0.00381637542446691
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JUN,Transcription factor AP-1,42370,0.0143978409053771,0.00498482614889304,0.00462758165354669,0.0241681001572074,0.00387919593973522
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN3,Perilipin-3,42636,0.012563047138706,0.00436852204476164,0.00400074393097315,0.0211253503464388,0.00403623182793472
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0139751010354968,0.00486738041074314,0.00443503543044029,0.0235151666405534,0.0040971195366336
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMA,Repulsive guidance molecule A,42711,-0.00955107466415442,0.00333127687505545,-0.0160803773392631,-0.00302177198904574,0.00414903849536021
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.00958761931196868,0.0033500677421194,0.00302148653741465,0.0161537520865227,0.00421858078926593
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDS,Iduronate 2-sulfatase,42754,0.00259330459120697,0.000908262522066173,0.000813110047957274,0.00437349913445667,0.00430700160792403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNW1,Interferon omega-1,40116,-0.0109515001111914,0.00384742101226786,-0.0184924452952364,-0.00341055492714641,0.0044291745733784
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX18,Sorting nexin-18,40449,0.0129662303275714,0.00456575073651861,0.0040173588839949,0.0219151017711479,0.00452100075425347
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC1,Hamartin,40199,0.0217186031519543,0.00765306989210655,0.00671858616342549,0.0367186201404832,0.0045495299724742
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGF,Beta-nerve growth factor,42495,0.00353652302864058,0.00124995696433642,0.0010866073785412,0.00598643867873997,0.00467174707025619
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,42594,0.0142884198418952,0.00505593230591278,0.00437879252230615,0.0241980471614842,0.00471926607356193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0155135588657882,0.00550647277480758,0.00472087222716532,0.026306245504411,0.00484969148371307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0143472358174722,0.00509283833298545,0.00436527268482074,0.0243291989501237,0.00485256433656861
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,42611,-0.0184597556730347,0.00655470466608323,-0.0313069768185578,-0.00561253452751158,0.00486571663022754
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,40199,0.0060700606244068,0.00215877374960243,0.00183886407518604,0.0103012571736276,0.00493508271548121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0153209336540865,0.0054825545486849,0.00457512673866413,0.0260667405695089,0.00520710564470257
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0101722271492918,0.00364459643809433,-0.0173156361679567,-0.0030288181306269,0.00526122655835022
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,40116,0.011695352698023,0.00420229312418703,0.00345885817461645,0.0199318472214296,0.00539366543458816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR4,Proline-rich protein 4,40198,-0.0201663057280723,0.00725074269557524,-0.0343777614113998,-0.00595485004474485,0.00542380410637827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0108706257626192,0.00391311956896825,0.00320091140744141,0.0185403401177969,0.00547713397472454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD55,Complement decay-accelerating factor,42201,0.00786575270003812,0.00283334397644098,0.00231239850621381,0.0134191068938624,0.00550875597864443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,40080,0.0120950317163856,0.00436004082411331,0.00354935170112348,0.0206407117316476,0.00554551170451916
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNG,Uracil-DNA glycosylase,40451,0.00981249190606479,0.00355592886274715,0.00284287133508038,0.0167821124770492,0.00579881391702844
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX9,Transcription factor SOX-9,40182,0.00797362693555817,0.00288977194060145,0.00230967393197933,0.013637579939137,0.00580286480389862
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA9,Carbonic anhydrase 9,42721,-0.0139076738238485,0.00504197785590241,-0.0237899504214173,-0.0040253972262798,0.00581672496225568
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00864997048392636,0.00313871319183769,0.00249809262792449,0.0148018483399282,0.00586278868785425
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP9,Fatty acid-binding protein 9,42594,0.0162382495983338,0.00590692741448167,0.00466067186594976,0.0278158273307179,0.00598541685625619
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0116911893182255,0.00425769308851547,-0.0200362677717158,-0.0033461108647352,0.00604443568006936
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.0100904258167941,0.00367997034429709,0.00287768394197175,0.0173031676916164,0.00611676997590744
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR5,Proline-rich protein 5,40199,0.0136604334160539,0.00498380581297422,0.00389217402262438,0.0234286928094833,0.00613580398692248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0186065688549216,0.00679591153909324,0.00528658223829889,0.0319265554715444,0.00619301588099217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO1,Alpha-enolase,42588,0.0223710991553979,0.00817168036808223,0.00635460563395674,0.0383875926768391,0.00619639245140802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QL2,Complement C1q-like protein 2,40199,0.0125622000212403,0.00459504083461029,0.00355591998540412,0.0215684800570765,0.00626966659080397
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0153940046040818,0.00563769364295896,-0.0264438841442813,-0.00434412506388219,0.00633299667341245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0112392446632572,0.0041170509048561,0.00316982488973929,0.0193086644367752,0.00634330597554532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKKL1,Dickkopf-like protein 1,42587,-0.0249331383328592,0.00914534655645278,-0.0428580175835067,-0.00700825908221177,0.00641282389344696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLNS1A,Methylosome subunit pICln,40182,0.00945194557420579,0.00348027306604592,0.00263061036475579,0.0162732807836558,0.00662065946184828
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,40223,0.0157610853383541,0.00580447548882165,0.00438431338026369,0.0271378572964446,0.00663121865212241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,42794,-0.00758031140530124,0.00279718649394438,-0.0130627969334322,-0.00209782587717025,0.00673721979196503
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,42636,0.00817692731917973,0.0030204778283316,0.00225679077564979,0.0140970638627097,0.00679465748294448
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,40483,0.00872741975328077,0.00322651073210317,0.00240345871835855,0.015051380788203,0.00684254808745884
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.020933041709085,0.00775676799303726,0.005729776442732,0.0361363069754381,0.00697019845691604
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,40182,-0.00818871032720139,0.00304032751262937,-0.014147752251955,-0.00222966840244784,0.00708422424400257
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G1B,Phospholipase A2,42782,-0.0126971468215979,0.00474200071580142,-0.0219914682245687,-0.00340282541862712,0.00742424279785777
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,40080,0.011636319681687,0.00434840970612484,0.00311343665768232,0.0201592027056917,0.00746194399117282
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL1,Follistatin-related protein 1,40223,-0.00630139381066451,0.00236111184324515,-0.010929173023425,-0.00167361459790402,0.00762285350979544
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKCQ,Protein kinase C theta type,42370,0.0121509160066434,0.00456059085460516,0.00321215793161724,0.0210896740816695,0.00772359185756652
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00900531292694264,0.00338369810523651,0.00237326464067908,0.0156373612132062,0.00779342794891152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0145095324396448,0.0054588011126377,0.00381028225887495,0.0252087826204147,0.00787167858627245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG3,Secretogranin-3,42638,-0.00941938020879342,0.00355191355240364,-0.0163811307715046,-0.00245762964608229,0.00801301153205104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRP15,RRP15-like protein,40136,-0.0254153136964575,0.00958477207927815,-0.0442014669718427,-0.00662916042107235,0.00802186228909106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFAP,Glial fibrillary acidic protein,42326,0.0134520186132851,0.00509263440937868,0.00347045517090286,0.0234335820556673,0.00826459697887313
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD3,Bromodomain-containing protein 3,40116,0.0136645361815215,0.00519069761538989,0.00349076885535728,0.0238383035076856,0.00848770986455832
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRXN3,Neurexin-3,40182,0.00975726555775543,0.00370975547549199,0.00248614482579114,0.0170283862897197,0.00854626569030843
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,42370,0.0180698748051023,0.00687121833106818,0.00460228687620863,0.0315374627339959,0.00855364136716278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.0159089779286169,0.00605205494155457,0.00404695024316998,0.0277710056140639,0.00858118776327629
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKAP12,A-kinase anchor protein 12,40283,-0.00601994808030089,0.00229613041083879,-0.0105203636855449,-0.00151953247505686,0.0087591430670945
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,40124,0.0269341382882346,0.0102891492699817,0.00676740571907048,0.0471008708573987,0.00886407287846756
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0167779283297734,0.00641412929004956,-0.0293496217382705,-0.00420623492127629,0.00891463502174385
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR1,Folate receptor alpha,42600,0.0082303542124979,0.00315899497507799,0.00203872406134504,0.0144219843636508,0.00918761869330688
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR4,Toll-like receptor 4,40199,0.00795509449947205,0.00305555659080135,0.0019662035815014,0.0139439854174427,0.00924052925393702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00628452059139902,0.00242222504740946,0.00153695949847648,0.0110320816843216,0.00948243034331833
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL25,Interleukin-25,40036,0.00945805071951722,0.00364816419942768,0.00230764888863896,0.0166084525503955,0.00953950104332833
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0110688787449598,0.00427829490250972,0.00268342073604076,0.0194543367538789,0.00968573179811402
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.0104885866084832,0.00405587003129791,-0.0184380918698271,-0.00253908134713935,0.00972177337333062
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,40199,-0.00593508072774593,0.00229523562463689,-0.0104337425520342,-0.00143641890345764,0.00972731487481371
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTO1,Protein LTO1 homolog,42370,0.0113268122639637,0.00438286214288643,0.00273640246390629,0.0199172220640211,0.00976717032023467
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMOD4,Tropomodulin-4,40080,-0.0111198020440422,0.00430458274762561,-0.0195567842293884,-0.00268281985869602,0.00980043039374464
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AREG,Amphiregulin,42587,0.0114232757034527,0.00442789262281953,0.00274460616272637,0.0201019452441789,0.00989502725300554
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00782141320863378,0.00303325126975161,0.00187624071992062,0.0137665856973469,0.00993424494792571
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS2,Thrombospondin-2,42611,0.0104010945880318,0.00403795725516344,0.0024866983679115,0.0183154908081522,0.0100105568615112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TG,Thyroglobulin,40451,-0.0308253429134635,0.0120041378976469,-0.0543534531928515,-0.00729723263407555,0.0102446563099937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN7,Septin-7,40302,0.014547685993755,0.00567508750400562,0.00342451448590403,0.025670857501606,0.0103774230678098
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0188853788726512,0.00736768977332543,0.00444470691693337,0.0333260508283691,0.0103819731942941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEF,Thyrotroph embryonic factor,40116,0.0115984219791255,0.00453422735589087,0.00271133636157939,0.0204855075966716,0.0105418630794736
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B4,Protein ATP1B4,40080,-0.0112766793465644,0.00441155404506609,-0.0199233252748939,-0.00263003341823488,0.0105966145132866
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM1,Myomesin-1,40136,0.0127735304279356,0.00502331493382202,0.00292783315764445,0.0226192276982268,0.0110089317504218
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.00657243308618993,0.00259574824292003,0.00148476653006668,0.0116600996423132,0.0113527490392302
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,42676,0.00575825940240851,0.00227651440032632,0.00129629117776892,0.0102202276270481,0.0114364443744963
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.00770230508641461,0.00304820364092858,0.00172782595019459,0.0136767842226346,0.0115209742082707
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,40199,-0.00772753167328302,0.00308353384903931,-0.0137712580174001,-0.00168380532916597,0.0122226830794233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBB,Inhibin beta B chain,40283,0.0142393161133902,0.00568203975995409,0.00310251818388023,0.0253761140429003,0.0122240121753568
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBH,Dopamine beta-hydroxylase,40515,0.0284939667262251,0.0114137671041402,0.00612298320211029,0.0508649502503398,0.0125582296621298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,42594,0.0119129334783176,0.00477237151436323,0.00255908531016569,0.0212667816464695,0.0125640639526117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4C,Semaphorin-4C,42587,-0.00719329894180761,0.00289334170324479,-0.0128642486801674,-0.00152234920344782,0.0129252283511703
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0159841177571741,0.0064304526977371,-0.0285878050447389,-0.00338043046960941,0.0129448362786732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00980968126244278,0.00395945395427142,-0.0175702110128148,-0.0020491515120708,0.0132443681765046
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0198794452597015,0.00804055005882699,0.00411996714440061,0.0356389233750024,0.0134335621879645
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDHB15,Protocadherin beta-15,40451,-0.0103738243378262,0.0041990584523162,-0.018603978904366,-0.00214366977128647,0.0135066835759899
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,42125,0.00863110894881926,0.00350649706194636,0.00175837470740438,0.0155038431902341,0.0138501687700383
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,42292,0.014401803385652,0.00585485151917531,0.0029262944080684,0.0258773123632356,0.0139140071176591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.0123032540960788,0.00500262469605796,-0.0221083985003524,-0.00249810969180525,0.0139338925174534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0129969676063279,0.0052859936455019,0.00263642006114417,0.0233575151515116,0.0139547638585588
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,40482,0.00924853071723465,0.00376187564122169,0.00187525446044014,0.0166218069740292,0.0139672028131892
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH3,Neurexophilin-3,40199,0.00787026758999351,0.00320441431429292,0.00158961553397939,0.0141509196460076,0.0140618981031443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.00968240965820768,0.00394395308911341,0.00195226160354541,0.01741255771287,0.0141010041924663
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELL,L-selectin,40539,0.00608265344304069,0.00248536992001237,0.00121132839981645,0.0109539784862649,0.0144048166665708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN8,Tetraspanin-8,40449,0.0261170091276266,0.0106724782342427,0.00519895178851091,0.0470350664667423,0.014414816605367
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0068623484539737,0.00281170264429448,-0.0123732856367909,-0.00135141127115653,0.014674161740545
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0311901184834943,0.012785015911443,0.00613148729706601,0.0562487496699227,0.0147173110202827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHB,Lutropin subunit beta,42346,0.0213550841099777,0.00877151267985592,0.00416291925746008,0.0385472489624953,0.0149216594172845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRLB,Fc receptor-like B,42346,0.0164406970132486,0.00676405585594518,0.00318314753559601,0.0296982464909011,0.0150872296149587
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00526280333536497,0.00216867833882761,-0.00951341287946709,-0.00101219379126285,0.0152515342138288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,40482,-0.0189395367141749,0.00780898148053502,-0.0342451404160235,-0.00363393301232623,0.0153090859430991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00659729804677073,0.00272392638718884,-0.0119361937656609,-0.0012584023278806,0.0154518017627134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3G,Semaphorin-3G,40283,0.0112770818900158,0.0046631039156942,0.00213739821525512,0.0204167655647764,0.0156064821158478
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMI,N-myc-interactor,40421,0.0181114212686167,0.00749400856583456,0.00342316447958093,0.0327996780576524,0.0156740223489334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0135126817485996,0.00559582156917203,0.00254487147302239,0.0244804920241768,0.0157605248627937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6,Interleukin-6,42587,0.0191440198012521,0.00799708000751661,0.00346974298651954,0.0348182966159846,0.0166850449872588
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0214235049844452,0.00902647955806733,0.00373160505063324,0.0391154049182572,0.0176388751392244
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0171590687070169,0.00730691909413965,0.00283750728250318,0.0314806301315306,0.0188719678226925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON1,Spondin-1,42638,0.00826447133007193,0.00352361839734888,0.00135817927126813,0.0151707633888757,0.0190185757607016
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,42711,0.00733736227107441,0.00313273583136295,0.00119720004160302,0.0134775245005458,0.019187031901534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTR,Methionine synthase,40116,0.0160644442627469,0.00692712880606997,0.00248727180284971,0.029641616722644,0.0204100080782596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTTG1,Securin,40302,0.00989752636977128,0.00427262892779667,0.00152317367128981,0.0182718790682527,0.0205493247904865
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB118,Beta-defensin 118,40136,0.0137633538005486,0.00595106370834676,0.00209926893218899,0.0254274386689083,0.0207545576289894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG3,Proteoglycan 3,40527,-0.0119963346338933,0.00519273522841882,-0.0221740956815942,-0.00181857358619243,0.0208941290390068
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK1,Kallikrein-1,42505,-0.0311337176723397,0.0134956316046699,-0.0575851556174928,-0.0046822797271866,0.0210730041277952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0154120068237759,0.00668247000196407,0.00231436561992633,0.0285096480276255,0.0211100073242959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.0083512234694372,0.00362117977755646,0.00125371110542654,0.0154487358334479,0.0211136902398468
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.02074633657241,0.00903328260405963,0.00304110266845316,0.0384515704763669,0.0216573365565502
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,40302,0.0130608966148392,0.0056881016810717,0.00191221731993867,0.0242095759097397,0.0216842078456409
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRV1,Acrosomal protein SP-10,40199,0.0191749227928889,0.00835920300537799,0.00279088490234802,0.0355589606834297,0.0218167331908347
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.00947363077696212,0.00413136842470033,-0.0175711128893748,-0.00137614866454948,0.0218611163000591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0221035831547391,0.00964136950105614,0.0032064989326691,0.0410006673768092,0.0218913462015226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0201009097041665,0.00877362532895909,0.0029046040594067,0.0372972153489263,0.0219787325075866
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPTC,Opticin,42587,-0.0110296175746206,0.00481946053478026,-0.0204757602227899,-0.00158347492645123,0.0221205143081146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0147537824207516,0.00645269678859761,0.00210649671510032,0.027401068126403,0.0222468368382809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,40302,0.0128780819372373,0.00566376973708098,0.00177709325255855,0.023979070621916,0.0229991104934725
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFD,Complement factor D,40539,0.00495400603286133,0.00218408194083719,0.000673205428820441,0.00923480663690222,0.0233337410806109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRAXIN,Draxin,42495,0.0103561525407519,0.0045663297305871,0.0014061462688012,0.0193061588127026,0.0233489536900505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLON5,IgLON family member 5,40080,-0.0223366480686956,0.00988911157938166,-0.0417193067642837,-0.00295398937310756,0.0239210526078237
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP350,Centrosome-associated protein 350,40080,0.00895517174684433,0.00396691661571673,0.00118001518003955,0.0167303283136491,0.0239988217859859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR1,Toll-like receptor 1,40199,0.00629484898209808,0.00279173772604622,0.000823043039047481,0.0117666549251487,0.0241645855498198
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GL3,Endophilin-A3,40250,0.0199902686955629,0.00890216385254638,0.00254202754457197,0.0374385098465538,0.0247524151703404
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1B,Protein phosphatase 1B,40199,0.0142801282018804,0.00636179878736432,0.00181100257864633,0.0267492538251145,0.024809217371343
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1,Methionine aminopeptidase 1,42311,0.00680242248952603,0.00303885908229807,0.000846258688221809,0.0127585862908303,0.0252065367210845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0127801878574245,0.00571121112679586,0.00158621404890466,0.0239741616659444,0.0252592271262532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,40302,-0.0100967003371618,0.00453007319772165,-0.0189756438046962,-0.00121775686962736,0.0258460672793802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.0160756400764886,0.00721764882578477,0.00192904837795044,0.0302222317750267,0.0259458964697377
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00835610940561127,0.00375865184455761,0.00098915179027835,0.0157230670209442,0.026221493787021
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.0115408540066229,0.00520706988752811,-0.021746710986178,-0.00133499702706782,0.026685780844536
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0223149132339696,0.0100720548754824,0.00257368567802404,0.0420561407899151,0.0267438212336651
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBR1,T-box brain protein 1,40182,0.0111229076388121,0.00506405523374679,0.00119735938066839,0.0210484558969558,0.0280810802215696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,40199,0.023240353949045,0.0105943585787668,0.00247541113466214,0.0440052967634279,0.0282811542723841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR1,Cadherin-related family member 1,42311,0.00972662857468914,0.00445380659724747,0.000997167644084097,0.0184560895052942,0.0289879028839041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00642671705411389,0.00294560868476966,0.000653324031965358,0.0122001100762624,0.0291418051438537
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5A,Cytochrome b5,40080,0.0166218089434499,0.00762722515282458,0.00167244764391368,0.031571170242986,0.0293327279113011
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXDNL,Peroxidasin-like protein,40451,-0.0126484483266298,0.00581016682846975,-0.0240363753104305,-0.0012605213428291,0.0295049320082848
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00932048145414458,0.00428460259168414,0.000922660374443671,0.0177183025338455,0.0296256146855641
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOH,Beta-2-glycoprotein 1,42611,-0.00824234528597236,0.00378923659272833,-0.0156692490077199,-0.000815441564224824,0.0296325764349287
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC1,Sialoadhesin,42676,0.00968608215649949,0.00448985542954424,0.00088596551459277,0.0184861987984062,0.0309978796015655
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,42711,-0.0285578739847587,0.0132517395085608,-0.0545312834215379,-0.0025844645479795,0.03117722204114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0161572392566312,0.00751704027719175,0.00142384031333535,0.030890638199927,0.0316227063169338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,42676,0.00647029980505098,0.00301076980940232,0.000569190978622438,0.0123714086314795,0.0316480539613174
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0168265331724749,0.00786733556522274,0.00140655546463829,0.0322465108803114,0.0324745444332283
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00605130275569051,0.00283335227005522,0.000497932306382274,0.0116046732049987,0.0327220968204056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,40116,0.0159448515466529,0.00747361992132873,0.00129655650084854,0.0305931465924572,0.0329072289427558
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2,T-cell surface antigen CD2,40116,0.00857132970123066,0.00402138084129965,0.000689423252283345,0.016453236150178,0.0330752171014729
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0143065195345322,0.00671567834112092,0.00114378998593518,0.0274692490831292,0.0331676168071402
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL1,Interferon lambda-1,42311,0.0101457725611099,0.004765692595485,0.000805015073959315,0.0194865300482605,0.0332795554951367
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0156796106666822,0.00737483509953097,0.0012249338716015,0.0301342874617629,0.0335172215304913
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF2,Trefoil factor 2,42654,0.0128509072662597,0.00605222036043666,0.000988555359803854,0.0247132591727156,0.0337437618124318
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00586404856981265,0.00276325584681914,0.000448067110047145,0.0112800300295782,0.0338475482413743
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1,DNA topoisomerase 1,40449,0.0247541077605167,0.0116955238041048,0.00183088110447131,0.047677334416562,0.0343203304665732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00863115855761621,0.00408844385103882,-0.0166445085056523,-0.000617808609580132,0.0347854378981986
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPN,Asporin,40511,0.00618240862361748,0.00292888704630693,0.000441790012855908,0.0119230272343791,0.0348080389048716
NMR metabolomics,X23495.Concentration of Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00876606534363837,0.00417076398869939,0.00059136792578757,0.0169407627614892,0.0355943952382816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00634303867284844,0.00302186130688498,-0.012265886834343,-0.000420190511353875,0.0358312734093403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00832933304612431,0.00397665473600127,0.000535089763561828,0.0161235763286868,0.0362329208763681
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPS,Calcyphosin,40483,0.0225685268982042,0.0107938978274662,0.00141248715637043,0.0437245666400379,0.0365629391178516
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,40449,0.00658975244379684,0.00316380929342078,0.000388686228692125,0.0127908186589016,0.0372870655169942
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKLR,Pyruvate kinase PKLR,42636,0.0141105531050022,0.00677748465552494,0.000826683180173322,0.0273944230298311,0.0373636299677938
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH23,Cadherin-23,40483,-0.00566778678736882,0.00272277995734001,-0.0110044355037552,-0.000331138070982393,0.0373998842637571
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.0108435505908505,0.00521255551088095,0.000626941789523817,0.0210601593921771,0.0375235007014957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.013767969648458,0.00662910670040295,-0.0267610187812478,-0.000774920515668255,0.0378340972068307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0324355674372784,0.0156945111232188,0.0016743256357696,0.0631968092387871,0.0387832703029225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00817892603782416,0.003960814013313,0.00041573057173068,0.0159421215039176,0.0389494807220595
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK14,Kallikrein-14,42721,-0.0100850004543071,0.00490538576237541,-0.0196995565485629,-0.000470444360051265,0.0398109522900298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00748841714379832,0.00365127905603492,-0.0146449240936268,-0.00033191019396988,0.0402962015889597
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,42370,0.00857697631883566,0.00418458758201503,0.000375184658086199,0.0167787679795851,0.0404175015864039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP6,Guanylate-binding protein 6,40116,-0.00985700651393721,0.00481631104809943,-0.0192969761682121,-0.000417036859662321,0.0407223971625173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,40451,0.0116868664349925,0.00573178709801028,0.000452563722892338,0.0229211691470926,0.041477647376154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0104526025982986,0.00512970701217149,-0.0205068283421548,-0.000398376854442516,0.0416033757203895
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0108353217521768,0.00532324075887999,-0.0212688736395816,-0.000401769864772018,0.0418265106002278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36G,Interleukin-36 gamma,40154,0.0145967186323168,0.00717756513469006,0.000528690968324272,0.0286647462963093,0.0420100453304507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_DRA,,42549,-0.00781096236388543,0.00384334999098874,-0.0153439283462234,-0.000277996381547495,0.0421398252264541
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT1,Diamine acetyltransferase 1,40116,-0.0108590020433086,0.00536424419261215,-0.0213729206608284,-0.000345083425788812,0.0429604679648291
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRC,Chymotrypsin-C,42626,0.0139083368325237,0.00688056492703593,0.000422429575533274,0.0273942440895141,0.043258725774194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0185565108314352,0.00918484877589035,0.000554207230690097,0.0365588144321803,0.0433725671432292
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRING1,SREBP regulating gene protein,40080,0.0124656321769111,0.00617428600062039,0.000364031615695167,0.0245672327381271,0.0435159153580206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0106497392635221,0.0052757661874747,0.000309237536071654,0.0209902409909725,0.043547535920004
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX2,Transcription factor SOX-2,40461,0.00497750459003622,0.00249510244709508,8.71037937298664e-05,0.00986790538634257,0.0460767526666927
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,40451,0.0129699839393046,0.00652245719207847,0.000185967842830769,0.0257540000357784,0.0467792741847232
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPN1,Epsin-1,40302,0.00923293123292051,0.00464327001035438,0.000132122012625928,0.0183337404532151,0.0467859428416902
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,42438,-0.00786602299223687,0.00396575703441926,-0.0156389067796986,-9.3139204775116e-05,0.0473338019003361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.0106522267674204,0.00537463066135836,0.000117950671158039,0.0211865028636828,0.0475104136594606
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.0106187241603065,0.00536161219742387,-0.0211274840672573,-0.00010996425335575,0.0476713055559374
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MB,Myoglobin,42794,-0.0109253340909869,0.00552021669935272,-0.0217449588217182,-0.000105709360255557,0.0478193128642785
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP73,Tumor protein p73,40182,0.0071391297728883,0.00360843465415066,6.65978507530095e-05,0.0142116616950236,0.0479022032712247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0077712438504035,0.00394590583619304,-0.0155052192893418,-3.7268411465145e-05,0.0489225997008637
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY6D,Lymphocyte antigen 6D,42548,0.0083341327120019,0.00424385529299454,1.61763377325933e-05,0.0166520890862712,0.049572646060369
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0066312862131594,0.00339045727308439,-0.0132765824684048,1.40100420859988e-05,0.0505058017113664
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00645879347790777,0.00330910025071795,-0.012944629969315,2.70430134994134e-05,0.0509840338640668
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUOX2,Dual oxidase 2,42357,0.0145092949175562,0.00743883993540701,-7.08313558415614e-05,0.0290894211909539,0.0511403462965148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM3,Paralemmin-3,40116,0.014549520306867,0.00746892939136441,-8.95813002072896e-05,0.0291886219139412,0.0514398104186156
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.0111337124358235,0.00572963410463163,-0.0223637952809015,9.6370409254521e-05,0.0520199821502471
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.0102013556866367,0.00525430685225549,-9.70857437840346e-05,0.0204997971170575,0.0522163028426665
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,42594,0.00983609855270713,0.0050749781326423,-0.000110858587271783,0.019783055692686,0.0526251889815749
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0201770495583507,0.0104337891389534,-0.0406272762706993,0.000273177153998008,0.0531613098202413
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00375463817886429,0.00195146312725066,-7.0229550546998e-05,0.00757950590827558,0.054378085708012
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,40482,0.0068503832535405,0.00357126504766058,-0.000149296239874235,0.0138500627469552,0.0551114710375329
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM19,Probable RNA-binding protein 19,40116,-0.00965091074868052,0.00504054074632615,-0.0195303706114798,0.000228549114118735,0.0555622523373501
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0135371785748108,0.00708295052146383,-0.0274197615968799,0.000345404447258316,0.0559957977496686
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00682182986953051,0.00357387617444609,-0.0138266271714448,0.000182967432383832,0.0563088862709454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0117570463504863,0.00618023645817364,-0.000356217107534041,0.0238703098085066,0.0571501358251916
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.0054183996707941,0.00286458529005404,-0.000196187497711812,0.0110329868393,0.058577336050949
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP7,Retinoid-binding protein 7,40449,0.0118124329285492,0.0062530261206928,-0.000443498268008682,0.0240683641251071,0.0589075150838609
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTNNA1,Catenin alpha-1,40136,-0.00693067039565121,0.00367134624973706,-0.0141265090451358,0.000265168253833436,0.0590827926607092
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00668086822175142,0.00355121261719025,-0.0136412449514443,0.00027950850794148,0.0599587231594223
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOP56,Nucleolar protein 56,40116,0.0219319217195118,0.0116818997729052,-0.000964601835382398,0.0448284452744059,0.0604861329573409
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALB,Ras-related protein Ral-B,40199,0.00585691134749462,0.00312597303150425,-0.000269995794253713,0.011983818489243,0.061008162685098
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00779806319570589,0.00416277682855752,-0.000360979388266848,0.0159571057796786,0.0610549972533081
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00724576352301522,0.00387747319865174,-0.000354083946342178,0.0148456109923726,0.0616934000257529
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00940750727955031,0.00505076859270504,-0.000491999162151563,0.0193070137212522,0.0625423391986561
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI16,Peptidase inhibitor 16,40532,-0.00486361499780202,0.00261426668382613,-0.00998757769810123,0.000260347702497196,0.0628530280817275
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDN1,Endothelin-1,40223,0.0058840656033878,0.00317249867924201,-0.000334031807926534,0.0121021630147021,0.063664294347224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0222570278171029,0.0120166001381011,-0.00129550845357533,0.0458095640877811,0.064024619675266
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.0112003142245668,0.00605788111972223,-0.000673132770088816,0.0230737612192223,0.0645016467564736
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL5,Fc receptor-like protein 5,42611,-0.0113343102018214,0.00613451818415745,-0.02335796584277,0.000689345439127161,0.0646781112292398
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0569238430043266,0.0308295480280779,-0.003502071130706,0.117349757139359,0.0648553665944334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,40116,-0.0148473167099162,0.00804360656072239,-0.0306127855689321,0.000918152149099663,0.0649405719281097
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGN,Secretagogin,42370,-0.00868041898995552,0.004708254200087,-0.017908597222126,0.000547759242214993,0.065255176354943
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00578137664032089,0.00314112900973853,-0.00037523621876662,0.0119379894994084,0.0657109987079718
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,0.00575053303270366,0.00312675121024152,-0.000377899339369712,0.011878965404777,0.065916689592571
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,40199,0.0122909916707541,0.00669212324831891,-0.000825569895950987,0.0254075532374592,0.0662906656086102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RA,Interleukin-17 receptor A,42611,0.0084027542388229,0.0045769657882134,-0.000568098706075361,0.0173736071837212,0.0663977073314541
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,40080,0.0167500206828301,0.00919043160192619,-0.00126322525694523,0.0347632666226054,0.0683990006539771
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0141689419676957,0.00777637169887409,-0.0294106304974889,0.00107274656209754,0.0684746576460184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCL2,Phosducin-like protein 2,40080,0.0100850294334803,0.00553643301203566,-0.000766379270109561,0.0209364381370702,0.0685468874556192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,40199,0.0237936650513372,0.0130739632817311,-0.00183130298085574,0.0494186330835302,0.0687972025605466
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.00798314900899418,0.00439531241083837,-0.000631663316249016,0.0165979613342374,0.0693485493716359
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.0126269879363118,0.00695929721319445,-0.00101323460154932,0.0262672104741729,0.0696381362673443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX101,Testis-expressed protein 101,40182,0.00998779590571977,0.00552306885044917,-0.000837419041160609,0.0208130108526001,0.0705750244324755
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,42370,0.0104846794063253,0.00579920388775424,-0.000881760213673028,0.0218511190263236,0.0706368409408802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC2,Mucin-2,40527,0.0175214695024303,0.00969150703925211,-0.00147388429450382,0.0365168232993645,0.0706454505652876
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANPEP,Aminopeptidase N,42666,-0.00520873433060636,0.00288520723033905,-0.0108637405020709,0.000446271840858173,0.0710462861428501
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA4,Apolipoprotein A-IV,40539,0.00676284922531675,0.00375830192846339,-0.000603422554471498,0.014129121005105,0.0719752311680384
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA3,Carbonic anhydrase 3,42770,0.0111461145629412,0.00619491577728021,-0.000995920360527982,0.0232881494864104,0.072003579029553
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00715164866559593,0.0039757650295012,-0.000640850792226422,0.0149441481234183,0.0720716097112602
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB5,Integrin beta-5,42679,-0.00694468804177944,0.00386882442331854,-0.0145275839114838,0.000638207827924893,0.0726699818829553
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MELTF,Melanotransferrin,40511,0.00563302745181255,0.00314581260663052,-0.000532765257183265,0.0117988201608084,0.0733773138739854
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0225276991433145,0.0125988880914725,-0.00216612151597157,0.0472215198026007,0.0737923079500614
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRC1,Macrophage mannose receptor 1,40532,0.00542115482442945,0.00304068608682287,-0.000538589905743376,0.0113808995546023,0.074633848999326
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNN,Tenascin-N,40527,0.00818986697876947,0.00459390573041734,-0.000814188252848513,0.0171939222103875,0.0746508771677671
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,40235,-0.00643595538063122,0.00362576611493259,-0.0135424569658991,0.000670546204636662,0.0759153889851168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,42754,-0.00469175152401262,0.00265600688741954,-0.00989752502335492,0.000514021975329686,0.0773398381877442
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,40182,0.00665440843902254,0.00377869081975582,-0.000751825567698867,0.0140606424457439,0.0782602165218721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP10,Bone morphogenetic protein 10,40283,-0.00526014447216438,0.00299550191294263,-0.0111313282215319,0.000611039277203166,0.0791135547118385
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.00777068385781145,0.00442802481483062,-0.000908244779256569,0.0164496124948795,0.0793012223040498
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARTN,Artemin,42370,0.0081634719818319,0.00465525307773612,-0.000960824050530888,0.0172877680141947,0.079521577117225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00950253170560623,0.0054305344794997,-0.0201463792854256,0.00114131587421318,0.0801752439655522
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAN,Aggrecan core protein,42488,0.00504417118846944,0.00288702476220317,-0.000614397345448785,0.0107027397223877,0.0806280529277688
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0120667417666319,0.00694791924534341,-0.00155117995424117,0.025684663487505,0.082456484011879
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP8,Neutrophil collagenase,42681,0.0131494363864689,0.00759149925740332,-0.00172990215804165,0.0280287749309794,0.083273920200332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM25,RNA-binding protein 25,40080,-0.00857976277958584,0.00495375812602141,-0.0182891287065878,0.00112960314741613,0.083307147700045
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,42600,-0.00318329574518585,0.00184455656713382,-0.00679862661676814,0.000432035126396434,0.0844103431038841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MBL2,Mannose-binding protein C,40379,-0.0195631042738659,0.0113413451646005,-0.041792140796483,0.00266593224875113,0.0845664772667507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0163378451717546,0.00948272878282458,-0.00224830324258154,0.0349239935860908,0.0849338772492852
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO6,Unconventional myosin-VI,40482,0.00650907898442461,0.00378977661007569,-0.00091888317132374,0.013937041140173,0.0859086512535092
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS53,Serine protease 53,40483,0.00666365851082519,0.00388969672134021,-0.000960147063001624,0.014287464084652,0.0867112422521323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00493082190675234,0.00288349947979749,-0.000720837073650744,0.0105824808871554,0.0872870159078059
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD7,FERM domain-containing protein 7,40182,0.00597129710169969,0.00349360152061785,-0.000876161878711296,0.0128187560821107,0.0874403768107802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBLN2,Fibulin-2,40527,-0.0057844014562632,0.00340464116927192,-0.0124574981480362,0.000888695235509769,0.0893512725254752
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH7B,Myosin-7B,40080,-0.00789749633146008,0.00468107157691145,-0.0170723966222065,0.00127740395928636,0.0916102914711098
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00855927024337118,0.00507739952811472,-0.018510973318476,0.00139243283173368,0.0918708565229764
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00569281315483661,0.00338704259722296,-0.000945790335720399,0.0123314166453936,0.0928367812338191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.00587552346589164,0.00349596538865612,-0.000976568695874346,0.0127276156276576,0.092857609819914
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,40116,-0.0087491065526736,0.0052147859459427,-0.0189700870067213,0.00147187390137409,0.0934245469828353
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",40116,0.0108406702905436,0.00646590845069557,-0.00183251027281976,0.0235138508539069,0.0936515186157329
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,42311,-0.00601505507739743,0.00359276992159559,-0.0130568841237248,0.00102677396892993,0.0941129706092167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00656569075271638,0.0039308391475149,-0.00113875397641282,0.0142701354818456,0.0948877358380553
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJP3,Tight junction protein ZO-3,40136,-0.00733266843858725,0.00439205310212816,-0.0159410925187584,0.00127575564158394,0.0950408140013338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTOA,Otoancorin,40136,-0.0094900422482284,0.00570399557017008,-0.0206698735657618,0.00168978906930497,0.0961903478903572
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00564763235527888,0.00340038699467701,-0.00101712615428806,0.0123123908648458,0.0967663941883511
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCG22,Protein PBMUCL2,40116,-0.00987388518565249,0.00595099692150451,-0.0215378391518013,0.00179006878049636,0.097104510302386
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.00546205389706818,0.00331517875578496,-0.00103569646427035,0.0119598042584067,0.0994603832104056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA1,Laminin subunit alpha-1,40116,-0.00927180041788173,0.00562892621431975,-0.0203044957979484,0.00176089496218497,0.0995518017028476
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL19,Interleukin-19,42261,0.012366899801697,0.00751712122082669,-0.00236665779112329,0.0271004573945173,0.0999599768021065
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH17,Cadherin-17,42636,-0.0118802331874435,0.00722722964826527,-0.0260456032980435,0.00228513692315639,0.100237674189761
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.00616832737846408,0.00376538063296079,-0.00121181866213906,0.0135484734190672,0.101410457470606
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHPK,Sedoheptulokinase,40302,-0.00700852839746243,0.00428471888557853,-0.0154065774131964,0.00138952061827149,0.101930051449131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,40283,0.00900144436595433,0.00553506363529438,-0.00184728035922265,0.0198501690911313,0.103923087725012
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00723706479366391,0.00446879186933663,-0.00152176727023588,0.0159958968575637,0.105375334900668
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00778327919640836,0.00481053366397777,-0.0172119251778048,0.00164536678498806,0.105698659749803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0125573802205041,0.00776332055994192,-0.00265872807698209,0.0277734885179903,0.105792452804058
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00609541798677724,0.0037866290062099,-0.00132637486539417,0.0135172108389487,0.107487402998638
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0105927600662778,0.00664292346916986,-0.00242736993329513,0.0236128900658507,0.110831325226422
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX1B,Syntaxin-1B,40182,0.00674290493378678,0.00423474204451395,-0.00155718947346056,0.0150429993410341,0.111350046111047
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3D,Protein FAM3D,40449,0.0142291751699473,0.00893670561022876,-0.00328676782610106,0.0317451181659957,0.111364022978492
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OBP2B,Odorant-binding protein 2b,42462,-0.0101607079115265,0.00639563222902428,-0.022696147080414,0.00237473125736113,0.11215313190038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.00999029081451878,0.00629243694013335,-0.00234288558814259,0.0223234672171802,0.112385398595256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,40136,0.0139239448338893,0.00877458074660188,-0.00327423342945035,0.031122123097229,0.11257548099602
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF3,Neurotrophin-3,42594,0.00592024297682927,0.00373322013634188,-0.00139686849040082,0.0132373544440593,0.112802052636291
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,42346,0.00535046804758915,0.00338229094265411,-0.0012788222000129,0.0119797582951912,0.11369496121755
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5,Interleukin-5,42370,0.0228265550122715,0.0145161700915093,-0.00562513836708677,0.0512782483916297,0.115860604719248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00978449493197073,0.006229858542994,-0.00242602781229751,0.021995017676239,0.116304136197047
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.0126963869985003,0.00811027486675872,-0.00319975174034683,0.0285925257373474,0.117501957329074
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00794426813165678,0.00507654754438114,-0.0178943013186438,0.00200576505533025,0.117636305530115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00671450676336237,0.00430029748695664,-0.00171407631107266,0.0151430898377974,0.118451614034735
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00986283316927156,0.00632094723828274,-0.00252622341776261,0.0222518897563057,0.118708238177256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.0070256611447001,0.00452140260351325,-0.0158876102475861,0.00183628795818588,0.120244968699803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00600696883239489,0.00386674053093467,-0.00157184260823705,0.0135857802730268,0.120333199061702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0184248481724644,0.0118657172017477,-0.00483195754296109,0.04168165388789,0.120499723636063
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB5,Serpin B5,42357,0.00777917874064148,0.00506381535532338,-0.00214589935579235,0.0177042568370753,0.12450632196262
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00378786569085342,0.00247487542558264,-0.0086386215249954,0.00106289014328855,0.125914154680488
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAPPA,Pappalysin-1,42370,0.00744048243220093,0.00486522958260145,-0.00209536754969791,0.0169763324140998,0.126209672938848
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.00725300593263301,0.0047431180102367,-0.00204350536743092,0.0165495172326969,0.126252234683771
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,42311,0.00641556564720012,0.00420591196707589,-0.00182802180826862,0.0146591531026689,0.127191319319812
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00643690976703504,0.00422731899107408,-0.00184863545547017,0.0147224549895402,0.127863952872154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBN,Ameloblastin,42370,-0.00453531361375553,0.00298321341447907,-0.0103824119061345,0.00131178467862344,0.12846512527548
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",42357,-0.00691121929584347,0.00457252018556669,-0.0158733588595542,0.00205092026786724,0.130693185648657
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,40136,0.0153786389194454,0.0101776739945515,-0.00456960210987547,0.0353268799487662,0.13081298444713
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00944699808069436,0.00626023672720217,-0.0217170620660106,0.00282306590462189,0.131315427603165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,40199,0.0115790095389739,0.0076777253167776,-0.00346933208191024,0.026627351159858,0.131549908942413
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF9,Fibroblast growth factor 9,40065,0.00647801384414476,0.00429993083635265,-0.00194985059510643,0.0149058782833959,0.131957898856896
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.0100423135033906,0.00668042361597278,-0.00305131678391607,0.0231359437906972,0.132804881324653
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNPO1,Transportin-1,40302,0.00554353246483627,0.00369677673037811,-0.00170214992670483,0.0127892148563774,0.133757259013118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAG,Myelin-associated glycoprotein,40182,0.00764889439087286,0.00512086589053359,-0.00238800275457297,0.0176857915363187,0.135290063722723
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR2,Toll-like receptor 2,40302,0.00363997220703581,0.00244295960633367,-0.00114822862137818,0.0084281730354498,0.136256676002668
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,42315,0.00450623225236718,0.00302824134882198,-0.00142912079132391,0.0104415852960583,0.136756714027497
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.0041972688721021,0.00283615732414155,-0.00136159948321534,0.00975613722741954,0.138923988707342
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0119993467442743,0.00813413994144977,-0.00394356754096728,0.0279422610295158,0.14019206407819
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,40136,0.0172329519819058,0.0116924104191739,-0.00568417243967513,0.0401500764034867,0.140548610486363
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0119058298839108,0.00808809038739332,-0.00394682727538014,0.0277584870432017,0.141039415347505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACHE,Acetylcholinesterase,40283,0.00509666300346916,0.00346522269764494,-0.00169517348391492,0.0118884994908532,0.141372535846101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,40451,0.00679672677803111,0.00464190324314519,-0.00230140357853346,0.0158948571345957,0.143164171488942
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.00928806401900367,0.00638459640592179,-0.0218018729746104,0.00322574493660304,0.145759273193591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NINJ1,Ninjurin-1,42346,0.0081748032393132,0.00562050867416269,-0.00284139376204567,0.0191910002406721,0.145842768428475
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00413779117975719,0.00285090533216124,-0.00144998327127884,0.00972556563079323,0.146692826843643
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00677516114377926,0.00468170247522134,-0.00240097570765456,0.0159512979952131,0.147876589336812
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL9,Interleukin-9,40302,0.00848436129419584,0.00586803998665567,-0.00301699707964927,0.0199857196680409,0.148244829201751
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL21R,Interleukin-21 receptor,40199,0.00843489037443607,0.00583630779257207,-0.00300427289900517,0.0198740536478773,0.148417760011871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17C,Interleukin-17C,42370,-0.0111884654592569,0.0077770194390588,-0.0264314235598122,0.00405449264129834,0.150271407553375
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00625182451089291,0.00435430219417405,-0.014786256811474,0.00228260778968823,0.151088000301261
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",40116,-0.00596520271531043,0.00415883452830098,-0.0141165183907803,0.00218611296015949,0.151502519134487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.00600112270700701,0.00418678670399724,-0.00220497923282757,0.0142072246468416,0.151786082573709
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL33,Interleukin-33,42370,0.00578245101126164,0.00403567773004725,-0.00212747733963097,0.0136923793621543,0.15192937946233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00951214637012857,0.006639688328475,-0.00350164275368242,0.0225259354939396,0.151994772607889
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.00491115630734527,0.00343778410550935,-0.0116492131541436,0.00182690053945307,0.153147661358609
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0210883351562571,0.0148067913719286,-0.0501096462452372,0.00793297593272306,0.15440628958486
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00718829452225244,0.00505314902156021,-0.0170924666045104,0.00271587756000556,0.154898800450715
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLNL,Mesothelin-like protein,40182,-0.00583040633885142,0.00410875452400948,-0.01388356520591,0.00222275252820716,0.155921443934448
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAV,Integrin alpha-V,42721,-0.00241786002382318,0.00170430974202111,-0.00575830711818457,0.0009225870705382,0.156017101643294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00793065419234427,0.00559416035792694,-0.00303390010919252,0.0188952084938811,0.156316606201617
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.00590776529993082,0.00417398361183972,-0.0140887731791367,0.00227324257927503,0.156986157764812
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITM2A,Integral membrane protein 2A,42594,-0.00908738687771611,0.00642286414151363,-0.0216762005950828,0.00350142683965061,0.157135829237684
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.00602004999382473,0.00427796031302102,-0.0144048522073459,0.00236475221969647,0.159383844547295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A3,Protein S100-A3,40451,0.00637707631720475,0.00453696101870058,-0.00251536727944838,0.0152695199138579,0.159875517125534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMCH,Pro-MCH,40116,-0.0124196352260295,0.00884704689103004,-0.0297598471324484,0.00492057668038933,0.16040176874457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYMP,Thymidine phosphorylase,42563,0.00945576187304321,0.00674677049330066,-0.00376790829382609,0.0226794320399125,0.161080601247862
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,40532,0.00385391896243528,0.00275191129446072,-0.00153982717470773,0.00924766509957829,0.1614054503434
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,42346,0.0107795266228025,0.0077007280919315,-0.00431390043738326,0.0258729536829882,0.161594959390855
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0108512616279792,0.00776364195417884,-0.0260679998581697,0.00436547660221131,0.162230763665678
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TUBB3,Tubulin beta-3 chain,40136,-0.00409460474618057,0.0029364063256546,-0.00984996114446358,0.00166075165210243,0.163216960091454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00729879812237343,0.00523518035367409,-0.0175597516155747,0.0029621553708278,0.163290349825072
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP1,Retinol-binding protein 1,40182,0.0099274233907786,0.00713335791150427,-0.00405395811576976,0.023908804897327,0.164044440462208
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00566186528460799,0.0040901385857287,-0.0136785369126362,0.00235480634342025,0.166303393978192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00542018434114584,0.00392809609893001,-0.00227888401275698,0.0131192526950487,0.167659969646038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO6,Coronin-6,40136,-0.00533223963483094,0.00388433452522549,-0.0129455353042729,0.00228105603461103,0.169856658688377
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB7,Integrin beta-7,42721,0.00657602894464464,0.00479445614908916,-0.00282110510757011,0.0159731629968594,0.170213803601825
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00384256757044082,0.00280713392510747,-0.00165941492276983,0.00934455006365147,0.171071928546721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBN2,Fibrillin-2,40182,0.00869439576037731,0.00635601748932601,-0.00376339851870168,0.0211521900394563,0.17137138100915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00569152103834466,0.00416825683093404,-0.00247826235028605,0.0138613044269754,0.172141512488335
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS2,Podocin,40199,-0.0149510355742196,0.0109559424555744,-0.0364246827871455,0.00652261163870632,0.172390733274781
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,40116,-0.0049403619448749,0.00362428368299801,-0.012043957963551,0.00216323407380119,0.172870327447157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,42721,0.00839207297586165,0.0061788347178988,-0.00371844307121999,0.0205025890229433,0.174423926333606
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGB,Secretogranin-1,42664,-0.00607154836277885,0.00447363347043988,-0.014839869964841,0.00269677323928332,0.174745166770803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN7,Tetraspanin-7,40136,-0.0132467344526351,0.0098393831796511,-0.0325319254847512,0.00603845657948108,0.178234563033183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00918143306691467,0.00683275909402113,-0.00421077475736676,0.0225736408911961,0.179056603183815
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,42721,-0.0081720122157865,0.0060849988529017,-0.0200986099674738,0.00375458553590084,0.179302022518697
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,42587,0.00633509351829223,0.00473537865694299,-0.00294624864931603,0.0156164356859005,0.180977199362009
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF1,Trefoil factor 1,42556,0.0115366582966161,0.0086301623739628,-0.00537845995635096,0.0284517765495832,0.181316089690722
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDNRB,Endothelin receptor type B,40199,0.00621521946149878,0.00465025780952506,-0.00289928584517033,0.0153297247681679,0.181403002701304
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,40482,0.00501327348129329,0.0037551879178513,-0.00234689483769526,0.0123734418002818,0.181894762240115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31,Interleukin-31,40199,0.00783312875606209,0.0058779517831084,-0.00368765673883036,0.0193539142509545,0.182681188079749
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,42754,0.00838005822067228,0.0063253765940717,-0.00401767990370825,0.0207777963450528,0.185249366378888
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHH,Sonic hedgehog protein,40199,-0.00583239472548422,0.00440596709054409,-0.0144680902229506,0.00280330077198219,0.185613900501328
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00650893860154182,0.0049222853029225,-0.00313874059218627,0.0161566177952699,0.18608217903881
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00657812691866553,0.00497494686068279,-0.0163290227656038,0.00317276892827273,0.186112467105604
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.00572291023337201,0.00433614455197616,-0.0142217535552453,0.00277593308850126,0.186919345082275
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100G,Protein S100-G,40482,-0.00662315302669159,0.00502969321349528,-0.0164813517251423,0.00323504567175916,0.18792887228464
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.00720846743985737,0.00549598146448397,-0.0179805911102459,0.00356365623053121,0.189681293070254
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00468467053140369,0.0035846267916004,-0.00234119798013308,0.0117105390429405,0.191281618361949
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RYR1,Ryanodine receptor 1,40116,-0.0046993143504149,0.00360104472585104,-0.0117573620130829,0.00235873331225314,0.191924975587134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.005116640384531,0.00392484512336798,-0.0128093368263322,0.00257605605727024,0.192373918099259
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00354523999764961,0.00272052366985758,-0.00178698639527124,0.00887746639057045,0.192547303689058
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.00288191259620377,0.00221317725248083,-0.00721974001106621,0.00145591481865866,0.192887896145672
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,40182,0.00663969447887433,0.00514251177209295,-0.00343962859442785,0.0167190175521765,0.196682848704895
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,40136,0.00997304345294507,0.00773743183471697,-0.00519232294310019,0.0251384098489903,0.197448079771102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,40527,0.00313166300164952,0.00243438110851259,-0.00163972397103516,0.00790304997433421,0.198319010037567
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00421823353517209,0.00329201169428698,-0.0106705764559746,0.00223410938563039,0.200096520693896
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00781679505386166,0.0061273094793167,-0.00419273152559906,0.0198263216333224,0.202078054209885
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.0058369457334244,0.00457947173654922,-0.00313881887021206,0.0148127103370609,0.202480955861399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.00434374827077832,0.00340861017244043,-0.00233712766720492,0.0110246242087616,0.202563344175296
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUCL3,Mucin-like protein 3,40080,-0.00564403963524839,0.00444289178986756,-0.0143521075433888,0.00306402827289202,0.203986169242317
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00386386388098069,0.00306500979628621,-0.00987128308170166,0.00214355531974029,0.207465717462267
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.0079231215126883,0.00629796474013308,-0.00442088937797254,0.0202671324033491,0.208402464992611
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00703243671988795,0.00559582836495181,-0.00393538687541759,0.0180002603151935,0.208878655123574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00477352275711598,0.00381362139941767,-0.00270117518574265,0.0122482206999746,0.210700192345211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH4,Cadherin-4,40136,0.00648740868302738,0.00519305233466399,-0.00369097389291404,0.0166657912589688,0.211601213328297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22,Interleukin-22,40451,0.00911574857636468,0.0072978406148708,-0.00518801902878209,0.0234195161815114,0.211653678713819
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00380036181105991,0.00304787311604883,-0.00217346949639579,0.00977419311851561,0.212460815691102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17A,Interleukin-17A,42347,-0.0055718431772414,0.00449478346488704,-0.01438161876842,0.00323793241393719,0.215136474379901
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,40302,0.0103150941579704,0.00833582548448896,-0.006023123791628,0.0266533121075687,0.215949476196066
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00394107857043091,0.00319815146141326,-0.00232729829393909,0.0102094554348009,0.217859474707299
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00867963403255963,0.00704501588877297,-0.0051285971094354,0.0224878651745547,0.217966197354117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,40136,-0.00776162590170927,0.0063051238721552,-0.0201196686911335,0.00459641688771491,0.218348231045493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.00830478435774805,0.00676398578823696,-0.0215621965026925,0.0049526277871964,0.219545595696192
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN5,Contactin-5,42640,-0.00486470813264448,0.00396350440821417,-0.0126331767727443,0.00290376050745529,0.219702985145934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLI2,Zinc finger protein GLI2,40199,-0.00410237543113349,0.00334737624603103,-0.0106632328733543,0.00245848201108733,0.220394461874096
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,42370,0.00768835157688669,0.00630714956784906,-0.00467366157609747,0.0200503647298709,0.222869851421279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00714383854908073,0.00586603999530293,-0.00435359984171302,0.0186412769398745,0.223314902660616
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,42311,0.00736244742855527,0.00605300182403396,-0.00450143614655128,0.0192263310036618,0.22388114231452
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00638366285842759,0.00525096198706988,-0.00390822263622937,0.0166755483530845,0.224120490241939
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKIV2L,Helicase SKI2W,40116,-0.00502953631304649,0.00415681508423168,-0.0131768938781406,0.0031178212520476,0.226324459376195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00685956684399719,0.00568311690514389,-0.0179984759780792,0.00427934229008484,0.227454863141909
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00456952044976952,0.00380466294640479,-0.0120266598247229,0.00288761892518387,0.22976482973674
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",42357,0.0104968692053228,0.00877375132236939,-0.00669968338652116,0.0276934217971669,0.231564134184794
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00631908924596748,0.00531445779258081,-0.0167354265194259,0.00409724802749091,0.234450787470636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,40539,0.00194237758291011,0.0016355543638717,-0.00126330897027842,0.00514806413609864,0.235017535045027
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,40511,-0.0048679994375614,0.00411457479794715,-0.0129325660415378,0.00319656716641501,0.236789941182885
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL4,Early placenta insulin-like peptide,40451,-0.00597572649778874,0.00507678252436334,-0.0159262202455409,0.00397476724996341,0.239192604900102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.0045217413473763,0.00384359486847731,-0.00301170459483924,0.0120551872895918,0.239446113707424
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00703779604228505,0.00600718165115536,-0.0188118720785495,0.00473627999397945,0.241397773634589
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.00527440436450294,0.00450991537483448,-0.0141138384991785,0.00356502977017264,0.242222170095959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD2,Leiomodin-2,40136,0.00759726126231786,0.00651198174055276,-0.00516622294916554,0.0203607454738013,0.243373584435644
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00417924702471721,0.00359555805485372,-0.00286804676279609,0.0112265408122305,0.245119353467107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNR,Tenascin-R,42495,-0.00511582206620413,0.00441462157039221,-0.0137684803441729,0.00353683621176461,0.246543875727952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2B,Alpha-amylase 2B,41779,-0.00604329494529685,0.005228529124232,-0.0162912120287916,0.00420462213819786,0.247772318538871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRAS,GTPase Hras,40286,0.0120169694584931,0.0103978884775983,-0.00836289195759959,0.0323968308745858,0.247823675907485
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,40283,0.00335742650772096,0.00290660838704515,-0.00233952593088754,0.00905437894632946,0.248073922571104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00381772978426657,0.00331802832451284,-0.0103210653003117,0.0026856057317786,0.249916958857949
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN3,Matrilin-3,42475,-0.00392187230522008,0.00341062945713323,-0.0106067060412012,0.00276296143076106,0.250207035420026
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00348053751203185,0.00302959883650903,-0.00941855123158953,0.00245747620752584,0.250645279919002
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,40182,-0.00853614017530296,0.00744414376189275,-0.0231266619486127,0.00605438159800683,0.251533902828685
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF15,Growth/differentiation factor 15,42794,-0.00547954725811728,0.00481101346463333,-0.0149091336487986,0.00395003913256405,0.254740301401488
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL2,Interferon lambda-2,40136,0.00735689120947369,0.0064628603154572,-0.00531031500882242,0.0200240974277698,0.25500612130602
NMR metabolomics,X23495.Concentration of Large VLDL Particles,H2AP,Huntingtin-interacting protein M,40080,-0.00620207175898001,0.00549707271763248,-0.0169763342855397,0.00457219076757964,0.259239258631489
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00334313863864795,0.0029657997407015,-0.00246982885312699,0.00915610613042289,0.259669798239271
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,42357,0.00712600230125617,0.00635001248669271,-0.00532002217266154,0.0195720267751739,0.261796657853428
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN4,Alpha-actinin-4,42370,0.0038057888580797,0.00340937433196012,-0.00287658483256214,0.0104881625487215,0.264326110433947
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00829610254048779,0.00744007080116799,-0.00628643622980147,0.0228786413107771,0.264850411366993
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTF,Ciliary neurotrophic factor,40136,-0.00399898651103271,0.00358793438010696,-0.0110313378960424,0.00303336487397694,0.26506130450209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,40116,0.00388001926322694,0.00348846821559314,-0.00295737843933562,0.0107174169657895,0.266058791872721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4,Interleukin-4,42370,0.0108221348137885,0.00975400181569274,-0.00829570874496924,0.0299399783725463,0.267231708373419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00393047110533745,0.00354351349931523,-0.0108757575639953,0.00301481535332041,0.267367612786128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GKN1,Gastrokine-1,42017,0.00323758311576898,0.00292494716864692,-0.00249531333477899,0.00897047956631694,0.268363976721829
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.00277422839057109,0.00252464088975554,-0.00217406775334978,0.00772252453449195,0.271848502150631
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",42311,-0.0061514634782234,0.00564660278389893,-0.0172188049346653,0.0049158779782185,0.275993298055528
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.00810921973194953,0.00745901644877991,-0.00651045250765909,0.0227288919715581,0.276981076594023
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,42594,0.0054172949830667,0.00499063467859247,-0.00436434898697453,0.0151989389531079,0.277723246961125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,40199,0.0100245122269077,0.00924349843350048,-0.00809274470275323,0.0281417691565687,0.278169888268041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD2,Bromodomain-containing protein 2,40136,0.00404501757398406,0.00373318211984019,-0.00327201938090272,0.0113620545288708,0.278596790304696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAX,Integrin alpha-X,40302,0.00613411691178359,0.0056784061362744,-0.00499555911531423,0.0172637929388814,0.280052857254923
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.0042465437765227,0.00394697128597944,-0.003489519943997,0.0119826074970424,0.281996045161394
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEFL,Neurofilament light polypeptide,42262,0.00516958793311885,0.00481447060914228,-0.00426677446080002,0.0146059503270377,0.282949904719029
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP4,Bone morphogenetic protein 4,42475,-0.00519055848611724,0.00485209832530989,-0.0147006712037246,0.00431955423149014,0.284748854467517
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,40451,0.00408321492508614,0.00381708888282214,-0.00339827928524525,0.0115647091354175,0.284768461855445
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00727565490137013,0.00686543224892296,-0.00618059230651887,0.0207319021092591,0.289280525103704
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL11,Interleukin-11,42370,0.00690701888008357,0.00652574026979738,-0.0058834320487193,0.0196974698088864,0.289880275785534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH4,Myosin-4,40116,-0.00497000227219995,0.0047344857322363,-0.0142495943073831,0.0043095897629832,0.293858639060799
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17F,Interleukin-17F,42370,0.0082481100128828,0.00787037908395814,-0.00717783299167515,0.0236740530174408,0.294660596915443
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00610598246057209,0.00584049610230161,-0.0175533548210832,0.00534138989993908,0.295835203295803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.0051918303885078,0.00501448476054846,-0.00463655974216717,0.0150202205191828,0.300520627904111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00409919398830849,0.00396393069286547,-0.00367011016970784,0.0118684981463248,0.301101188131162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLMP,CXADR-like membrane protein,42721,0.00234115865934587,0.00228489858034303,-0.00213724255812647,0.00681955987681821,0.305559632438233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAGE2A,G antigen 2A,40080,0.00712569027872196,0.00695749056156758,-0.00651099122195049,0.0207623717793944,0.305775220816624
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.0089588176826066,0.00882730703726572,-0.0262603394756474,0.00834270411043421,0.310176930521313
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0133980966035079,0.0132140554502455,-0.0125014520789732,0.039297645285989,0.310635913708924
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,42311,0.0051835417314102,0.00512964663235179,-0.0048705656679993,0.0152376491308197,0.312271282816279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.00648248098599742,0.00643262581046444,-0.00612546560251288,0.0190904275745077,0.313592653272558
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTKN2,Rhotekin-2,40116,-0.00540588209361441,0.00538780697457575,-0.0159659837637829,0.00515421957655405,0.315711923182958
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13,Interleukin-13,42370,-0.00494448310864291,0.00494463234058268,-0.014635962496185,0.00474699627889915,0.317343477326387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.00471761902833249,0.00472572513502454,-0.0139800402929806,0.0045448022363156,0.31816273061582
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00426923164748179,0.00427858662296719,-0.0126552614284975,0.0041167981335339,0.318391757835475
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMCN2,Hemicentin-2,40269,-0.0060604511942576,0.00609462495788643,-0.018005916111715,0.00588501372319981,0.320053395685666
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD10,Frizzled-10,40182,0.00628584382915468,0.00633414124157343,-0.00612907300432924,0.0187007606626386,0.32103645001278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,40080,0.00652356389245312,0.00658951900529092,-0.00639189335791709,0.0194390211428233,0.322200567461512
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,40080,0.00352635645674888,0.00356613468684401,-0.00346326752946539,0.0105159804429631,0.32276068663252
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,40483,-0.00280302918968949,0.00284612391930747,-0.00838143207153213,0.00277537369215315,0.32471471230397
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPN3,Calpain-3,40451,-0.00391711540501243,0.00398603793097795,-0.0117297497497292,0.00389551893970436,0.325771792884521
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00279837186342375,0.00286282522630417,-0.00840950930697993,0.00281276558013243,0.3283459429829
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPA33,Cell surface A33 antigen,42587,-0.0140771025793721,0.0144499020325929,-0.0423989105632542,0.0142447054045101,0.329974563891859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLINT1,Clathrin interactor 1,40080,0.0046958548530813,0.00482107240551649,-0.00475344706173102,0.0141451567678936,0.330064759388614
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH22,Cadherin-22,40302,-0.00285356375140989,0.00293213243576527,-0.00860054332550983,0.00289341582269005,0.330472990164298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,42611,-0.00297533804797129,0.00306651050702009,-0.00898569864173067,0.00303502254578809,0.331930246333313
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,42611,0.00370858056950902,0.00382246414551286,-0.00378344915569618,0.0112006102947142,0.33196092912198
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD82,CD82 antigen,40302,-0.00414376995545775,0.00427377597716215,-0.0125203708706956,0.00423283095978007,0.332276734918222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00744531584147917,0.00772614839337513,-0.0225885666924944,0.00769793500953609,0.335241567396255
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00325095698402405,0.00337895569049532,-0.00987371013739488,0.00337179616934678,0.336007239522162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYT1,Synaptotagmin-1,40483,0.004236418146824,0.00441810913131776,-0.00442307575055881,0.0128959120442068,0.337641827566703
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.0045414625538833,0.00474715587090362,-0.00476296295308779,0.0138458880608544,0.338751375292832
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAYN,Layilin,42476,-0.00376983758122749,0.00394362772573091,-0.0114993479236601,0.00395967276120509,0.339124290862938
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1A,Interleukin-1 alpha,42370,0.00572889103811639,0.00607101217026319,-0.00617029281559946,0.0176280748918322,0.345367484892891
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00475072177761521,0.00503469211750011,-0.0146187183279154,0.00511727477268501,0.34539635558919
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS4,Galectin-4,42618,0.00553857723320901,0.00587369235596189,-0.0059738597844763,0.0170510142508943,0.345725274294677
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.00438784730826185,0.00466496193188671,-0.0135311726947598,0.0047554780782361,0.346928475919495
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,42679,0.00782156493078106,0.00833950817033851,-0.00852387108308241,0.0241670009446445,0.348316284762845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAG,S-arrestin,40136,-0.00509697465694336,0.00547021241343709,-0.0158185909872801,0.00562464167339334,0.35147644749752
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN1,Transcobalamin-1,40337,0.00331401336369346,0.00355775106209711,-0.00365917871801687,0.0102872054454038,0.351619779520288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNB2,Ephrin-B2,40182,0.00526078341427268,0.00569558683019203,-0.00590256677290369,0.0164241336014491,0.355683858344368
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSTN,Osteocrin,40182,-0.00402753376318144,0.00436701608145274,-0.0125868852828288,0.00453181775646593,0.356412086664375
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH2,Growth hormone variant,42346,0.0160197838396587,0.0173753067970207,-0.018035817482502,0.0500753851618193,0.356552963852871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,40199,0.00205879020740053,0.00225421873232979,-0.00235947850796585,0.00647705892276691,0.36110193534447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00290389961607467,0.00319483149790107,-0.00335797011981142,0.00916576935196076,0.363400178661963
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00351098960567296,0.00387351326005861,-0.0111030755953878,0.00408109638404192,0.364738968936306
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,42311,-0.00631289595128965,0.00697226972449788,-0.0199785446113055,0.0073527527087262,0.36525473157234
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX1,Neuronal pentraxin-1,42611,-0.00376004765990593,0.00416992661251609,-0.0119331038204375,0.0044130085006256,0.367229274655671
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,40302,0.00346034085449314,0.00385043543024176,-0.00408651258878071,0.011007194297767,0.368838247945241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK12,Kallikrein-12,42346,0.0130333863023308,0.0145412239665895,-0.0154674126721847,0.0415341852768462,0.37010575981359
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00655091016826882,0.00732533002011881,-0.00780673667116405,0.0209085570077017,0.371190742649188
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00504034054516448,0.00563922221782552,-0.00601253500177353,0.0160932160921025,0.37144791990698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSG1,Tryptase gamma,40199,0.00247867001448839,0.00277326515978532,-0.00295692969869084,0.00791426972766762,0.371462807951595
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAN,Neurocan core protein,42711,0.00349516551188348,0.00395224118019194,-0.00425122720129272,0.0112415582250597,0.37652289477305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD177,CD177 antigen,42595,-0.0120876128355111,0.0137140888442647,-0.0389672269702698,0.0147920012992476,0.37811657644427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN15,Lipocalin-15,40482,-0.00574241740116407,0.00652709345181616,-0.0185355205667238,0.00705068576439561,0.378996306652501
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",40136,0.00785685020652453,0.00893614191480586,-0.00965798794649496,0.025371688359544,0.379300368898043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK15,Kallikrein-15,40429,0.00483693807622473,0.00556470064942479,-0.00606987519664787,0.0157437513490973,0.384746461724444
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D2,DCN1-like protein 2,40080,0.00726615379573191,0.0083642242394796,-0.00912772571364811,0.0236600333051119,0.38502043762036
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,40116,-0.00431050286106714,0.00498041667282679,-0.0140721195398077,0.00545111381767338,0.38678868797661
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,42638,0.00214233491715331,0.00249073576279241,-0.0027395071779198,0.00702417701222643,0.389737510906756
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00282773319472238,0.00329125364865056,-0.00362312395663272,0.00927859034607749,0.390264590608946
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MN1,Transcriptional activator MN1,40182,-0.00531753332186284,0.00618940038416417,-0.0174487580748246,0.00681369143109892,0.390284529695043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00524087080901081,0.00610436645000285,-0.0172054290510164,0.00672368743299477,0.390610624275919
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC8,Histone deacetylase 8,40199,0.00525934677377924,0.00616504687074421,-0.0068241450928794,0.0173428386404379,0.393627338856373
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.0071432127435485,0.00840657176552656,-0.0236200934039806,0.00933366791688356,0.395500373942532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,40449,0.00437481674671638,0.00521507333762194,-0.00584672699502263,0.0145963604884554,0.40155489586429
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00659760145029205,0.00789370653466433,-0.00887406335765003,0.0220692662582341,0.403282716674326
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00670101021378932,0.00804307681632182,-0.00906342034620143,0.0224654407737801,0.404783801615332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,40182,0.0089208024023515,0.0107396361833836,-0.0121288845170804,0.0299704893217834,0.406193447213126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00619313011430206,0.00748546348475535,-0.00847837831581843,0.0208646385444225,0.408054263963295
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00517082805999932,0.00625437841407571,-0.0174294097515877,0.00708775363158907,0.408394959154904
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00375063823202958,0.00453880416515516,-0.0126466943957337,0.00514541793167454,0.408623816266116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0051484021649779,0.00623655858963181,-0.00707525267070045,0.0173720570006562,0.409091454068278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.00336155456426745,0.00407613264233384,-0.00462766541470689,0.0113507745432418,0.409564403518222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00316806917063419,0.00384794005004809,-0.00437389332746007,0.0107100316687285,0.410346398058393
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,40199,0.00608304747009221,0.0074057871032834,-0.00843229525234326,0.0205983901925277,0.411441335940825
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STEAP4,Metalloreductase STEAP4,40136,0.00623626410849605,0.00760250418523007,-0.00866464409455489,0.021137172311547,0.412068228371813
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.00558469691502659,0.00688580382633585,-0.00791147858459168,0.0190808724146449,0.417354228687456
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,42114,-0.00412535216506651,0.00509445609492153,-0.0141104861111127,0.00585978178097968,0.418085660186821
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00338910070082001,0.00418548698164454,-0.00481445378320328,0.0115926551848433,0.418114757026063
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,40182,0.00437937506034942,0.00543988263461887,-0.00628279490350357,0.0150415450242024,0.420808506721987
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,40083,-0.00738193276871329,0.00917638796920368,-0.0253676531883525,0.0106037876509259,0.421155485743446
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.00532166177956505,0.00661869520934794,-0.018294304389887,0.0076509808307569,0.421394227781578
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAGLN3,Transgelin-3,40080,0.00506963563384075,0.00639762437806267,-0.00746970814716209,0.0176089794148436,0.428130344987914
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00325383690927321,0.00411595755248169,-0.0048134398935909,0.0113211137121373,0.429228526011719
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELB,Transcription factor RelB,40199,0.00408860231312125,0.00518263070743218,-0.00606935387344582,0.0142465584996883,0.430184636580871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,42370,0.0052746640840821,0.00671481625826181,-0.00788637578211105,0.0184357039502752,0.432159241277808
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBZ,Hemoglobin subunit zeta,40511,0.0086938021811549,0.0110869946586707,-0.0130367073498396,0.0304243117121494,0.43297193434408
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCN,Decorin,42357,-0.00195689148086067,0.0025007144742045,-0.00685829185030149,0.00294450888858014,0.433915504296895
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00332844495213876,0.00425830694882456,-0.0116747265718349,0.00501783666755737,0.434445063417662
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10,Interleukin-10,42370,0.00689738308613048,0.00884492220537673,-0.0104386644364079,0.0242334306086689,0.435515108979655
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,40136,0.00490371761019196,0.00636825920258632,-0.00757807042687722,0.0173855056472611,0.441301796774194
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,42592,0.0039150771208059,0.00510643150526831,-0.00609352862952,0.0139236828711318,0.443276197436731
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.00261808542181199,0.00342189262035388,-0.0093249949577056,0.00408882411408161,0.44422921074358
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF3,Fibroblast growth factor 3,40199,0.00230792539786799,0.00303494534960988,-0.00364056748736738,0.00825641828310337,0.447001699777014
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00290414216206172,0.00391711348592594,-0.0105816845944766,0.00477340027035312,0.458465314833379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSCA,Prostate stem cell antigen,40449,0.0205269974620903,0.0277493282742607,-0.0338616859554607,0.0749156808796413,0.4594795568276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI2B,Protein EVI2B,40080,-0.00315337160896812,0.00427324337505632,-0.0115289286240785,0.00522218540614226,0.460570458677503
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPLX2,Complexin-2,40080,-0.00242368481833057,0.00331417725133056,-0.00891947223093847,0.00407210259427732,0.464606697269814
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A16,Protein S100-A16,42292,-0.00459676527244985,0.00632160138884786,-0.0169871039945917,0.00779357344969196,0.467145825621572
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.00467911190909085,0.00647820997441807,-0.00801817964076856,0.0173764034589503,0.470134808639445
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCLRE1C,Protein artemis,40080,0.00232448517151958,0.0032615963134573,-0.00406824360285673,0.00871721394589589,0.476057037786299
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0200679058895028,0.0282651431315199,-0.0353317746482762,0.0754675864272818,0.477726732036102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASN,Vasorin,42449,-0.00203160759686797,0.00286289318776551,-0.00764287824488837,0.00357966305115242,0.477943341013909
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00263966058011435,0.0037392034399899,-0.00468917816226586,0.00996849932249455,0.480236508837929
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,42636,0.00249245142810087,0.00353257500872186,-0.00443139558899398,0.00941629844519571,0.480472658961683
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,40182,0.00308916908969613,0.00438703590143875,-0.00550942127712382,0.0116877594565161,0.481348927899928
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00185544673441354,0.00263960213677382,-0.00702906692249023,0.00331817345366315,0.482115899704687
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.0019556550985027,0.00279322604628359,-0.00743037814921854,0.00351906795221314,0.483853006918031
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGN,Cingulin,40182,0.00300842119101998,0.00430200907716031,-0.00542351660021424,0.0114403589822542,0.484375557954205
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP4,Caspase-4,40302,0.0125586276875087,0.0180220481143998,-0.0227645866167149,0.0478818419917323,0.485912522852724
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP15,Matrix metalloproteinase-15,40511,0.00354029825932095,0.00509208084912346,-0.00644018020496103,0.0135207767236029,0.48690934321906
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.00213894958057534,0.00309648973961347,-0.00393017030906707,0.00820806947021775,0.489726901603988
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00516558948164759,0.00748299098397768,-0.00950107284694865,0.0198322518102438,0.490013426816714
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00215771393229824,0.00313366862091679,-0.00398427656469868,0.00829970442929515,0.491115285661377
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00687017434483201,0.00998688084681109,-0.0127041121149177,0.0264444608045817,0.491517815993438
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00494208527328818,0.00726230999936798,-0.0191762128720494,0.00929204232547307,0.496195085036622
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAN,Brevican core protein,42495,0.00245112456010035,0.00360733917713177,-0.00461926022707791,0.00952150934727862,0.496843890328141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,40302,-0.0031560406028534,0.00465297662544002,-0.0122758747887158,0.00596379358300904,0.497605633690641
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0034087903716579,0.00503568107753158,-0.0132787252836198,0.006461144540304,0.498463971753005
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSP90B1,Endoplasmin,42247,-0.00469761136597218,0.00694576336950942,-0.0183113075702106,0.00891608483826627,0.498844665932487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYAL1,Hyaluronidase-1,42544,-0.00162058921057298,0.00241263669667017,-0.00634935713604652,0.00310817871490056,0.501780744855676
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.0100279948581615,0.0149564663486258,-0.019286679185145,0.0393426689014681,0.50256678667692
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAL,Galanin peptides,42676,0.00447662316906307,0.006678460738351,-0.00861315987810488,0.017566406216231,0.502673187394277
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3A,Uroplakin-3a,40136,0.00355125298045191,0.00533624610671084,-0.00690778938870133,0.0140102953496052,0.505747024175366
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PITHD1,PITH domain-containing protein 1,40065,-0.00558566140506358,0.00842555099803705,-0.0220997413612162,0.010928418551089,0.50738101388358
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL6B,Myosin light chain 6B,40182,0.00628220786578678,0.00949519634867257,-0.0123283769776115,0.024892792709185,0.508228926398403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSND,Barttin,40080,0.00235629804691613,0.00356323042011215,-0.00462763357650369,0.00934022967033596,0.508445854327966
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD2,Glutamate decarboxylase 2,40199,-0.00317685495521142,0.00480976644034484,-0.0126039971782873,0.00625028726786447,0.508946280187063
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,42679,-0.00299817051886878,0.00454960068115084,-0.0119153878539244,0.00591904681618687,0.509909325748001
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.00538063522264364,0.00819016915867295,-0.0214333667736426,0.0106720963283553,0.511218750733694
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRNN,Cornulin,42209,0.00472705032549612,0.00719754238680253,-0.00938013275263685,0.0188342334036291,0.511347540160432
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,0.00260181906219089,0.00398574508313697,-0.00521024130075757,0.0104138794251393,0.513908593786739
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,42311,0.00219991952929397,0.00337192033298796,-0.00440904432336243,0.00880888338195036,0.514139543836168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GJA8,Gap junction alpha-8 protein,40080,0.00441533829135253,0.00681081483139988,-0.00893385877819123,0.0177645353608963,0.51681533303879
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD70,CD70 antigen,42594,-0.00290710703515719,0.0045052231531741,-0.0117373444153784,0.00592313034506404,0.518760158641385
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFRC,Transferrin receptor protein 1,42673,0.00253120468460267,0.00393490035856319,-0.00518120001818119,0.0102436093873865,0.520059642670305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00311007578255613,0.00484173407673698,-0.0125998745729606,0.00637972300784835,0.52065847302414
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSHB,Follitropin subunit beta,40223,-0.00362243551029318,0.00564762362923618,-0.0146917778235961,0.00744690680300973,0.521270443964643
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00452612138355956,0.00705739707009738,-0.0183586196409504,0.00930637687383129,0.521321674532389
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,42611,0.00304548296556175,0.00474972058598878,-0.00626396938297626,0.0123549353140998,0.521408881864824
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,0.00317869791531317,0.00498328257600036,-0.00658853593364753,0.0129459317642739,0.523567581854646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.0029810114868181,0.00468098803031671,-0.0121557480262389,0.00619372505260266,0.524246044126892
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN4,Nectin-4,42679,-0.00228498519928845,0.00359242073051306,-0.00932612983109404,0.00475615943251714,0.524749912026987
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM2,Isthmin-2,40527,0.00287027810835387,0.00451883560324031,-0.00598663967399714,0.0117271958907049,0.525323256333391
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,40182,-0.00278038417335849,0.00438511781135759,-0.0113752150836194,0.00581444673690237,0.526061357237559
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSPN,Claspin,42292,0.00228318329547167,0.00365129355106201,-0.00487335206460986,0.00943971865555321,0.531779783474575
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLGAP5,Disks large-associated protein 5,40482,0.00331207457758845,0.00529833265390701,-0.00707265742406929,0.0136968065792462,0.531907308308735
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.00308525876920718,0.00493961939177911,-0.00659639523867988,0.0127669127770942,0.53225010333203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,40182,0.0032891502056674,0.00527840943930132,-0.0070565322953632,0.013634832706698,0.533210171117833
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,40136,0.00313088056445727,0.00502662654003729,-0.00672130745401583,0.0129830685829304,0.533390034870694
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",42562,0.00456047672812233,0.00733968691881831,-0.00982530963276155,0.0189462630890062,0.534383339484532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORN4,MORN repeat-containing protein 4,40080,-0.00496352597756932,0.00802498540378814,-0.0206924973689941,0.0107654454138554,0.53625278480913
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00711198047057008,0.0115094950677204,-0.0154466298621618,0.029670590803302,0.53663905242901
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL24,Interleukin-24,42370,0.00323774359947,0.00526335988480028,-0.00707844177473855,0.0135539289736786,0.538467823012853
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,42346,0.00290596785576828,0.00481503517211775,-0.00653150108158251,0.0123434367931191,0.546173522635778
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,40080,-0.00265433665433167,0.00439846445013883,-0.0112753269766038,0.00596665366794045,0.546209349189928
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00306248688866743,0.0051076756694074,-0.00694855742337106,0.0130735312007059,0.548795037143714
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBX2,Chromobox protein homolog 2,40116,-0.00250504709615312,0.00419095874582496,-0.01071932623797,0.00570923204566381,0.550034833954812
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,40223,-0.00266714048683232,0.00446454598372072,-0.0114176506149249,0.0060833696412603,0.55024952109584
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00231125484751103,0.00387043298739244,-0.00989730350280022,0.00527479380777816,0.550414767237413
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00438588514373269,0.00735611692906656,-0.0100321040372378,0.0188038743247031,0.551038498911222
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00157069168731875,0.00263568667057559,-0.0035952541870094,0.0067366375616469,0.551232135603082
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR1B,Cornifin-B,40302,-0.00515735450619906,0.00866588834402235,-0.0221424956604829,0.0118277866480847,0.551766819879742
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.00355711427510039,0.00601225997432712,-0.00822691527458077,0.0153411438247815,0.5540994026054
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,40283,0.00254310909495565,0.00430303635335417,-0.00589084215761853,0.0109770603475298,0.554530191600806
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,42240,0.00247093515123623,0.0041973899155548,-0.00575594908325117,0.0106978193857236,0.556083645996453
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL1,Delta-like protein 1,42679,-0.0019111316290875,0.00327385101388275,-0.00832787961629769,0.00450561635812269,0.559393949206284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCP11,T-complex protein 11 homolog,40302,0.00359513314976416,0.00617639512727169,-0.00851060129968836,0.0157008675992167,0.560527109234707
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.0025382148609305,0.00437635529351352,-0.011115871236217,0.00603944151435599,0.561937532653012
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALLD,Palladin,40199,-0.00235719580122855,0.00406529322328731,-0.0103251705188717,0.00561077891641458,0.562038342405358
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,40451,-0.00253399657730535,0.00437617466237743,-0.0111112989155651,0.00604330576095441,0.562571240648142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKZF2,Zinc finger protein Helios,42346,0.0052878857492229,0.00916240310374515,-0.0126704243341176,0.0232461958325634,0.563862399381962
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NENF,Neudesin,40451,0.00655519441597881,0.0114747058042793,-0.0159352289604087,0.0290456177923663,0.567825721865056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00168166336686428,0.00295132522559685,-0.00410293407530554,0.0074662608090341,0.56882327925055
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00313349795259133,0.00557329374046925,-0.00779015777872839,0.0140571536839111,0.573967804917043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00236696169433503,0.00424138594464259,-0.00594615475716443,0.0106800781458345,0.576812600911242
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00274810820631363,0.00495341179494008,-0.0124567953243962,0.00696057891176892,0.579046814073698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1,Integrin beta-1,42638,-0.00123074024543256,0.00222249834166554,-0.00558683699509702,0.00312535650423189,0.579749370925316
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00164251673743016,0.00296881997795222,-0.00746140389421651,0.00417637041935619,0.580099202174385
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK3,Prostate-specific antigen,40527,0.00565907752550718,0.0102390949895381,-0.0144095486539874,0.0257277037050018,0.580484454439457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,40302,0.00428158574671489,0.00782844160732149,-0.0110621598036352,0.019625331297065,0.584439901523806
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEB,Nebulin,40116,-0.00218788915147692,0.00400936471899696,-0.010046244000711,0.00567046569775712,0.585286947544354
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00142992978906265,0.00263186375967655,-0.00658838275802869,0.00372852317990339,0.586924395072785
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.00293759123109425,0.00541781462071441,-0.007681325425506,0.0135565078876945,0.587683189247657
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00399513745300642,0.007433378626667,-0.0185645595612737,0.0105742846552609,0.590961415614983
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEBP1,Heme-binding protein 1,42357,0.00294771325929829,0.00548705967041748,-0.00780692369471997,0.0137023502133166,0.591130394728336
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1B,Lithostathine-1-beta,42794,-0.00326694832011007,0.00609134820319743,-0.015205990798377,0.00867209415815688,0.591742047412294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00168766540724625,0.00315077313128723,-0.00786318074456923,0.00448784993007674,0.592221492733311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20,Interleukin-20,42370,-0.00270602763134098,0.00512065271926817,-0.0127425069611066,0.00733045169842463,0.597193408084847
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,40199,-0.00482365965629282,0.00914075440250127,-0.0227395382851953,0.0130922189726097,0.597711866582934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN6,Prefoldin subunit 6,40182,0.00356785599825817,0.00676283448902828,-0.00968729960023727,0.0168230115967536,0.597809764541585
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGR,Progesterone receptor,40199,0.00538236920105619,0.0102024787220213,-0.0146144890941056,0.025379227496218,0.597818831834429
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC5D,Netrin receptor UNC5D,40199,0.00143882597022788,0.00272891353944934,-0.00390984456709282,0.00678749650754859,0.598029014720245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00293651880664176,0.00558297402518085,-0.0138791478959962,0.0080061102827127,0.598914346741221
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,42689,0.0015119729803556,0.00288023095738763,-0.00413327969612415,0.00715722565683536,0.599627601614707
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3,Interleukin-3,40080,0.0033370778221602,0.00644950953226176,-0.00930396086107284,0.0159781165053932,0.604876479450967
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REST,RE1-silencing transcription factor,40080,-0.00185247245217455,0.00358035671611112,-0.00886997161575235,0.00516502671140325,0.604888274167558
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERVV_1,,40116,-0.00235106187552257,0.00455667356760936,-0.0112821420680369,0.00658001831699177,0.605892702083511
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.00430666426149392,0.00838290954247851,-0.0207371669647518,0.012123838441764,0.607440050840444
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00178886029137934,0.00348464927056849,-0.0050410522789349,0.00861877286169359,0.607712001553958
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00418396598387635,0.00820247015553255,-0.0118928755209674,0.0202608074887201,0.610001390802282
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00270508663208029,0.00531787657816638,-0.00771795146112582,0.0131281247252864,0.610988183535589
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00221126560121135,0.00434913861617936,-0.0107355772889229,0.0063130460865002,0.611156681065496
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00154431388865901,0.00305726954539738,-0.00444793442031986,0.00753656219763788,0.613478721302962
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POF1B,Protein POF1B,40199,0.00242919682506885,0.00486524757649644,-0.00710668842486417,0.0119650820750019,0.617581118405675
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDSN,Corneodesmosin,42710,-0.0023075511117063,0.00463364061688537,-0.0113894867208016,0.00677438449738903,0.618492436045382
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY96,Lymphocyte antigen 96,42495,-0.00185194845044915,0.00371930834309604,-0.0091417928029174,0.00543789590201909,0.61854289325773
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPE,Coatomer subunit epsilon,42311,0.00245767325836906,0.00493871638840822,-0.00722221086291106,0.0121375573796492,0.618750367158588
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLLT1,Protein ENL,40080,0.00343178777572457,0.00692877497378422,-0.0101486111728925,0.0170121867243416,0.620401879222575
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENG,Endoglin,42794,-0.000892458323687916,0.00180853766027894,-0.00443719213783463,0.0026522754904588,0.621688795696548
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00198125307796568,0.00408831110216588,-0.00603183668227944,0.0099943428382108,0.627958187762879
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPGN,Epigen,40451,0.00228599276810319,0.00474465704142004,-0.00701353503308009,0.0115855205692865,0.629954849423492
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,42636,0.00158263239931155,0.00329187816870183,-0.00486944881134404,0.00803471360996714,0.630688633955451
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,40116,0.00243291252379578,0.00507802938614572,-0.00752002507304983,0.0123858501206414,0.631873068786569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.0031537610662337,0.00660958530629541,-0.00980102613410531,0.0161085482665727,0.633265167199866
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,40182,0.00302019987165141,0.00639699617535865,-0.00951791263205154,0.0155583123753544,0.636844930529556
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00192469131567428,0.00411381379325121,-0.00613838371909809,0.00998776635044665,0.639893368791006
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,40182,0.00208612051899986,0.00447127400533054,-0.006677576531448,0.0108498175694477,0.640823493359781
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDAN1,Codanin-1,40483,0.00109968316501724,0.00235880915077985,-0.00352358277051127,0.00572294910054575,0.641079421177531
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA2,Adenosine deaminase 2,42572,0.0021433863983608,0.00461489081328056,-0.00690179959566909,0.0111885723923907,0.642332876595845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,42511,-0.00162110716632567,0.00349928058940547,-0.0084796971215604,0.00523748278890906,0.64317934968217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RUVBL1,RuvB-like 1,42346,0.00508377259135898,0.0110077390760854,-0.0164913959977684,0.0266589411804864,0.644206414314465
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2,Interleukin-2,42370,-0.00151900506824304,0.0033411346224202,-0.00806762892818664,0.00502961879170056,0.64937754658844
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF3,Trefoil factor 3,42613,-0.00202279058439638,0.0044801191182121,-0.0108038240560921,0.00675824288729933,0.651633819250418
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAND5,DAN domain family member 5,40199,0.00260845116805028,0.00578170406745635,-0.00872368880416417,0.0139405911402647,0.651885922882815
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00380444751838835,0.00846424970279736,-0.0203943769358712,0.0127854818990945,0.653099607638889
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.00342927064323096,0.00765715580566248,-0.0184372960223294,0.0115787547358675,0.654269057342713
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00169305474360963,0.00378547598552463,-0.0091125876752379,0.00572647818801864,0.654703316721385
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP2,Dipeptidase 2,42587,-0.0013722453222254,0.00307072212923763,-0.00739086069553115,0.00464637005108035,0.654968692009211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF6,Fibroblast growth factor 6,40199,-0.00189385018709616,0.00432606826383847,-0.0103729439842196,0.00658524361002724,0.661557039466284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,40286,0.00464637194676621,0.0106785625610046,-0.0162836106728028,0.0255763545663352,0.663489515244206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLHL41,Kelch-like protein 41,40482,-0.00215667174881767,0.00499681254884709,-0.011950424344558,0.00763708084692263,0.666033498160646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,40059,0.00223805510881929,0.00518617666210203,-0.0079268511489007,0.0124029613665393,0.66608259441342
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L,Seizure 6-like protein,42679,0.0012561404730772,0.00292059374464647,-0.00446822326642988,0.00698050421258427,0.667131490483636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00194140101141545,0.00451439031416767,-0.0107896060271841,0.00690680400435318,0.667169760306631
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.00249409024573302,0.0058239695160919,-0.00892089000580711,0.0139090704972731,0.668480649021532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESPL1,Separin,40080,0.002538674082982,0.00600365380729242,-0.00922848737931114,0.0143058355452751,0.672409524217601
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00130187234326644,0.0030987542829443,-0.00477168605130439,0.00737543073783727,0.67439905813202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00250647089471746,0.00598092153029175,-0.00921613530465437,0.0142290770940893,0.675166017296355
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00128523182153748,0.00307208029903351,-0.00730650920764316,0.0047360455645682,0.675692764855423
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15,Interleukin-15,42594,0.00142663792015042,0.0034527035353129,-0.00534066100906286,0.0081939368493637,0.67947076952591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,0.00506976114157518,0.0123488130316875,-0.0191339124005324,0.0292734346836827,0.681411705129137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00267795480717325,0.00653547358449415,-0.0154874830327818,0.0101315734184353,0.681992373182138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF7,Fibroblast growth factor 7,40080,-0.0033707064148693,0.00827525068320459,-0.0195901977539503,0.0128487849242117,0.683778206274516
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",40483,-0.00252257585238872,0.00626639962249191,-0.0148047191124729,0.00975956740769542,0.687282613471964
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMP,Olfactory marker protein,40136,-0.00211439672552723,0.00525378292191211,-0.012411811252475,0.00818301780142051,0.687359089454392
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.00122683612209569,0.00308367175957818,-0.00481716052667754,0.00727083277086892,0.690748904966616
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPO,Lactoperoxidase,42134,-0.00250237857785695,0.0063384006682072,-0.0149256438875431,0.00992088673182915,0.692999564293507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCIN,Adseverin,40136,0.00293348695824824,0.00761286545950448,-0.0119877293423805,0.017854703258877,0.699998334608077
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVPL,Envoplakin,40302,-0.00141498474386994,0.00367236200682224,-0.00861281427724153,0.00578284478950164,0.700017765954681
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",40451,0.00168984628304633,0.00445462262381381,-0.00704121405962873,0.0104209066257214,0.704437598478208
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WNT9A,Protein Wnt-9a,42370,-0.00117046313292245,0.0030910815715425,-0.00722898301314575,0.00488805674730085,0.704947858607698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.00123102344364527,0.00327015690979363,-0.00517848409955025,0.00764053098684079,0.706595620489322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNLZ,DNL-type zinc finger protein,40136,0.00357062048282695,0.00950414961614023,-0.0150575127648079,0.0221987537304618,0.707154146310301
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00189750215348574,0.0051063879611175,-0.00811101825030457,0.011906022557276,0.710202453034512
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESR1,Estrogen receptor,40199,-0.00214075191462194,0.0057692275327092,-0.013448437878732,0.00916693404948809,0.710597100697637
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN1,Cerebellin-1,40136,0.00366319814151511,0.00990735553619154,-0.0157552187094203,0.0230816149924505,0.711579431280302
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00210147317483277,0.00571822364547134,-0.0133091915199566,0.00910624517029106,0.71324976984993
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00668401853908841,0.0182623050343154,-0.0291100993281698,0.0424781364063466,0.714371345808561
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,40080,-0.00162887958771756,0.00445126903777657,-0.0103533669017596,0.00709560772632451,0.714419943062886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.0018715589317058,0.00511613101126408,-0.0118991757137834,0.0081560578503718,0.71450866160801
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.00117527401105319,0.00326996156468895,-0.00523385065573715,0.00758439867784354,0.719290057818656
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA8,Carbonic anhydrase-related protein,40199,0.00106519100348088,0.00298727398519514,-0.00478986600750158,0.00692024801446335,0.721415883988827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.000842931534756447,0.00236644317482621,-0.00379529708790293,0.00548116015741582,0.721694900929397
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGM2,Phosphoglucomutase-2,40182,0.00220187170604132,0.00624167838953993,-0.0100318179374569,0.0144355613495396,0.724268264794574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD1,Glutamate decarboxylase 1,40080,-0.000953482965765544,0.00273164513058413,-0.00630750742171044,0.00440054149017936,0.727057910070389
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,42679,-0.00101802258141239,0.00294344943802395,-0.00678718347993934,0.00475113831711456,0.729453030429052
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D1,DCN1-like protein 1,40136,-0.00270219556054819,0.00782359071605813,-0.0180364333640221,0.0126320422429257,0.729807298899607
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHDC3L,KH domain-containing protein 3,40080,-0.00247756973171516,0.00720396059152959,-0.0165973324911132,0.0116421930276828,0.730914804504128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD8,Frizzled-8,40136,0.00162463915500266,0.00477686108028161,-0.00773800856234931,0.0109872868723546,0.733783225576899
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.00154606382585539,0.00455555817713999,-0.0104749578530498,0.007382830201339,0.734329052288029
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,40223,0.00140555732110807,0.00417248717449919,-0.00677251754091035,0.00958363218312649,0.736226448257669
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00221600064908676,0.00661244632370142,-0.0151763954435416,0.010744394145368,0.737536601301818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00176461643925979,0.00527637312382124,-0.00857707488342985,0.0121063077619494,0.73805597420121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00165291506027139,0.0049782217255134,-0.0114102296422777,0.00810439952173488,0.73987358988418
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL4,Myosin light chain 4,40223,0.00178858000141005,0.00544210182078712,-0.00887793956733272,0.0124550995701528,0.742421873754441
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_A,,40482,-0.00112886619062199,0.00345935733657424,-0.0079092065703075,0.00565147418906352,0.744186403936899
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.0016210419823088,0.00496803521352679,-0.00811630703620371,0.0113583910008213,0.744207889717112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.0011779016835855,0.00362884282376629,-0.00829043361816742,0.00593463025099642,0.745493181178702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF20,Fibroblast growth factor 20,40199,-0.00152190192020999,0.00470737173928913,-0.0107483505292167,0.00770454668879671,0.746472807478258
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00174030215621087,0.00538541661547966,-0.012295718722551,0.00881511441012925,0.746587148654344
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",42618,-0.00316415335239891,0.00979764787054265,-0.0223675431786625,0.0160392364738647,0.746737909099119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRN1,Neuritin,40482,0.00121584237799563,0.00379348785588056,-0.00621939381953027,0.00865107857552152,0.748589364998187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00148012927274581,0.0046692433897841,-0.00767158777123104,0.0106318463167227,0.751252858099897
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABO,Histo-blood group ABO system transferase,40532,-0.00478233586858279,0.0151298917802174,-0.0344369237578089,0.0248722520206433,0.751943608281484
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,40182,-0.00219359656920307,0.0070301647936443,-0.0159727195647459,0.0115855264263398,0.75502642826688
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,42679,0.000911771171287763,0.00304578837844475,-0.00505797405046394,0.00688151639303946,0.764674009481521
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2BP,LRP2-binding protein,40182,0.00269568370382541,0.00900853178174049,-0.0149610385883859,0.0203524059960368,0.764765075964595
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00234508420451058,0.00798921744293192,-0.013313781983636,0.0180039503926571,0.769121602435454
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF830,Zinc finger protein 830,40451,-0.00234821399495365,0.00808467443614723,-0.0181941758898022,0.0134977478998949,0.771475426171467
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,40080,-0.00117737560074136,0.00406884312977094,-0.0091523081350924,0.00679755693360968,0.772308562588412
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00133083688249221,0.0046563151498667,-0.0104572145762309,0.00779554081124652,0.775026517523401
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF75D,Zinc finger protein 75D,40302,0.00182607862684054,0.00640122029694061,-0.0107203131551631,0.0143724704088441,0.775442312827004
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,42547,0.000821472793629322,0.00292038215853878,-0.00490247623710669,0.00654542182436533,0.77849273308491
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,40511,-0.00106917173052744,0.00380603568267714,-0.00852900166857464,0.00639065820751977,0.778780888577293
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.00500470577764512,0.0179454046273162,-0.0401776988471848,0.0301682872918946,0.780337370128387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00263407450343793,0.00944524039420963,-0.0211467456760888,0.0158785966692129,0.780343189069761
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPT1,Translationally-controlled tumor protein,42370,-0.00189757680229796,0.00680639227351355,-0.0152381056583845,0.0114429520537886,0.780407804798898
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN4,Prefoldin subunit 4,40080,0.00152677057428413,0.0054807472192647,-0.00921549397547468,0.0122690351240429,0.78058029434987
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN1,Neuroligin-1,40182,-0.00198666751737979,0.00729477563435359,-0.0162844277607128,0.0123110927259532,0.785364842801496
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00138499491098333,0.00510990439032726,-0.0114004075160248,0.00863041769405811,0.786364439661019
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXOSC10,Exosome component 10,40116,0.00168646280795849,0.00630623644264634,-0.0106737606196283,0.0140466862355453,0.789144862722265
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.0023468823860092,0.00884595843261068,-0.0196849609139261,0.0149911961419077,0.790779002610288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00142442152273446,0.0054077005249046,-0.0120235145515475,0.00917467150607856,0.792242497571929
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRND,Prion-like protein doppel,40483,0.00143589968399409,0.00545850945246624,-0.00926277884283973,0.0121345782108279,0.792511367197863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00171393031450891,0.00688816556004136,-0.01521473481219,0.0117868741831721,0.803502809116984
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSMB,Beta-microseminoprotein,42559,0.00186212305486351,0.00753322144459125,-0.0129029909765353,0.0166272370862624,0.804766414387652
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB2,Integrin beta-2,42569,0.000720331723245058,0.00297768066475047,-0.00511592237966587,0.00655658582615598,0.808853351541626
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBQLN3,Ubiquilin-3,40116,0.00134972925695481,0.00566436116749552,-0.00975241863133642,0.012451877145246,0.811664941514392
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN1,Prorelaxin H1,40482,0.00119533856581331,0.00504905162700544,-0.00870080262311735,0.011091479754744,0.812858789256959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSB,Lupus La protein,42311,0.00142799599766741,0.006063316728973,-0.0104561047911197,0.0133120967864545,0.813813487926768
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTH3,Cytohesin-3,40080,-0.00180588795667185,0.0077959283706848,-0.017085907563214,0.0134741316498704,0.81681809404647
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,0.000729243973004548,0.00322194305704991,-0.00558576441881328,0.00704425236482238,0.820943663223951
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.00088362546419804,0.00393996331774014,-0.00860595356696871,0.00683870263857263,0.822549460001383
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN1,Calsyntenin-1,42311,-0.00124058763553616,0.00553227129471827,-0.012083839373184,0.00960266410211164,0.82256967613316
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTN3,Myeloblastin,42276,0.00113275028456684,0.00507767023698904,-0.00881948337993169,0.0110849839490654,0.823473108363863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00065282078559319,0.00296352520346465,-0.00646133018438391,0.00515568861319753,0.82565312048383
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171A2,Protein FAM171A2,40482,0.00365711804671709,0.0166769974169635,-0.0290297968905313,0.0363440329839655,0.826427215452905
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA10,Annexin A10,42311,0.00196440509572267,0.00898050046902711,-0.0156373758235705,0.0195661860150158,0.82685508691265
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.000395668919165721,0.00181895355536482,-0.00396081788768076,0.00316948004934932,0.827802079277873
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAEP,Glycodelin,42495,0.00202775916767738,0.00938383221030759,-0.0163645519645255,0.0204200702998803,0.828920337811539
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF174,Zinc finger protein 174,40199,0.000833035204165338,0.0039050472128716,-0.006820857333063,0.00848692774139368,0.831079222711285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00128872318062421,0.00604382941228161,-0.0105571824674478,0.0131346288286962,0.831151893609966
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00097514785251749,0.00457948069396891,-0.00995093001269655,0.00800063430766157,0.831378822361625
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.000902148359929119,0.00425961194167132,-0.00744669104574667,0.00925098776560491,0.832273218243275
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.00128083907011687,0.00618191546071821,-0.0108357152328908,0.0133973933731246,0.83586432088574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM132A,Transmembrane protein 132A,40223,0.0013499632472462,0.00653726919646095,-0.0114630843778173,0.0141630108723097,0.836402126625013
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00120519358080056,0.00601922269350305,-0.0105924828984654,0.0130028700600665,0.84130904241215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN2,Contactin-2,42721,0.000910426917202394,0.00463996859986594,-0.00818391153853484,0.0100047653729396,0.844445598147796
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53BP1,TP53-binding protein 1,40199,0.00175610197995462,0.00905481530759434,-0.0159913360229303,0.0195035399828395,0.846225482494675
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC4A1,Band 3 anion transport protein,40527,0.000944106484168442,0.00488980905472557,-0.00863991926309367,0.0105281322314305,0.846902634040059
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,42721,0.00118796897017289,0.00627007620241443,-0.0111013803865594,0.0134773183269052,0.849730104178463
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB116,Beta-defensin 116,40136,-0.00150106176867233,0.00803906583670521,-0.0172576308086145,0.0142555072712699,0.851882914463739
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00134437638452494,0.00728755200634531,-0.0129392255479119,0.0156279783169617,0.853643642548561
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.000644295167529375,0.00360816879794302,-0.00642771567643895,0.0077163060114977,0.858281404211817
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.0011854630645285,0.00665894293737769,-0.0142369912217888,0.0118660650927318,0.858706077763907
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,40302,0.000719651464166749,0.00416646113844992,-0.00744661236719509,0.00888591529552858,0.862870839997018
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00055254391707267,0.00330446037559735,-0.00702928625324348,0.00592419841909814,0.867206692486653
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000593082955549413,0.00361024548525853,-0.00766916410665614,0.00648299819555731,0.869515557423937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.000578074975046129,0.00358515772808588,-0.00760498412209446,0.0064488341720022,0.871905895418535
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BEX3,Protein BEX3,40080,0.000803193670170448,0.00498987123757099,-0.0089769539554687,0.0105833412958096,0.872124104494331
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,40080,0.000932980930912011,0.00579867857003672,-0.01043242906636,0.012298390928184,0.872178740673789
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,40116,0.000636274191347166,0.00395632394323719,-0.00711812073739773,0.00839066912009206,0.872234528671017
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN15,Tetraspanin-15,40116,0.000868127937586897,0.00544124855357726,-0.00979671922742453,0.0115329751025983,0.873241887609482
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.000701235308020092,0.00442880217197648,-0.00797921694905382,0.009381687565094,0.874195572156685
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASQ2,Calsequestrin-2,40116,-0.000809242026362896,0.00512737855553798,-0.0108589039952173,0.00924041994249155,0.874595540372337
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,40483,0.000432587946849739,0.00295001145738763,-0.00534943450963001,0.00621461040332949,0.883419261720625
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF12,Fibroblast growth factor 12,40199,0.000709116331704372,0.00488424202523839,-0.00886399803776287,0.0102822307011716,0.88456784686471
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.000920175375659043,0.00639947111636676,-0.0134631387637379,0.0116227880124198,0.885669517100708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.000696744190499071,0.00579552502103208,-0.0106624848507238,0.012055973231722,0.90431024991578
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.000686024371534458,0.00598342524790349,-0.0110414891143564,0.0124135378574253,0.908721386509183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,40223,0.000586274081536227,0.00515975603864174,-0.00952684775420159,0.010699395917274,0.909537628089998
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.000670704591039801,0.00599177542140776,-0.012414584416999,0.0110731752349194,0.910874996136421
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.00104601224292045,0.00944735749377205,-0.0195628329307137,0.0174708084448728,0.911840335875081
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.000369501964263789,0.0034602445711552,-0.0064125773952004,0.00715158132372798,0.914961232873532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA5,Annexin A5,42261,-0.00033315645888258,0.00319319414129682,-0.00659181697582435,0.00592550405805919,0.916906459607805
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.000354665806221753,0.00351408412651952,-0.00724227069420001,0.0065329390817565,0.919610298876717
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,40302,-0.000910683958352824,0.0090584618409551,-0.0186652691666248,0.0168439012499192,0.919922157137281
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.000539175187371014,0.00552317021094468,-0.0113645888008226,0.0102862384260806,0.92223530453925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR3,Folate receptor gamma,42629,-0.00187275839126957,0.019300579485758,-0.0397018941833553,0.0359563774008162,0.922703064557036
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.000529492016576629,0.00562201609490914,-0.0104896595294453,0.0115486435625986,0.924966406964382
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAP1,Antigen peptide transporter 1,40302,-0.000602108389384238,0.00642836192933732,-0.0132016977708854,0.0119974809921169,0.925377473702972
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.00044818207831236,0.00517308405292461,-0.0105874268220446,0.00969106266541988,0.930961397756493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.000704203795450402,0.00822809058995503,-0.0154228537608615,0.0168312613517623,0.931797625065111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOS,Proto-oncogene c-Fos,40065,-0.000316933391679857,0.00372919934251949,-0.00762616410301806,0.00699229731965835,0.932273306344362
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.000495922378168176,0.00594624737792224,-0.0111587224825594,0.0121505672388958,0.933534299177873
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,40502,0.000131155131271572,0.00158350120457706,-0.00297250722969947,0.00323481749224262,0.933991330768875
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.000452810135909961,0.00549380023966372,-0.0112206586056509,0.0103150383338309,0.934312588327636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36A,Interleukin-36 alpha,40199,-0.000474334950673944,0.00600498994586026,-0.0122441152445601,0.0112954453432122,0.937041907936403
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD27,CD27 antigen,42679,-0.000330361601303901,0.00460663322781558,-0.00935936272782244,0.00869863952521464,0.94283031779794
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB2,Beta-crystallin B2,40483,-0.000570033201923703,0.00851526367121441,-0.0172599499975039,0.0161198835936565,0.946628648967424
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,40449,-0.000300182244025446,0.00485539667082525,-0.00981675971884294,0.00921639523079205,0.95070372771552
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.000329393528125357,0.00542661668826783,-0.0103067751808796,0.0109655622371303,0.951599551188695
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.000169409600506952,0.00296161622287162,-0.00597417739733532,0.00563535819632142,0.954385337787187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,40080,0.000208195566745115,0.003836505406466,-0.00731135502992825,0.00772774616341848,0.956723451781158
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,40080,0.000353491274043027,0.00652795606857629,-0.0124413026203665,0.0131482851684526,0.956816350713828
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP9,Matrix metalloproteinase-9,42594,-0.00031949499606659,0.00625039277107682,-0.0125702648273772,0.011931274835244,0.959233858699583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,42311,0.000251730476973219,0.00513460525705915,-0.00981209582686271,0.0103155567808091,0.960899117460826
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,42794,-0.000156237851794592,0.0033726662473523,-0.0067666636966051,0.00645418799301591,0.963052109294229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELENOP,Selenoprotein P,40539,0.000109962799701364,0.00239819602274392,-0.00459050140487672,0.00481042700427945,0.963428781529619
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.000267382616130413,0.00585394121733075,-0.0117411074020987,0.0112063421698379,0.963569461084246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.000122568392952169,0.00270067546324478,-0.00541589230091194,0.0051707555150076,0.96380178694884
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX33,Testis-expressed protein 33,40302,-0.00017002924374383,0.00398068658355973,-0.0079721749475209,0.00763211646003324,0.965930648144197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00014485358364706,0.00347269428240865,-0.0066616272098739,0.00695133437716802,0.966728920236543
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPT,Microtubule-associated protein tau,42311,-0.000217153968966241,0.00554188924991858,-0.0110792568988067,0.0106449489608742,0.968744202790384
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.000263090433820123,0.006718611163092,-0.0134315683134804,0.0129053874458402,0.968764770601978
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.000201630591650667,0.00536502177989137,-0.0107170732802378,0.0103138120969364,0.970021315809038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC9,Histone deacetylase 9,40136,-0.000253130616943595,0.00685128529033499,-0.0136816497860002,0.013175388552113,0.970528383352399
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.00021777927456164,0.00656591536832835,-0.0126514148473619,0.0130869733964852,0.973541091633099
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCLN,Nicalin,42370,-0.000175680236458593,0.00539920791499835,-0.0107581277498554,0.0104067672769382,0.974043385758232
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,42794,-9.73805105156431e-05,0.00310706852428104,-0.00618723481810647,0.00599247379707519,0.974997571605093
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSD1,Tryptase delta,40482,0.000118780701459116,0.00400460732892444,-0.00773024966323279,0.00796781106615102,0.976337931425862
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.000134567903853855,0.00472016006115986,-0.00911694581601947,0.00938608162372718,0.977256567157592
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,42698,0.000181321530611575,0.00681248489564606,-0.0131711488648547,0.0135337919260778,0.978766354262487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTN,Neuroplastin,42346,-0.00019969821502377,0.00819187480342299,-0.0162557728297328,0.0158563763996853,0.980551788591562
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.000169949053460463,0.00729930433246047,-0.014476585545083,0.0141366874381621,0.981425028362269
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRX,Cone-rod homeobox protein,42357,-0.000172065658970322,0.0110590951053841,-0.0218478920655231,0.0215037607475825,0.987586652899039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,40080,3.82875455481278e-05,0.00319651420718233,-0.00622688030052923,0.00630345539162549,0.990443462030643
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.000103708089384487,0.0100486386310149,-0.0195916236274048,0.0197990398061738,0.991765679207372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANK2,Ankyrin-2,40116,7.72127725931227e-05,0.00768767956989805,-0.0149906391844071,0.0151450647295933,0.991986602378767
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,42346,-4.93550040252206e-05,0.00503059815803037,-0.00990932739376475,0.0098106173857143,0.992172259807145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,42474,2.54214862632379e-05,0.00299774258383224,-0.00585015397804795,0.00590099695057443,0.993233979944583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT2,Angiopoietin-2,42721,-3.29951686878568e-05,0.0039309361141204,-0.00773762995236384,0.00767163961498812,0.993302984526572
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HK2,Hexokinase-2,42357,2.25090438305297e-05,0.00287121300055646,-0.00560506843726014,0.0056500865249212,0.993745119752886
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,40449,0.000113483230668553,0.0154930173546589,-0.0302528307844628,0.0304797972457999,0.994155838424845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPE4,NXPE family member 4,40116,-2.37892857143142e-05,0.00351983102218004,-0.00692265808918719,0.00687507951775856,0.994607546588532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHIT1,Chitotriosidase-1,42699,-0.000107171207068433,0.0160514877428693,-0.0315680871830922,0.0313537447689553,0.994672890477263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,42346,9.07299703476236e-06,0.00328404434642941,-0.00642765392196688,0.00644579991603641,0.997795688280776
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-1.15501288258955e-05,0.00699390636765402,-0.0137196066094278,0.013696506351776,0.99868235898746
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHC1,SHC-transforming protein 1,40080,-3.89937948978999e-07,0.0123303209222297,-0.0241678189455192,0.0241670390696212,0.999974768027039
